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Abstract
The number of women experiencing opioid use disorder (OUD) in Canada has increased
exponentially. In Canada, healthcare is socialized and free for all citizens and often
medications like methadone are free as well, yet few individuals with OUD access
treatment services. The purpose of this study was to describe the lived experiences of
Canadian women with OUD who were receiving methadone treatment. Interpretive
phenomenology was used to investigate the treatment experiences of seven women with
OUD. The conceptual framework of self-care of chronic illness was used examine this
phenomenon. Data was analyzed using a seven step process of interpretive
phenomenological analysis. Four major themes emerged: learning how to be you again,
reaching out for help, finding your way to methadone, and going down the path of
methadone. Women’s experiences were influenced by family, friends, and healthcare
providers. Accessibility and self-determination were important factors in entering and
sustaining treatment. This study contributes to positive social change by providing
accurate information regarding women’s experiences with OUD and uncovering practice
changes that can attract and retain women in treatment.
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Chapter 1: Introduction to the Study
Globally, there has been an increase in the use, production, and importation of
opioids for non-prescription use (World Health Organization, 2018). Opioid deaths,
hospitalizations, and emergency department visits have increased exponentially
throughout Canada and the United States (Public Health Ontario, 2018; The Centers for
Disease Control and Prevention, 2016). In central Canada opioid abuse in has been
increasing dramatically for the past decade (Public Health Ontario, 2018). In fact, since
2016 more than 8,000 Canadians have died from opioid related causes; in Ontario, 734
people died from opioid related causes in 2015 (Canadian Institutes of Health Research,
2017).
Further, there is a significant increase in women experiencing opioid use disorder
(OUD) (Public Health Ontario, 2018). In Ontario, since 2015, opioid related emergency
department visits by women have increased from 1,808 to 2,972 in 2017 (Public Health
Ontario, 2018). Women are also dying at alarming rates (Public Health Agency of
Canada, 2018). Since 2015, death rates from opioids have increased from 253 to 352 per
year in Ontario women (Public Health Ontario, 2018). Though in comparison, more men
have died from opioids (Public Health Ontario, 2018). While fewer women have died
from OUD women are entering treatment sicker than men with more physical and
psychological illness and significantly higher rates of family psychiatric history
compared to men (Bawor et al., 2015).
Men and women also differ when it comes to treatment. Opioid substitutes, such
as methadone, are effective for the treatment of OUD (Rawson & Clark, 2017). Retention
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rates in the first year of methadone treatment are 70–80% (Peddicord et al., 2017). This
rate is comparable to suboxone, another form of opioid addiction treatment, which has a
60–90% retention rate in the first year (Peddicord et al., 2017). Methadone is effective at
low doses, with few adverse events and high abstinence rates in addicted individuals
(Barrio et al., 2017). However, compared to their male counterparts, fewer Canadian and
American women enter opioid replacement therapy (ORT; Belzak & Halverson, 2018;
Leone et al., 2017). Women also experience a shorter period from initial addiction to
treatment compared to men. However, they experience gender specific barriers to
treatment like raising children and socially determined gender roles that are inconsistent
with abusing drugs (Bach et al., 2015; Bawor et al., 2015; Leone et al., 2017). The
inconsistent findings of these studies indicate suboptimal understanding of how best to
support the successful treatment and recovery of women undergoing treatment for opioid
addiction.
There are several potential social implications for this study. Studying Canadian
women’s experiences of OUD and their choice for methadone as treatment needs to be
better understood to inform recovery care. What leads women to enter treatment and how
they persist is important information for healthcare providers and legislators.
Additionally, understanding women’s experiences may promote changes in negative
stigma associated with OUD. As treatment practices for OUD continue to evolve, this
investigation helps to shed light on the impact of treatment. This type of study may help
to better understand how the healthcare system and providers can facilitate treatment for
women; by targeting gender specific care requirements. More specific treatment can lead
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to more successful recovery for women with OUD. Each of these implications may have
a positive impact on healthcare and those utilizing the healthcare system for recovery.
This chapter will include a variety of sections previewing the study. First, the
background of the study will be presented with a summary of the research literature
related to the topic. This will be followed by an overview of the problem including the
gap in the literature that the study will help to address, the purpose of the study, the
research question, conceptual framework, the nature of the study, key definitions,
assumptions, delimitations and limitations of the study, and its significance to practice,
theory, and social change.
Background of the Study
The focus of this study was an understanding of women’s unique experiences
managing OUD with methadone. The number of women experiencing OUD is growing
(Public Health Ontario, 2018) as are the number of women dying from opioid overdoses
(Public Health Ontario, 2019). The need to attract women into treatment and support
persistence in recovery is essential and can only be accomplished with research efforts
that focus on women. When women enter treatment, they are sicker (Bawor et al., 2015),
significantly younger, more likely to participate in the sex trade, and use different drugs
in comparison to men (Palis et al., 2017). Women’s experiences in methadone
maintenance treatment (MMT) can include physical and psychological health disparities
as well as family history of psychiatric illness, social and emotional issues, and initiation
of opioid use through prescription (Bawor et al., 2015; Leone et al, 2017). These unique
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addiction issues for women speak to the need to investigate women, opioid use disorder,
and MMT from the female perspective.
Healthcare factors can challenge a women’s ability to access addiction care, and
women have unique addiction experiences that need to be considered in care practices.
Healthier women are more likely to engage in health-related behavior change (Marks &
Leukefeld, 2017), yet many women report not having health insurance coverage, a health
card, or access to health practitioners. Women in the perinatal period have additional
concerns for finding an obstetrician/gynecologist who has experience and is willing to
take on a pregnant woman on methadone treatment (Mattocks et al., 2017).
Subsequently, women have unique addiction experiences that need to be
considered in care practices. One study by Rubio (2016), investigates women’s unique
experience of OUD and MMT. However, the transferability of this study is limited due to
participants being from a small geographical location. The women in this study were
from a single clinic in Texas, USA where healthcare is mostly privatized. In Southern
Canada, where I plan to conduct this study, healthcare is socialized and access to
treatment easier. Therefore, Canadian experiences may be different than American
experiences regarding: the types of barriers experienced, adequacy of services, and even
treatment outcomes. The need for further studies with different groups of women, in
unique healthcare environments is warranted to understand the cultural, geographic, and
health system related factors; that may influence the lived experience of women entering
methadone treatment in other settings.
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This study is needed to provide insight into the experiences of women who have
chosen treatment with methadone for OUD. Such insights can help healthcare
professionals better understand why women enter and persist in treatment and may help
identify the best gender specific treatment modalities. The research conducted thus far
lends itself to greater knowledge of women’s addiction experience. Yet there is a lack of
clarity of factors that support or deter women into treatment in a Canadian context. This
lack of clarity makes understanding the process of first using opioids to treatment
difficult to understand. This study will address this gap in knowledge and is needed to
further the understanding of women’s unique needs when seeking treatment for OUD.
Problem Statement
Despite the global increase in opioids for non-prescription use, particularly in
women (Public Health Ontario, 2018; World Health Organization, 2018), there has been
little inquiry into the perspectives of women undergoing treatment for OUD. Rubio
(2016) investigated the lived experiences of women in the United States (U.S.) who were
accessing methadone as treatment for OUD. While the majority of participants expressed
positive perceptions regarding methadone treatment, a few expressed negative
perceptions such as that the treatment was simply exchanging one dependence (opioids)
for another (methadone) and that the financial cost was too high. However, these findings
may not persist if a study is conducted in a different context, as participants in the U.S.
treatment program were required to have private insurance or to self-pay. The
implications of this are that those who are considered the working poor and those who
cannot afford to pay out of pocket but are not eligible for public insurance, are missing
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from this study. A recent study found that approximately 40% of U.S. women with OUD
reported limited access to health care, and this lack of access to a clinic, healthcare
center, or doctor was identified as a major barrier to recovery (Marks & Leukefeld,
2017).
The healthcare system in the United States is mostly privatized and thus stands in
stark contrast to that of Canada’s socialized healthcare system. Canadian women have
access to physicians, nurse practitioners, and various other health services available
through a universal healthcare system, which removes the economic barrier to access
(Bach et al., 2015). In Canada, all women are allotted the opportunity to access ORT, and
therefore a broader demographic of women can be included in an investigation. Many
women in Canada are not required to pay for methadone treatment and may not have the
same perceptions of methadone treatment. The implication is that Canadian women may
experience different barriers and facilitators to treatment initiation and retention than
women in the United States due to differences in the context in which healthcare is
delivered. Nonetheless, fewer women than men in both Canada and the United States
enter treatment programs that use ORT (Belzak & Halverson, 2018; Leone et al., 2017).
Thus, it is unknown if such differences in access affect women’s experiences of
methadone treatment.
Opioid use disorder is an increasing public health concern for both the United
States and Canada. A substantial proportion of those seeking treatment for opioid use
disorder are women. Yet research that elicits the perspectives of women receiving
methadone treatment is limited in the literature. The potential impact of socialized

7
healthcare on the experiences of women who have accessed methadone treatment has not
been studied.
Purpose of the Study
The purpose of this study was to describe the lived experiences of women with
OUD who are receiving methadone as their treatment of choice. By understanding their
experience more fully, from their perspective, nurses and healthcare professionals will be
able to provide women with individualized health promotion strategies and treatment
(Rubio, 2016). This can provide insight that leads to further research and eventually to
better outcomes for women experiencing OUD, which may improve their quality of life.
Interpretive phenomenological qualitative methodology was used to elicit insights and
experiences from the participants through interviews and observations.
Research Question
What are the lived experiences of Canadian women with opioid use disorder who
choose methadone for treatment?
Conceptual Framework
The conceptual framework of self-care of chronic illness (Riegel et al., 2012) was
used examine the phenomenon under investigation. The concept of self-care is important
when working with addiction because addiction is considered a chronic illness that
requires ongoing care, often on an outpatient basis (Ausili et al., 2014). The foundation of
this framework is based on studies of chronic illnesses like heart failure (Riegel &
Dickson, 2008). The theory involves three main components: self-care maintenance, selfcare monitoring, and self-care management (Riegel et al., 2012). Self-care is defined as
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health promoting practices and managing illness. The concept of self-care maintenance is
defined as behaviors used by patients to maintain physical and psychological stability.
Self-care monitoring is observing oneself for changes in signs and symptoms. Finally,
self-care management is person’s response to signs and symptoms when they occur
(Riegel et al., 2012). The factors influencing self-care are experience and skill,
confidence, habits, motivation, cultural beliefs and values, functional and cognitive
abilities, support from others and access to care (Riegel et al., 2012). Each of these
concepts within the self-care of chronic illness theory can be applied to women
experiencing OUD and receiving methadone treatment.
The concepts within the self-care for chronic illness framework can be thoroughly
explored in interviews using open ended questions, a technique synonymous with
phenomenology. Women’s experiences with self-care maintenance, self-care monitoring,
and self-care management relate to women’s OUD self-care. OUD is a chronic illness
like those used to develop this framework. A more detailed analysis of how this theory
has been applied will be given in Chapter 2. By eliciting women’s perspectives of OUD
and treatment, the concepts within the framework provided a lens to better understand
their experiences.
Nature of the Study
The use of a qualitative, phenomenological methodology provided an opportunity
to explore the lived experience of women with OUD from first experiencing addiction to
treatment with methadone. This method explores a common theme or experience among
a group of individuals (Creswell & Poth, 2018). This methodology was most appropriate
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to address the problem statement and research question. In qualitative tradition, the
approach is broad and considers truth and knowledge to be constructed by individuals
and groups of individuals (Rudstenom & Newton, 2012). Understanding the lived
experience of women living with OUD and treatment calls for a subjective approach that
honors their individual experiences, consistent with qualitative research. Additionally, the
use of words rather than numbers and measurements are appropriate for answering the
research question (Creswell, 2014).
There are several types of phenomenological investigations (Sloan & Bowe,
2014). Husserl’s descriptive phenomenology is used to assert that the investigator can
transcend the phenomenon to understand its essence that occurs through individual
interpretations. Hermeneutic or interpretive phenomenology is like descriptive
phenomenology but also considers temporality and the relationship of individuals to
existence as defining aspects (Sloan & Bowe, 2014). Once a description of what has
occurred and how it is experienced is determined, descriptive phenomenological
investigation ceases. However, interpretive phenomenology focuses on meaning and
interpretation (Patton, 2015). Understanding the interpreted meaning of the experience to
the individual, searching for themes interpretively through out the data, and taking an
unstructured approach to data analysis is key to utilizing the interpretive
phenomenological method. Interpretive phenomenology was the ideal approach for my
study because I wanted to develop a greater understanding of the phenomenon of interest
and make sense of the experience in consciousness (Patton, 2015). Further, this approach
helped to understand individual and collective interpretations of experiences by
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supporting the identification of themes in responses by participants. These themes can
contribute to evidenced-based care provision to women experiencing opioid use disorder
and methadone treatment.
Definitions
Addiction: A primary chronic disease of brain reward, motivation, memory, and
brain circuitry. When there are problems with the circuitry it is manifested in a variety of
ways leading to pathological pursuing the substance for reward or relief. The
characteristics of addiction include inability to abstain, changes in behavior, cravings for
the substance, reduced awareness of the negative effects on the self and others, and an
unfitting emotional response (American Psychiatric Association, 2013).
Harm reduction: Attempts to reduce the adverse consequences of substance use
without requiring the individual to completely abstain from using the substance. Harm
reduction can include but is not limited to access safe injection sites, availability of
naloxone, and access to various medications (Vearrier, 2019). Women in the study have
chosen methadone, as a harm reduction strategy, to combat opioid use disorder (OUD).
Methadone maintenance treatment (MMT): A long acting opioid used in medical
treatment of opioid addiction. Methadone helps prevent feelings of withdrawal and
manages associated symptoms. Treatment helps individuals return to normal life; and
prevents risky behavior associated with drug seeking. The optimal standard of care in
Canada for opioid use disorder in Canada includes MMT, counseling, and other supports
(Centre for Addiction and Mental Health, 2019a).
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Opioid replacement therapy (ORT): A well-understood and researched method of
pharmacological treatment for opioid addiction or dependence. A variety of agents are
used in ORT, including, but not limited to methadone, buprenorphine, naltrexone and
slow-release oral morphine. Methadone is the most frequently used form of ORT in
North America (Bell, 2014). Each of the women participating in the study was actively
receiving methadone for opioid use disorder.
Opioid use disorder (OUD): The problematic use of opioids causing serious
impairments or suffering. Misusing prescription opioids or accessing them illegally, for
their intense, pleasurable effects or to avoid the effects of withdrawal, are elements of the
disorder (American Psychiatric Association, 2013). This misappropriation of opioids can
have serious or even fatal outcomes. OUD is also known as opioid addiction. Women in
the study were experiencing OUD.
Recovery: An ongoing process of change where people attempt to maintain and
improve their health by striving to not misuse substances. Recovery is based on the belief
that individuals can overcome their substance abuse. A variety of treatments can be
employed in recovery including but not limited to professional clinical treatment,
medications, support from family and friends, faith-based approaches, and peer support.
During recovery, individuals commonly experience setbacks, in the form of relapse,
despite prior growth and improvements. For this reason, it is essential that these
individuals are resilient and continue on with their recovery despite setbacks. Recovery is
a holistic process involving a variety of individuals, treatments and outcomes (Substance
Abuse and Mental Health Service Administration, 2010).

12
Assumptions
Assumptions related to the investigation of women experiencing OUD who
choose methadone as treatment include that the women participants want to recover. This
assumption was necessary because they are acting on their own free will, which has led
them to recovery. How they get to recovery and their experiences leading up to it are
more relevant if they are choosing to get help. Additionally, how women persist in
recovery is more informative if they are choosing to be in recovery rather than if they are
being forced to participate. Even if participants feel as though they have no choice to
participate due to parole issues or child protective services (CPS), if they are choosing to
come and participate in recovery, their responses are still relevant.
Another assumption was that women are participating in recovery to improve
their lives. This was assumed because otherwise ongoing participation in methadone
treatment is a moot point. How life improvement is defined is subjective to the individual
women and may be expressed in their responses. Examples of life improvements may be
holding a job or improving relationships with others.
The final assumption was that the women provided an honest description of their
experience from their perspective without intent to mislead me. This assumption was
necessary because the insights and experiences of these women provided information that
can influence the current and future practices of women’s addiction recovery care. If the
participants intended to mislead me, the analysis of responses would be inaccurate and
inappropriately affect recommendations and suggestions for practice that come from the
research. Women were asked to voluntarily participate and had the right to withdraw
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from the study at any time. Each woman was made aware of this; therefore, there was no
reason to misrepresent their experiences. Each of these assumptions were believed to be
true but cannot be demonstrated as such.
Scope and Delimitations
The research problem included a variety of issues that indicate a need to develop a
better understanding of women’s specific issues with OUD. Gaps in knowledge include
how women begin to use, experience, and treat their disorder. By eliciting women’s
experiences, research can begin to fill these gaps and direct future care.
Adult women were chosen to participate in the study because most women
reporting having OUD are adults, and individuals must be an adult to receive methadone
in central Ontario. It would not have been reasonable to include children. Further, women
are a unique group that is largely missing from the literature on OUD and methadone
treatment. Currently, most studies focus on men or have a much greater proportion of
men, compared to women participating in their studies.
Many theories and conceptual frameworks were considered but not included in
the study due to a lack of alignment with the research question. Other qualitative
approaches to research were considered including ethnography, which would have meant
studying women who suffer from OUD as a culture sharing group, but this was not the
focus of the research question. The research question did not focus on finding
contextualized cultural meaning within this group but rather understanding their lived
experiences is the aim. Narrative research was also considered, but its focus is on stories
that unfold collaboratively with the researcher rather than the experiences told directly by
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the individual (Creswell & Poth, 2018). None of the other qualitative approaches were
considered because they did not align with the research questions as closely as
interpretive phenomenology.
Unlike quantitative studies, generalization of research findings is not the goal of
qualitative studies. In qualitative research, the goal is to make the research as descriptive
as possible, including the outcomes and context to enable readers to determine if the
findings apply or transfer to other contexts, in part or whole (Ravitch & Carl, 2016). By
using thick descriptions including detailed accounts of outcomes and contexts, the reader
can determine the transferability for additional purposes.
Limitations
Potential difficulties existed in conducting this research study. Finding sites,
participants, and maintaining objectivity were major limitations, challenges, and barriers
of this research project. Some community addiction clinic sites refused to participate in
the study. Two addictions treatment centre locations, with their accompanying
pharmacies, elected to participate in allowing for recruitment posters to be posted and
space for private interviews to occur but did not have their own institutional review board
(IRB). But IRB approval from Walden University was deemed enough for these
institutions to allow me to recruit and interview at their locations. Recruiting participants
willing to be interviewed and audiotaped was also challenging due to the personal nature
of participants’ responses, potential illegal activity, and concerns with child welfare
involvement, making data saturation difficult (Moser & Korstjens, 2018). This limitation
was mitigated by using multiple sampling methods and informing participants upfront
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that their identity will be masked. Another challenge was maintaining a professional
distance from the data due to the personal nature of what was expressed by participants.
Keeping a research journal gave me the opportunity to self-reflect on my thoughts,
feelings, and practices throughout the research process (Ravitch & Carl, 2016).
Potential issues within the methodology also existed. In qualitative research, the
goal is not to generalize the findings to be applied to other people in other settings but to
transfer findings where appropriate (Ravitch & Carl, 2016). The validity criterion of
transferability was addressed by providing thick descriptions of the data and contexts
(Ravitch & Carl, 2016). Consumers of the research can determine transferability to their
context based on the descriptions. The issue of dependability is addressed within the
study by providing discussion to support the data collection methods of interviews and
journal keeping. How these methods map to the research question is also conferred
(Ravitch & Carl, 2016). Although these limitations did exist, they were addressed within
the study.
Significance of the Study
This study fills the identified gap in current research knowledge by shedding light
on the topic of Canadian women with OUD who are using methadone treatment, a
population that is growing (Marks & Leukefeld, 2017; Public Health Ontario, 2018). No
published studies were found that considered opioid use disorder and methadone
treatment from the perspective of Canadian women.
This study also has professional significance to nursing. By deepening the body of
nursing knowledge, nursing professionals can understand how to positively influence
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women with OUD who are receiving methadone therapy. Current knowledge is key to
providing the most relevant care related to women’s addiction. Study results can also
inform future studies that will continue to grow the body of knowledge for the profession.
This study promotes positive social change by distributing accurate information
that gained from the study findings. By producing accurate knowledge of women’s
experiences with OUD and methadone treatment, negative stigma associated with it can
be addressed. This information can inform healthcare professionals and society to
establish a more accurate and empathetic understanding of women with OUD.
Significance to Practice
Nurses and other healthcare professionals are in direct contact with women who
are experiencing OUD and are in a unique position to provide support and individualized
care, encouraging them to enter treatment and to persist in recovery. Research indicates
that current practices are inadequate to meet needs of this population of women (Belzak
& Halverson, 2018; Leone et al., 2017), but nurses, as advocates, can influence practice
changes. The study provides insight on the factors that women feel support them in
accessing and persisting with methadone treatment over time. Relapse is common in
OUD and brings with it the risk of overdose and death (Stone et al., 2018). Nurses can
adapt their practices to meet these needs and advocate for change that may improve
current statistics for women with OUD.
Significance to Theory
This study provides knowledge that is missing from the current body of literature.
By conducting research into women’s experiences of OUD and methadone treatment,

17
addictions research is furthered. As with all research, the findings from this study elicit
more questions and further areas that require investigation. This study utilized the selfcare for chronic illness framework in a way that has not been done in previous studies.
No research exists using this framework to provide a lens to interpret findings of research
with individuals with OUD or any type of addiction or mental health issue. Therefore,
this research contributes to theory by adding to current knowledge and developing areas
of future study.
Significance to Social Change
Changes in addiction practices for women who are experiencing opioid use
disorder and utilizing methadone treatment contributes to positive social change. Changes
to inadequate care practices, related to the findings of the research, can benefit women
and society. Current practices do not address the unique needs of woman (Raheimi et al.,
2018), and research that accurately exposes these needs can support practice change.
Once needed practice changes have been identified, organizations can reexamine their
individual practices and consider if the care they are providing is optimal. Similarly, this
research exposes whether aspects of the healthcare system influence women’s
experiences with methadone treatment. Information related to these aspects may
contribute to changes in public policy related to women’s addiction care. This social
change can effectively support women’s care needs on a larger scale. Research with
women with OUD who choose methadone for treatment can begin to evolve to become
more comprehensive and reflective of the needs that women themselves see as essential,
drawing more women into treatment and retaining them.
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Further, women are still overwhelmingly the central caregivers for their families
(Claffey & Mickelson, 2009) and important contributors to household incomes (Statistics
Canada, 2018); thus, improving OUD treatment for women has the potential to produce
positive changes in society that reach beyond those receiving care. Future studies can be
initiated based on the findings of this research that can contribute to ongoing evaluation
and identification of MMT practices. However, further research with each unique
population is necessary. Ensuring that women in Canada and other locations are receiving
evidence-based care contributes to positive social change by improving health outcomes
and reducing harm, including death from overdose (Rawson & Clark, 2017).
Summary
This chapter provided an introductory review of the current literature related to
women’s experiences of OUD and their choice of methadone for treatment. The problem
is that despite growing numbers of women with OUD in both Canada and the United
States, fewer women are consistently entering treatment when compared to men. The
reasons for this problem are not well understood as there is currently no research that
considers the personal perspective of the experiences of Canadian women with opioid
addiction. This study describes the lived experiences of women with OUD who are
receiving methadone as their treatment of choice in Canada. In this chapter, the self-care
of chronic illness model was also explained as well as the choice of interpretive
phenomenology, which was appropriate based on the research question. The key
constructs of this study were also delineated as ORT, OUD, MMT, harm reduction and
recovery. Assumptions underlying this study include that women are providing an honest
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account of their experiences and that they wish to improve their lives. The scope and
delimitations of the study were provided to give boundaries to the work. The study is
significant in that it expands our current knowledge of addiction care for women. Finally,
this study contributes to positive social change by encouraging further research that could
result in policy changes regarding the care and treatment of women with OUD. By
furthering knowledge of OUD, stigma may be mitigated when realities of women’s
experiences are exposed.
Chapter 2 provides a more comprehensive review of the literature related to
women experiencing OUD and their choice of methadone as treatment. Additionally, the
literature applying the conceptual framework of self-care of chronic illness is explored in
the following chapter.
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Chapter 2: Literature Review
Introduction
In North America, there is growing concern over the dramatic increase in the
misuse of opioids leading to OUD (Bruneau et al., 2018). Deaths, hospitalizations, and
emergency department visits have increased exponentially over the past decade (Public
Health Ontario, 2018; The Centers for Disease Control and Prevention, 2016). In Canada,
more than 8,000 people have died related to opioid causes since 2016 (Canadian
Institutes of Health Research, 2017). Further, the number of women with OUD is
increasing (Public Health Ontario, 2018). Although men experience OUD more
frequently, women are entering treatment sicker and have unique barriers compared to
their male counterparts (Bawor et al., 2015). Yet women’s experiences with OUD are
sparsely represented in the literature.
Differences exist in men’s and women’s experiences with OUD including
demographics, health disparities, and barriers to treatment (Bawor et al., 2015; Palis et
al., 2017). In comparison to men, women have an increased prevalence of psychological
health issues requiring treatment (Bawor et al., 2015; Leone et al., 2017). Women’s
emotionality is an important factor to consider such as feelings of fear, worthlessness,
and power (Hanpatchaiyakul et al., 2017), which contribute to understanding women’s
psychological well-being. Women’s psychological health contributes to their addiction
experiences. Women’s unique experiences must be considered in future research to
provide them with optimal assessment and treatment of OUD. Further research should
also focus on access to healthcare services, factors that support women in recovery and
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interpersonal relationships (Marks & Leukefeld, 2017) as well as the factors that led to
their addiction and decision to seek treatment (Rubio, 2016). Rubio (2016) did conduct a
qualitative study examining several factors and reported themes that included women’s
journey of addiction, the tipping point, and perceptions of methadone (Rubio, 2016).
However, limitations of this study include that it was conducted in the United States,
limiting the transferability to other populations especially one with a different type of
healthcare system like Canada.
Options exist for OUD treatment like opioid substitution therapies, which are a
harm reduction treatment, but women access treatment at low rates. Medications such as
methadone are known to effectively treat OUD and improve health outcomes (Rawson &
Clark, 2017). Though other substitution therapies exist including buprenorphine/naloxone
and naltrexone, methadone continues to be the most preferred opioid substitution
therapies in Ontario, Canada (Kurdyak et al., 2018). In the United States, healthcare
including addictions treatment are privatized; however, in Canada the healthcare system
is socialized, making care for addictions virtually free. Yet women access treatment at
low rates. However, little is known about women’s experiences of OUD and nor their
treatment with methadone in Canada.
In the United States, privatized healthcare limits accessibility to women who may
desperately need these services yet do not have insurance or the ability to pay for
addictions out of pocket. Taking place in a country with socialized healthcare, this study
addresses this gap by including the perspectives of women across all socioeconomic
backgrounds. The purpose of this study was to describe the lived experiences of women
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with OUD who were receiving methadone as their treatment of choice. By understanding
their experience more fully, from their perspective; nurses and healthcare professionals
can provide women with individualized health promotion strategies and treatment
(Rubio, 2016). This study provides insight for further research and better outcomes for
women experiencing opioid use disorder like improved quality of life. Finally, outcomes
of this research enable our understanding of the facilitators and barriers to methadone
treatment. This will assist healthcare professionals to support women who chose OST by
supporting facilitating factors and mitigating barriers to treatment.
Major sections of this chapter are organized chronologically to build
understanding of the issues of women and opioid use disorder. These sections include the
literature search strategy, pathophysiology of opioids and the epidemiology of opioid use
disorder, treatments for opioid use disorder, and the current state of OUD nationally, and
gender differences in OUD. Each section will provide detailed evidence, analysis, and
synthesis of the relevant literature.
Literature Search Strategy
An exhaustive search of the literature was performed on the topic of women
experiencing opioid addiction who choose methadone for treatment. The databases
searched included CINAHL and MEDLINE Combined search, Cochrane Review and
ProQuest Health and Medical Collection. In addition, a Google Scholar search was
conducted to look for additional relevant articles and evidence. The search terms opioid
addiction, opioid abuse, opioid use disorder, drug addiction, methadone, heroin,
experiences, women, and female were explored in the databases. Combinations of these
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search terms in each database included women and opioid addiction, women and opioid
abuse, women and opioid use disorder, women and methadone, women and heroin and
methadone, women and drug addiction, and female and opioid use disorder. The
timeframe for the search was 2014 to 2019. The initial search returned 158 articles. I
chose to include articles that directly related to the research question. Research that was
conducted in foreign countries other than the United States and Canada were not included
due to concerns of applicability of their findings. Articles that focused on pregnancy and
birthing or included women who were incarcerated were also excluded from the literature
review. However, articles that considered the experiences of having children and
incarceration as they relate to methadone treatment and opioid addiction were included.
The total number of relevant articles to be included in this literature review is 12.
Conceptual Framework
The conceptual framework for this study is derived from the middle range theory,
self-care of chronic illness (Riegel et al., 2012). The definition of self-care is a process of
maintaining health through health promoting practices and managing illness (Reigel et
al., 2004). Self-care of chronic illness theory can be applied to a host of chronic
conditions, including those in mental health like opioid use disorder [OUD] (Riegel et al.,
2012). Self-care is an essential element of chronic illness that is required to achieve
optimal health outcomes (Riegel & Dickson, 2008). Substance use disorder (SUD) is
considered a chronic illness that requires ongoing treatment including medication and
behavioral interventions, which includes self-care (Morse, 2018). The conceptual
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framework can be appropriately applied to patients with OUD, as it is a chronic medical
condition that is influenced by self-care practices.
The theory of self-care of chronic illness evolved from the previously identified
situational theory heart failure self-care (Riegel & Dickson, 2008). The situation-specific
theory of self-care of heart failure in chronic illness along with the corresponding SelfCare of Heart Failure Index formed the theoretical base for self-care of chronic illness
theory (Reigel & Dickson, 2008). In the situation specific theory, patients were
challenged to care for themselves in a manner that is consistent with the care
requirements of their chronic heart condition. Similarly, patients with opioid use disorder
are required to care for themselves consistent with the requirements of their chronic
condition, which may include counselling and medication assisted treatment like
methadone (Morse, 2018). The theory of self-care of chronic illness was also influenced
by Dorthea Orem’s grand theory of self-care (Orem, 1991). Orem’s theory considers
broader self-care activity including self-care needs, abilities to perform self-care, and the
role of nursing. Riegel et al. (2012) focused on self-care of chronic illness and the role of
all professionals in promoting self-care. Specifically, these authors investigated the
processes and behaviors in those dealing with chronic conditions (Riegel et al., 2012).
Self-care of chronic illness theory has been applied in a variety of contexts such
as heart failure, diabetes mellitus, and caregiver contributions to self-care. Initially, the
theory was derived from practice caring for individuals with heart failure. Difficulties
having to perform self-care that is consistent with heart failure were evident for these
patients. Self-care has been found to be a major contributor to improving heart failure
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outcomes including reducing hospitalizations and death in patients with heart failure
(Jaarsma et al., 2013). In another context, complex self-care practices are required in
individuals with diabetes mellitus (Ausili et al., 2017). Researchers developed a scale
based on the middle range theory of self-care of chronic illness called the Self-Care of
Diabetes Inventory. The tool was found to be valid and reliable in measuring self-care in
individuals with type one and two diabetes. Recently, another situation specific theory
has materialized from the continued study of self-care called the situation specific of care
giver contributions to self-care (Jaarsma et al., 2013). Correspondingly, the Caregiver
Contribution to Self-Care of Heart Failure Index was developed.
Self-care of chronic illness theory is a middle range theory that explains and
describes the process of individuals and their families maintaining health while managing
symptoms related to the chronic illness (Riegel et al., 2012). Middle range theories focus
on a narrow scope of nursing reality and include a limited number of concepts (Peterson
& Bredow, 2017). Concepts within the framework of self-care of chronic illness include
self-care maintenance, self-care monitoring, and self-care management (Riegel et al.,
2012). Each of these concepts in the theory applies to OUD.
The first concept in self-care of chronic illness theory is self-care maintenance.
This concept requires adaptation to changes that occur in experiencing a particular
chronic illness. Often, required changes involve recommendations by healthcare
professionals (Riegel et al., 2012). In OUD, changes can include taking medication such
as methadone, naltrexone, or buprenorphine; attending counselling sessions; coping with
withdrawal symptoms; and avoiding substance use triggers, such as people and places
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where previous opioid use has taken place (Morse, 2018). Reflecting on these changes
can assist in determining the ongoing effectiveness of the changes (Riegel et al., 2012).
Adhering to self-care maintenance practices facilitates optimal health outcomes for
patients with chronic illnesses.
Self-care monitoring is the second concept within the self-care of chronic illness
theory. Three criteria must exist for self-care monitoring to be successful (Riegel et al.,
2012). The three criteria include the possibility of clinically significant changes, reliable
detection of changes and finally, and a reasonable response must be conceivable. Selfcare monitoring includes being attentive to the body, known as body listening, and
ongoing methodical monitoring of physical and psychological experiences (Riegel et al.,
2012). In OUD, self-care monitoring can take the form of blood, urine, and vital sign
assessments. Additionally, to prevent relapse monitoring emotions and thoughts can be
essential for those experiencing OUD (Sancho et al., 2018). The goal of self-care
monitoring is to be vigilant and recognize when changes occur due to the chronic illness.
When a change is identified and understood, decisions can be made as to how to proceed
to act on the change, including seeing a healthcare provider (Riegel et al., 2012). Selfcare monitoring is the link between the other two concepts within the theory of self-care
of chronic illness (Riegel et al., 2012). Self-care monitoring requires attentiveness,
evaluation, and decision-making.
The third and final concept in the framework is self-care management. When
signs and symptoms occur that indicate a change in the chronic condition, action is
sometimes required. When an individual decides to act, treatment occurs and evaluation
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of treatment effectiveness is needed (Riegel et al., 2012). A healthcare professional may
be required in response to the sign or symptom to facilitate treatment. An individual with
OUD may decide to seek assistance from a healthcare provider when experiencing
withdrawal symptoms or environmental triggers. Relapse can occur when the response to
the sign or symptom is inappropriate like using opioids to relieve withdrawal symptoms.
Therefore, self-care management requires decision-making and action.
Each of the three concepts within the self-care of chronic illness theory work
together and independently, promoting health and managing chronic illness (Riegel et al.,
2012). The activities and behaviors within each concept are dynamic; they do not occur
in a linear order, nor will they necessarily occur. The processes that influence these
concepts and underlie self-care are decision-making and reflection. First, decisionmaking is a complex process in which an individual is required to choose a course of
action in self-care (Riegel et al., 2012). Often, the individual must make decisions
quickly and with incomplete information. It is important to consider decision-making due
to the potentially dangerous outcomes of some self-care decisions. When experiencing
symptoms of withdrawal, individuals taking methadone for OUD may consider using
opioids, which can lead to overdose and possibly death due to excessive amounts of
opioids in the body (Sordo et al., 2017). Otherwise, they may seek assistance from a
healthcare provider for treatment as part of the process of naturalistic decision-making
(Klien, 2008). Potentially faced with such circumstances as losing children to protective
services, losing a job, or death, individuals must decide how to respond. Serious
situations can be stressful, confusing and with competing outcomes, yet decisions must
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be timely (Klien, 2008). Decision-making is an essential process in determining the
outcome of self-care in chronic illness.
The second process affecting self-care is reflection. Reflection promotes
knowledge development and helps to determine the quality and effectiveness of self-care
(Fearon-Lynch et al., 2019). When individuals make decisions they can be sufficient or
insufficient, purposeful or unintentional, reasoned and reflective, or automatic and
unobservant (Riegel et al., 2012). The quality of self-care is dependent on the actions and
decisions by the individual. For the individual who has little knowledge or consideration
of their self-care, poor quality of self-care can result. The same outcome occurs for the
individual who has sufficient knowledge and reflection yet who chooses not to participate
in adequate self-care, resulting in poor self-care. For the individual who performs selfcare adequately but is not reflective, education is required to improve their understanding
of the rational for care. Ideally, the individual is both reflective and knowledgeable with
self-care. This occurs when they have received adequate education and know when signs
and symptoms warrant assistance from a healthcare provider (Riegel et al., 2012).
Accordingly, when individuals with OUD receive adequate education, are reflective, and
perform sufficient self-care, the outcome is ideal. Both decision-making and reflection
influence self-care and have the capacity to improve care when these processes are done
effectively.
Further, three assumptions exist within the theory of self-care of chronic illness.
Assumptions are beliefs that are taken for granted and underlie the theory of a
phenomenon (McEwen & Wills, 2014). The first assumption is that there are differences
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between general and illness-specific self-care practices (Riegel et al., 2012). Examples of
general self-care practices can include brushing your teeth or having annual physical
exams. Illness specific self-care practices are restrictive and influenced by others such as
healthcare professionals (Riegel et al., 2012). In someone with OUD, these practices can
include vaccinations for hepatitis A and B and having infectious disease testing
completed (Perlman, et al., 2014). The second assumption is that decision-making
requires focus, thinking, memory, and understanding (Riegel et al., 2012). To make
reasoned decisions, individuals need to be able to consciously consider options and
alternatives to make the most informed decision. The third and final assumption indicates
that conflict can exist in self-care when multiple comorbidities exist (Riegel et al., 2012).
Different healthcare providers may offer advice that stands in opposition from one
another, making them difficult to integrate. An individual with OUD may receive a
prescription from a general practitioner for a benzodiazepine medication, which can
cause further central nervous system depression (U.S. Food and Drug Administration,
2017); however, they received information from their addictions healthcare practitioner
to refrain from taking these types of medications while on methadone. Assumptions of
self-care of chronic illness state that illness specific care is unique and prescriptive and
requires advanced cognitive processes for decision-making. Having multiple
comorbidities can further complicate self-care.
Additionally, seven testable propositions of the theory of self-care of chronic
illness exist (Riegel et al., 2012). The first proposition is that there are similarities within
different chronic illnesses. Next, quality of self-care is influenced by previous
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experiences. Furthermore, limited reflection in self-care limits the complexity of
situations that an individual can handled. In addition, knowledge deficits,
misunderstandings and misconceptions, negatively influence self-care. The proposition of
self-care monitoring is required to identify changes in signs and symptoms leading to
appropriate action. Finally, evidenced based self-care results in better health outcomes
(Riegel et al., 2012). Each of these seven propositions can be tested in studies about
chronic illness self-care.
Self-care outcomes can be intended or unintended. Intended outcomes include
chronic illness stability, adequate management of symptoms, and improved quality of life
(Riegel et al., 2012). However, unintended outcomes can also be important. Managing
self-care can lead to a decrease in hospitalization (Boyde et al., 2018), healthcare costs,
and death (Abe et al., 2019). This is an important finding considering the current opioid
crisis where healthcare expenditures and the death rate are climbing dramatically
(Canadian Centre on Substance Use and Addiction, 2018; Government of Canada, 2018).
Potentially, self-care is an important component to reduce healthcare spending and reduce
the number of avoidable deaths occurring due to opioid related causes. Other unintended
outcomes include seeking healthcare prematurely due to hypervigilance; and avoiding
seeking healthcare due to over confidence in the ability to manage signs and symptoms
independently (Riegel et al., 2012). These unintended factors can lead to additional
concerns of healthcare costs and death contributing to the already overwhelming issues in
chronic illnesses like OUD.
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Self-care is a complex process involving a variety of barriers and facilitators.
Factors that influence self-care include: experience and skill, motivation, cultural beliefs
and values, confidence, habits, functional and cognitive abilities, support from others and
access to care (Riegel et al., 2012). Previous experience with self-care can provide a
foundation to compare future outcomes (Riegel et al., 2012). As well, previous
experience can contribute to developing skills to perform self-care activities. Motivation
is required to perform actions. It can be intrinsic, driven by internal drivers to achieve
self-care (Kruglanski et al., 2018). Whereas, extrinsic motivation involves the desire to
achieve a specific outcome. Both factors influence motivation to perform tasks like selfcare. Culture can also influence the value of performing self-care activities (Riegel et al.,
2012). Some cultures may value independence while others value providing and
receiving care when there is a need. When an individual performs self-care, confidence
positively influences ability (Riegel et al., 2012). Further, the more confident someone is,
the more likely they will be to act; when signs and symptoms are recognized (Grafton et
al., 2017). Habitual practice of a self-care routine can positively influence behavior.
Those who adopt imposed self-care behaviors may have better healthcare outcomes
(Riegel et al., 2012). Self-care practices are often complex. They require that individuals
have substantial and sustained functional and cognitive abilities to perform them
effectively, especially for those with complex chronic conditions (Parham et al., 2017).
Self-care is reasonably performed by both self and often in collaboration with others.
When family and friends participate in self-care communication, decision making and
reciprocity, it is identified as ‘shared care’ (Sebern et al., 2016). A final factor affecting
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self-care is access. Access to healthcare providers is essential in managing chronic
illness. Without access to appropriate healthcare providers, individuals may seek
alternative sources of information, which may or may not provide evidenced based
interventions and treatments (Riegel et al., 2012). Reasons for lack of access may vary
including insurance, cost, and geographic location (Riegel et al., 2012). Self-care is a
complex multi-faceted process.
Individuals employ a variety of processes, when attempting to manage self-care.
First, they need to be able to attentively be aware of and determine changes in their
health; in order to intervene appropriately in each situation. Further, they need to
continue the course of care that is often determined by healthcare professionals. Having
the capacity to make decisions during care and reflect on the care given is essential to
achieve the optimal outcomes in chronic illness self-care. Outcomes can be intended or
unintended. Individuals must consider a variety of factors that influence these outcomes.
Having the motivation and expertise to perform self-care confidently, the support of
others and access to care influences the quality of self-care performance. At times, selfcare is not possible and shared care must be sought. In this circumstance individuals work
together to achieve self-care goals. Individuals must consider each of these aspects, when
determining self-care in chronic illness. What is missing from this literature is how the
theory of Self-Care of Chronic illness applies to various types of chronic illness, like
mental health and addictions. This type of chronic illness requires unique methods of
self-care. In my study, I will be able to use this conceptual framework to provide a lens
through which to understand the experience of women with OUD who choose methadone

33
as treatment. In this study, how women experience and perform self-care is illuminated.
How they understand, monitor and treat their chronic illness will shed light on themes to
help understand their unique experience. Below is an application of the Theory of SelfCare of Chronic Illness in women with OUD.
Women with OUD, who choose methadone as treatment, attend the addictions
clinic or pharmacy to receive their oral dose of methadone every one-to-seven days. The
clinics may offer counselling services to help those with OUD cope with triggers, answer
questions and work through personal issues (self-care maintenance). They are required to
do laboratory blood draws, urinalysis and vital sign measurements. Women are
encouraged to pay attention to how they are feeling; whether they are experiencing
withdrawal symptoms or having difficulty coping with emotions. It is essential they be
able to recognize these changes; in order to react appropriately by self-help or seeking
help from others, including healthcare professionals (self-care monitoring). Once the
woman recognizes changes in her health, she can determine the needed actions. The
woman can consider her options and act (self-care management). Women will have the
opportunity to express themselves openly, which may facilitate understanding of the
processes that underlie self-care; and factors influencing each individual woman. Using
their own voice and personal stories, women elaborate on the outcomes of their efforts in
caring for themselves. Self-Care of Chronic Illness theory provides a lens to view the
research topic, facilitating understanding of women’s unique experiences with OUD and
methadone treatment. Further, this study assists in evaluating the validity and reliability
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of this theory, by applying it to chronic illness, other than heart failure and diabetes care,
which have been identified in the literature.
Literature Review
Background
Pathophysiology of Opioids
Opioids are a broad group of powerful narcotic pain relievers that are available by
prescription or purchased illegally (Centre for Addiction and Mental Health, 2019b). In
their natural form, they are produced from the poppy plant as opium. Some examples of
natural source opioid medications are codeine and morphine (Centre for Addiction and
Mental Health, 2012). Opioids can be synthetic, as with methadone or fentanyl. They can
also be semi-synthetic, as with hydromorphone or hydrocodone. In the body, all types of
opioids interact with opioid receptors on cells located in the brain, spinal cord and other
body organs (National Institute of Health, 2018). This activity stops the pain sensation
from the brain to the body and simultaneously produces dopamine, a neurotransmitter
associated with feelings of pleasure and euphoria. The pleasurable feelings produced by
taking opioids contribute to their abuse (National Institute of Health, 2018). As users
experience pleasurable feelings from opioids, the desire to repeat this experience is
reinforced. Opioids in synthetic or natural form effectively relieve pain and increase
pleasure resulting in pain control and the likelihood of abuse.
Historically, opioids have been used to treat a variety of conditions. Cough,
diarrhea, addiction, and commonly, acute and chronic pain can be effectively treated with
opioid medications (National Institute of Health, 2018). Several side effects occur with
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the use of opioids including euphoria, respiratory and central nervous system depression,
tolerance, addiction and death (Centre for Addiction and Mental Health, 2012). Tolerance
occurs when an opioid is taken long term and higher doses of the medication are required
to achieve the same effect, as was experienced at a lower dose. Eventually, the desired
effect of the medication is compromised, and new treatment is sought (National Institute
of Health, 2018). Opioids are an effective treatment option for a variety of conditions; but
are at risk of being abused due to their effects. However, opioids come with serious side
effects even when used properly.
Types of Opioids
There are several types of opioids and each is known by a variety of names.
According to Health Canada’s Drug Analysis Service (Health Canada, 2017) the most
commonly abused opioids in Canada include fentanyl, oxycodone, hydromorphone,
morphine and heroin. Each of these opioids is briefly described below.
Fentanyl. This is a potent frequently abused opioid. On the street, fentanyl is
known as apache, China girl, China town, China white, murder 8, jackpot, poison, TNT,
and Tango & Cash. It is a laboratory produced synthetic opioid. When taken legally,
fentanyl takes the form of pills, lozenges and transdermal patches. Street Fentanyl can
take a variety of forms but is often swallowed, smoked, snorted or injected (Centre for
Addiction and Mental Health, 2017). Used on the street, fentanyl patches can be smoked
or chewed. Street Fentanyl is produced illegally in labs; or by obtaining stolen patches
from those who have a legal prescription. Fentanyl is fifty to one-hundred times stronger
than morphine contributing to the danger in its use (National Institute of Health, 2018).
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When purchased from non-prescription sources Fentanyl is often cut with cocaine or
heroin making it particularly dangerous (Centre for Addiction and Mental Health, 2017).
As well, it is often sold by another name, so, users may take fentanyl unknowingly. Due
to its dangerous attributes, Fentanyl is responsible for seventy-two percent of accidental
apparent opioid-related deaths in Canada (Government of Canada, 2018b). Fentanyl is a
major contributor to the opioid crisis and when used illegally it brings dangerous
consequences.
Oxycodone and Hydromorphone. These medications are potent pain relievers
(Centre for Addiction and Mental Health, 2019c) that are chemically like heroin
(National Institute of Health, 2018). A long acting oxycodone replaced a medication
called OxyContin because of abuse of this medication; which ultimately led to its
production becoming illegal in 2012 (Government of Canada, 2013). Oxycodone is a
medication that is much more difficult to tamper with than OxyContin. Hydromorphone
is used to manage moderate to severe pain relief in a variety of conditions (National
Institute of Health, 2018). Both oxycodone and hydromorphone are opioids that continue
to be abused and pose potentially dangerous consequences for those abusing them.
Morphine. This opioid is a naturally occurring opioid derived from the poppy
plant. It is effective in managing cancer and non-cancer types of chronic pain, of
moderate to severe intensity (Kim et al., 2016). Morphine, like other opioids, has the
potential for dependence, tolerance, and misuse.
Heroin. This opioid is a highly addictive opioid made from morphine. Rates of
heroin use have increased, in part due to the costly nature of prescription opioids
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(National Institute of Health, 2018). It is often mixed with additives contributing to the
health disparities associated with long-term use of heroin including liver, kidney, lung,
and cardiac conditions (National Institute of Health, 2018).
Defining Opioid Use Disorder
Abuse of opioids occurs when they are used in any way that is unintended which
includes taking someone else’s prescription or taking opioids to experience a high
(National Institute of Health, 2018). Euphoria that is produced with the use of opioids,
contributes to its abuse. It is concerning considering the dangerous side effects of opioids,
including central nervous system depression and death. Abuse of opioids can lead to
addiction, the most serious form of SUD (National Institute of health, 2018). According
to the American Psychiatric Association (2013), SUD is defined as use of alcohol or
other substances that leads to problems in daily life or causes noticeable suffering.
Inappropriate use of opioids can lead to problems in personal and professional life, as
well as health and well-being.
SUD includes the inappropriate use of opioids. Addiction to opioids is often
referred to specifically, as opioid use disorder (OUD). OUD is defined in The Diagnostic
and Statistical Manual of Mental Disorders (DSM–5) as: problematic use of opioids
causing serious impairments or suffering (American Psychiatric Association, 2013).
OUD includes those who take opioids more often than prescribed, take improperly, or
illegally to experience the pleasurable side effects of this powerful narcotic. Abuse and
addiction to opioids can cause serious and even life-threatening consequences. SUD is an
overarching category of mental disorders that OUD is a sub-section of.
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When someone who is addicted to opioids attempts to stop taking them or reduce
their dose, withdrawal symptoms occur. These symptoms can include: widespread pain
and body aches, insomnia, diarrhea, vomiting, irritability, agitation, tremors, chills, and
severe cravings (Government of Canada, 2019a; National Institute of Health, 2018). The
length of time of withdrawal and the severity depends on a variety of factors. However,
these negative side effects cause opioid users to actively seek out opioids; making it
tremendously difficult to stop using (Government of Canada, 2019a). Withdrawal from
opioids can be so severe that in order to obtain opioids, the person may resort to any
means to obtain them.
When someone with OUD experiences withdrawal or cravings, the desire to take
opioids can cause the user to resort to illegal or immoral means to obtain the drug.
Stealing from others to buy drugs and finding drugs on the street, presents immense
dangers to the user. Drugs manufactured and sold on the street can contain a variety of
substances, some toxic. Additionally, these drugs can contain unknown amounts of
different types of opioids that can add to the danger of taking them. In fact, the drug
dealers selling street opioids may be unaware of what they are selling. The unknown
contents of the street opioids make them much more dangerous than prescription opioids.
Street opioids can contain an unknown amount of any opioid including fentanyl, an
extremely high potency opioid; that there is a small difference between a dose that will
cause a high and one that will kill the user (Centre for Addiction and Mental Health,
2017). Opioids commonly come in tablet, liquid and powder form and used by snorting,
smoking, swallowing, and injecting.
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Epidemiology Opioid Use Disorder in Canada
The growth in medical use of prescription opioids for issues like pain
management has fueled the growing problem of OUD (Government of Canada, 2017).
While it is important to note that patients and healthcare providers are best suited to make
decisions on care; the use of opioids can cause dependence and therefore should be
considered judiciously. In the mid 2000’s high dose opioid prescription began to rise and
has led to Canada being identified as the second highest users of opioids per capita in the
world; the United States is the first highest users globally (Government of Canada, 2017).
Prescription opioids, while effective in managing pain, can cause dependence and have
led, in part, to the growth of opioid abuse in Canada.
Nationally, the addiction to opioids has reached epic proportion and is commonly
referred to as the opioid crisis (Government of Canada, 2017). According to the
Government of Canada Report (2018a) opioids are responsible for more than eight
thousand deaths between January 2016 and March 2018 and 1,804 (between April and
December 2018) suspected overdoses reported by emergency medical services
(Government of Canada, 2019b). Eighty-one percent of accidental apparent opioidrelated deaths involved Fentanyl or Fentanyl analogues and an average of 17 Canadians
were hospitalized every day in 2017 due to opioid poisoning (Government of Canada,
2018b). By province and territory, Ontario is second only to British Columbia in opioid
related deaths, experiencing 638 deaths from January to June 2018 (Government of
Canada, 2018b). Further, emergency visits in Ontario, attributed to opioid use, increased
73% between 2016 and 2017. The opioid crisis in Canada is growing and is
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disproportionately affecting provinces like British Columbia and Ontario. Data on
Canada’s opioid epidemic shows that some Canadians experience these negative effects
disproportionately. Overdoses caused by opioids were more commonly experienced by
men (76%) and more commonly occurred in persons ages 20 to 39 (Government of
Canada, 2018a). Due to the severity of the opioid crisis and the devastating effects on the
lives of Canadians, the Government of Canada is seeking to better understand and guide
treatment of OUD. Research that seeks to investigate this phenomenon is much needed to
combat this growing epidemic.
Stigma exists around addiction and substance abuse. Although addiction is a
common phenomenon in Canada and throughout the globe, stigma persists. Stigma is
defined as negative attitudes and beliefs (Canadian Mental Health Association, 2019).
Negative judgements caused by stigma can adversely influence the quality of life of those
battling addiction and can act as a deterrent from getting the much-needed help to treat
addiction (Canadian Mental Health Association, 2019; Government of Canada, 2019a).
Stigma can take the form of social, structural, and self-stigma (Government of Canada,
2019a). Social stigma is the negative attitudes, labels, images, and treatment of those with
SUD. Structural stigma is treatment by those in social service departments, who ignore
their requests, don’t provide services, and design social services to promote
stigmatization against those with SUD. Finally, self-stigma is when those who are facing
SUD internalize the negative attitudes and beliefs of those who stigmatize against them.
Cheng et al. (2019), found that self-stigma negatively impacted psychological distress,
social functioning, and quality of life in a large sample of heroin users who were in
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MMT. These authors found that treating psychological distress effectively reduces the
negative effects of self-stigma on the quality of life of heroin users. Despite the muchneeded treatment for those battling OUD, many will not seek treatment due to the barriers
such as stigma deterring them from seeking and entering treatment (Government of
Canada, 2019a). Promoting knowledge of stigma and treating the negative effects like
psychological distress, may reduce stigma and promote treatment of those with OUD.
Treatment for Opioid Use Disorder
A variety of treatment options for OUD are examined. Methadone,
buprenorphine-naloxone are opioid agonist therapy options. Methadone continues to be
the most commonly used drug treatment for OUD in Ontario, Canada. However, recent
evidence supports buprenorphine-naloxone as a first line treatment and methadone as the
second (Bruneau et al., 2018). Medication with behavioral therapy is considered effective
treatment for OUD (National Institute of Health, 2018). Standalone withdrawal
management is not recommended due to the increased risk of tolerance and relapse that
can result in overdose and death (Bruneau et al., 2018). Similarly, treatment retention is
essential since those who relapse have an increased risk of overdose and death (Sordo et
al., 2017). The initiation period of beginning on Methadone and the cessation of
methadone treatment are particularly vulnerable periods where the risk of death is
increased.
Methadone. Methadone is a long-acting, synthetic, full agonist opioid. It has
been extensively studied as a first-line drug to treat OUD since 1964 (Canadian Institute
of Health Research, n.d.). Studies have indicated that methadone is a safe and effective
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method of treatment reducing or eliminating death, heroin use, and criminal activity in
opioid users (McCance-Katz et al., 2010). Safe dosing and administration of methadone
are required to follow national and provincial guidelines for the management of OUD as
well as product monographs approved by Health Canada (Bruneau et al., 2018; The
College of Physicians and Surgeons of Ontario, 2011). The goal of methadone dosing is
to eliminate withdrawal symptoms, cravings, avoid opioid toxicity, and block the
euphoric effects of other opioids (Canadian Institute of Health Research, n.d.; Socias et
al., 2018). Maintenance doses of methadone are 60-120 mg/day with daily witnessing of
ingestion. Take home doses, often called “carries”, can eventually be allowed once a
healthcare provider deems it appropriate based on individual stability (Socias et al.,
2018). Methadone is an effective treatment for OUD with appropriate dosing and
maintenance therapy.
As with all medications, there are benefits and challenges with taking methadone.
Among these challenges is attending witnessed dosing for the medication (Bruneau et al.,
2018). Attending methadone dispensing clinics exposes those on methadone maintenance
therapy and can be the cause of humiliation by an otherwise misinformed public (Woo, et
al., 2017). In fact, one study found that participants were willing to drive hours away to a
methadone clinic to avoid being seen fearing stigmatization by others (Woo, et al., 2017).
In an attempt to taper opioid therapy independently, others reduced their doses too
quickly resulting in withdrawal and having to increase the dose of methadone (Woo, et
al., 2017). Stigmatization by others associated with methadone therapy, negatively
influences MMT outcomes and the emotional well-being of patients.
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Facilitators and Barriers to Treatment
Treatment for OUD presents unique challenges that can prevent or delay care.
Feelings of stigmatization and discrimination based on ethnicity, drug use, chronic pain
needs, and residency can prevent resource access by those in need of treatment
(Muthulingam et al., 2019; Olding, et al., 2018; Rivera-Suazo et al., 2015). In a study by
Olden et al. (2018), those with SUDs experienced inadequate treatment, were denied
treatment, and treatment was ended abruptly due to their drug use. These aspects of
experience led individuals in Canada’s west coast to hesitate when accessing services or
refuse them all together. This lack of access to care resulted in poor outcomes.
Financial barriers exist in accessing treatment for OUD. Lack of ability to pay for
medications, medical devices and dental services act as barriers for both men and women
despite having a universal healthcare system in Canada (Olden, et al., 2018). Financial
barriers to treatment are commonly noted in the uninsured population of the United States
(Ali, Teich & Mutter, 2016; Browne, et al., 2016). In a study by Gueta (2017), women
noted that economic hardship, lack of social support, immigration status, and being
postpartum acted as barriers to treatment. Financial barriers to treatment act to prevent
men and women from accessing necessary services.
Other barriers limit accessibility to care for individuals seeking treatment for
OUD including police presence around clinics, inadequate number of providers accepting
new patients, and untimely access to treatment services (Olding, et al., 2018). Individuals
experiencing these barriers may find it difficult to access care and continue to use
substances. In contrast, Muthulingam et al. (2019) found that the side effects of both
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methadone and buprenorphine acted as barriers to ORT. Switching to buprenorphine
either from illicit opioids or methadone, resulted in experiencing moderate withdrawal
symptoms for a period of seven to ten-days. Noted barriers to treatment with ORT
included the inconvenience of daily treatment requirements with short acting ORT
(methadone) and unmet expectations of treatment (side effects). Finally, participants in
Muthulingam et al. (2019) considered ORT as trading one addiction for another which
individuals found frustrating. Each barrier is important to consider as they may play are
role in whether individuals’ access or persist in treatment for OUD.
A variety of factors contribute to treatment access and retention of individuals
with OUD. Individuals in Olding et al. (2018) identified harm reduction or low barrier
approaches as supportive treatment practices. Harm reduction includes measures to
reduce the harmful effects on health, social, and economic status for individuals who use
drugs without requiring them to stop using substances (Government of Canada, 2018c).
Low barrier approaches to care improve accessibility by removing barriers to treatment
using a non-judgmental approach that does not require abstinence from substances
(Carter et al., 2019). Additionally, continuity of care with a trustworthy care provider,
centralized access to care needs, and having peer navigators facilitated individuals into
treatment (Olding, et al., 2018). In a study by Muthulingam et al. (2019), ORT was
considered the most significant facilitator of treatment. Specifically, methadone was seen
to relieve withdrawal cravings, improve quality of life, save money, improve employment
opportunities, foster and improve familial relationships, reduce legal issues, and omit the
need to obtain illegal opioids. A study with only female participants identified custody of
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children, treatment availability, social support, and formal financial backing as supportive
in their journey to treatment for OUD (Gueta et al., 2017). These supportive practices
may help contribute to successful treatment access and retention. Care providers should
advocate for practices that facilitate treatment and attempt to mitigate or eliminate
practices that deter care access.
Focused Literature Review
Gender-Based Differences Among Methadone Treatment Participants
Both men and women experience OUD. Bawor et al. (2015) examined gender
specific issues in methadone treatment in Ontario, Canada. Demographic information,
treatment characteristics, psychiatric history, addiction severity, and drug use patterns
were determined in a purposive sample of 503 participants to determine different factors
effecting men and women. All participants had OUD and were receiving methadone for
treatment. Of the sample, 54% were men and 46% women. Reported outcomes included
differences in substance use, health, and social functioning among a group receiving
MMT for OUD. The researchers used univariate analysis and logistic regression to
identify the significant factors affecting both groups in this investigation. For most
women, their initial contact with opioids was through a doctor’s prescription. The women
in the study were younger and had commonly abused both opioids and benzodiazepines
in the past three months, while their male counterparts had higher rates of smoking and
cannabis use. Substance use was measured using urine toxicology over a three-month
period. The findings indicated the following frequency of substance use: 48.5% illicit
opioids, 39.6% benzodiazepines, 34.7% cocaine and 23.1% cannabis. Heroin use
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decreased in women as a result of increased opioid dependence. Women experienced
more psychological and physiological issues compared to men and they reported greater
prevalence of family psychiatric history. Additionally, women in the study reported high
unemployment rates and children to care for. The comorbidities to OUD and the
socioeconomic challenges that women face when enrolled in MMT programs are unique.
Limitations of the study include the cross-sectional design. Disorders such as this
are chronic, as is treatment, and would benefit with longer times frames for study. There
were also numerous strengths of the study. The large number of participants from 13 sites
yielded a robust, geographically diverse sample. In addition, the researchers provided a
comprehensive update of characteristic factors of those with OUD using methadone as
treatment. The authors identified gender differences in treatment and used urine
toxicology with self-reporting to strengthen the report findings. There were considerably
more strengths than limitations of this study.
Gender differences also exist in access to MMT in Canada. Bach et al. (2015)
examined gender differences in MMT initiation, among a sample of individuals who
injected drugs within a community setting. The nature of the study was quantitative using
data collected with the Vancouver Injection Drug Users Study. Semi-annual blood
samples were drawn, and interviews were completed. The researchers used Cox
proportional hazards modelling to examine gender differences in rates of MMT
enrollment. A large and diverse group of individuals made up the participant group of
1848 opioid addicted individuals were included in the investigation. Only 32% of
participants were female. The authors followed the community recruited sample of
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individuals between May 1996 and May 2013. This allowed the authors to determine the
time to initiation of treatment with methadone.
The study findings indicated that female participants were younger than men
when entering MMT. Being female was also associated with a shorter time from first
opioid use to time of entry into treatment. The authors speculate that this is related to the
unique bio-psycho-social aspects associated with addiction in women. Pregnancy and
heroin use were also identified as factors strongly associated with initiating MMT.
There are limitations and strengths to this research. The disproportionate number
of males to females is a noted limitation of the study. The study was based on selfreported data on methadone initiation, drug use patterns, sex work involvement, and
housing. The use of self-reports can contribute to under or over reporting. Strengths of
this research include the large number of participants and that the participants were from
a group receiving community-based methadone treatment rather than impatient treatment.
As well, the results of the study demonstrate differences in behavior related to MMT
highlighting the need for gender-based recruitment and retention in care.
Understanding the predictors of retention and opioid abstinence during MMT is
important to support patients entering MMT and to reduce their drug use. Levine et al.
(2015) performed regression analysis stratified by gender with a convenience sample of
290 individuals (173 males, 117 females) admitted to outpatient MMT at an urban
university affiliated program in the United States. The authors conducted the study to
determine if predictors of retention and abstinence during MMT were different for men
and women. The marker of one year in treatment was considered treatment success; urine
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drug screens were taken initially to determine intake values and were included in the
study analysis. The findings indicated that gender itself did not predict treatment
retention. Methadone dose was not significantly related to opioid abstinence or treatment
retention, in either gender. However, the predictors of MMT retention and long-term
abstinence differed between men and women. For men, significant predictors of greater
than one-year retention in MMT included urine samples negative for opioids and
cannabinoids during the first month and not being cocaine dependent. Predictors of
greater long-term opioid abstinence for men were first month urine samples that were
negative for opioids and cocaine. First month urine samples that were negative for
cocaine and cannabinoids; and no history of sexual victimization were significant
predictors of greater than one-year retention in MMT for women. Sexual abuse had an
impact on treatment outcomes for women. It is necessary to address the psychological
impact of victimization experienced by women, to promote treatment retention. The only
significant predictor of greater long-term opioid abstinence for women was first month
opioid free urine samples. These differences noted between genders warrants further
understanding; in order to support individuals to persist in treatment and be abstinent
from other drugs that can impede their treatment success.
There are several limitations to the study by Levine et al. (2015). The first
limitation is that the intake data that was collected was not detailed enough to provide a
clear understanding of the characteristics of the sample. Future studies should focus on
extrapolating details about each variable. The second limitation is the low retention rate.
The rate was 39% which is lower than anticipated by the authors. They suggest that the
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older age of the sample, fifty years of age on average, and higher amounts of previous
attempts to complete treatment may have resulted in influence the low retention rates.
However, this study is one of the few that has investigated differences in the variables of
treatment retention and opioid abstinence between genders. The findings suggest gender
specific, targeted interventions to prevent treatment failure and inform policies.
Outcomes of MMT among those using other illicit drugs are an important
consideration. Understanding gender differences in the use of cannabis during methadone
treatment is the focus of a study by Zielinski et al. (2017). The researchers performed
multivariable logistic regression analysis to determine gender differences in the
association between any cannabis use and illicit opioid use. A convenience sample of
414 men and 363 women with opioid use disorder (OUD) who were receiving MMT
were recruited for participation in the study from sixteen Canadian Addiction Treatment
Centre site in Ontario, Canada. The quantitative method of multiple logistic regression
allowed for a comparison between groups, by gender, on cannabis, and opioid use. Other
methods of analysis would not allow for this type of comparison. Data was collected
using self-reports by participants regarding demographic information and drug use, and
urinalysis to detect for cannabis and illicit opioid use.
The findings of the study indicated that there were gender differences in the
association of methadone treatment and cannabis use. Men used more cannabis than
women in the past thirty days; but women experienced significantly worse physical and
psychological functioning compared to men. The use of cannabis during MMT was found
to be a predictor of illicit opioid use in women. The authors indicate that cannabis use is a
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gender specific predictor of poor outcomes during MMT. Further, they suggest
systematic screening for cannabis use in women with OUD promotes better outcomes of
treatment because it can be used to initiate addiction counselling for illicit drug use and
psychological issues.
There are limitations and strengths of the Zielinski et al. (2017) study to consider.
The cross-sectional nature of the study limits the authors from making causal inferences.
Also, self-reported data on cannabis use by participants may lack accuracy because of
short-term memory loss among chronic cannabis users. Nonetheless, this was the largest
study of its kind to investigate the relationship between cannabis used and illicit opioid
use in men and women on MMT.
Other research has compared psychosocial factors affecting men and women in
MMT. Polenick et al. (2019) investigated loneliness and illicit opioid use among MMT
patients. The study included a convenience sample of 371 participants, from four opioid
treatment programs, in southern New England and the Pacific Northwest. Participants
completed self-reports that included sociodemographic and health information,
loneliness, illicit opioid use, and MMT characteristics. Logistic regressions were then
performed to investigate the relationship between odds of illicit opioid use in the past
month and perceived loneliness. Using these methods, the authors determined if illicit
opioid use and loneliness varied by gender.
The results of the study indicated that both men and women used opioids during
MMT and reported experiencing loneliness. One third of participants reported use of
illicit opioids during the month and one quarter reported severe loneliness. However,
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gender modified the outcomes of illicit opioid use and loneliness differently. Women
who reported severe loneliness were three times more likely to use illicit opioids while in
MMT, compared to those reporting little or no loneliness or moderate loneliness.
Whereas, men reported illicit opioid use when they had little or no loneliness versus
moderate or severe loneliness. Therefore, the researchers offer that a better understanding
of the relationship between loneliness and illicit opioid use, in women receiving MMT
for OUD, would support effective treatment to sustain recovery. Limitations of the study
include the inability to make causal associations due to cross-sectional analysis.
Additionally, a convenience sample of self-selected participants and self-reported data
may introduce bias in the findings. While the researchers controlled for marital status,
they did not consider living conditions and relationship quality; which may play a role in
drug use and loneliness. A final limitation for consideration is that of missing data.
Missing data for loneliness and depressive symptoms were 10% and 11% respectively;
potentially indicating that those who experience these feelings may have been less likely
to report them. This could indicate bias in the data collection with those experiencing
severe symptoms not represented in the data. Strengths of the study include a large
sample from multiple sites. As well, participants from wide range of ages participated in
the study. Numerous characteristics were included in the analysis and gender differences
in the statistical comparisons. The method of multivariate analysis controlled for many
confounding variables; to ensure that the resulting relationship between illicit opioid use
and loneliness in women in MMT was valid.
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Synthesis. The studies of gender-based differences in methadone treatment
contain similarities and differences. All the studies had ample sample sizes to draw
conclusions from the data. Further, many of the studies include data from multiple sites
(Bawor et al., 2015; Polenick et al., 2019; Zielinski et al., 2017). All the research studies
have more men than women represented in the sample. In fact, Bach et al. (2015) has
only 32% female representations. Women were younger and entered treatment sooner
than men in the studies by Bach et al. and Bawor et al. (2015). Yet, what leads to their
early initiation of treatment was not determined. More men than women continue to enter
MMT, however, the demographics of opioid addiction are changing.
The five studies utilized quantitative methods of analysis; most of the studies used
regression analysis (Bawor et al., 2015; Levine et al., 2015; Polenick et al., 2019;
Zielinski et al., 2017) and many used self-reporting for data collection (Bach et al., 2015;
Bawor et al., 2015; Polenick, et al., 2019; Zielinski et al., 2017). Studies using qualitative
methodology to describe men’s and women’s perspectives on methadone treatment were
absent in the literature.
Among the research reviewed, several unique outcomes were found. In both
Canadian and American studies there was an increased prevalence of physiological and
psychological issues in women entering treatment (Bawor et al., 2015; Levine et al.,
2015; Polenick et al., 2017; Zielinski et al., 2017). For example, findings from Levine et
al. (2015) included the negative relationship between sexual abuse history and MMT
outcomes. Whereas, Zielinski et al. (2017) reported cannabis use among women as a
predictor of poor MMT outcomes. Similarly, Polenick et al. (2019) related severe
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loneliness in women with illicit opioid use during MMT. Using illicit opioids during
MMT can lead to poor outcomes during treatment. The findings indicate that certain
psychosocial and behavioral factors influencing the successful completion of MMT are
unique to women.
Three of the studies are Canadian where healthcare provision is provincially and
federally funded (Bach et al., 2015; Bawor et al., 2015; Zielinski et al., 2017); two of the
studies were from the United States where healthcare is mostly privatized (Levine et al.,
2015; Polenick et al., 2019). Yet, in the two Canadian studies, women experienced higher
unemployment rates and the responsibility of children to care for which may challenge
womens’ ability to access healthcare services and obtain extended healthcare coverage
through an employer (Bach et al., 2015; Bawor et al., 2015). Thus, the role of healthcare
systems in treatment success requires further exploration.
Perspectives of Women in Treatment for OUD
The trajectory from addiction to treatment for opioid addiction is not well
understood. Women with OUD begin by either using illicit opioids or transition from
medically prescribed opioids to using illicit opioids to manage their addiction symptoms
(Marks & Leukefeld, 2017). Marks and Leukefeld (2017) examined strength-based
factors that support women in recovery from non-medically prescribed prescription
opioid use, in a recovery framework. The focus of the strength-based factors was on
physical health. Self-reported secondary data from Kentucky’s Targeted Assessment
Program was used in the analysis. The purposive sample of 1,247 women self-identified
as having problematic non-medical prescription opioid use. Participants had also been
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identified as having substance use as a barrier to self-sufficiency and had completed pretreatment services for substance abuse. Bivariate and logistic regression analysis was
used to analyze whether physical health and access to health services were associated
with substance-related behavior change when pre-treatment was completed.
The authors found that the healthier women reported they were, the more likely
they were to engage in substance-related behavior change (i.e. taking action to change
problematic substance use). Women engaged in substance-related behavior change,
reported better health and less pain than those who were not engaged in change. All
women in the study indicated that access to healthcare services was a significant barrier
but especially those with a low income. Forty percent of women in the study reported
issues with accessing health insurance, a clinic, health center or physician. Women
receiving additional financial support through various government services were more
likely to participate in substance-related behavior change, than those who were not.
Women’s physical health was directly related to participation in substance related
behavior change, but health service accessibility was a problematic.
This study had several limitations. Retrospective analysis and self-reporting limits
the reliability of the findings. However, the study provides important insight as to
women’s perceptions of their health, which can directly influence their resilience (Marks
& Leukefeld, 2017). The study was also limited by the homogeneity of race of
participants; most participants were white (96.2% in the no behavior change group and
95.7% in the behavior change group). Another limitation is that the data from the study is
from one point in time and neglects to consider that health is a continuum, changing
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throughout one’s life. Finally, only physical health was considered as a strength-based
aspect of recovery, neglecting other strengths that women may possess that positively
influence their journey to recovery. Despite these limitations, strengths of the study were
evident.
The study sheds light on the importance of accessibility of healthcare services.
Access to health services was a barrier for low income participants. According to the
authors, health insurance is a critical factor for women’s treatment of OUD. The research
findings support previous findings in women’s health literature that impoverished women
with non-medical prescription opioid use experience limited healthcare service access
(Larson et al., 2005; Rosenblum et al., 2003). Finally, the findings provide evidence of
the strength-based factors of women experiencing this phenomenon. These strengths are
essential to women’s recovery and health behavior change.
Understanding the process of moving from using opioids to OUD and then
recovery is the focus of a study by Rubio (2016). The researchers examined women’s
experiences from their perspective using an interpretive phenomenological approach
(IPA). The authors focused on reasons for using drugs, entering recovery, the choice of
methadone, and treatment experiences. Individual interviews were performed with a
purposive sample of 13 women from an outpatient methadone treatment clinic in the
southern United States. Women’s experiences were collected using interviews. Three
major themes were developed from the data: the journey of addiction, the tipping point
and perceptions of methadone. In their journey to addiction, women identified a moment
when they began to use drugs. Contributors commonly included stressors, peer pressure,
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as triggers that began their addiction. Drug experiences all began positive, according to
the women, and eventually spiraled out of control, leading to addiction and treatment.
Each of the trigger events were unanimously extrinsic. The tipping point included a “rock
bottom” event that was a choice they made, or others made for them. Wanting to have
their normal life back was a common thread among participants entering treatment.
Finally, perceptions of methadone were mixed; both positive and negative experiences
were described. Nine of the 13 participants felt that methadone treatment was a positive
experience to get back to a “normal life”. Two of the participants had mixed feelings
about methadone treatment and two others had entirely negative views. One of the two
participants with negative feelings described methadone as evil, a trap and a money grab.
Limitations in this study are related to the methods used for conducting research.
By using purposive sampling and a smaller sample size, the generalizability of the
findings is limited. However, the purpose of the study is not generalizability; it was to
develop a deeper understanding of women’s experiences. The research is performed in a
large urban center in the United States. Finally, participants were from a fee-for-service
clinic which limits the participant pool to those who can afford to pay for care. Due to the
interpretive phenomenological methodology of the study, the experiences of women
through their own words and phrasing were brought to the fore. The statements made
captured the uniqueness of the experience for each of the 13 participants. This research
provides important insights that may not have been discovered using an alternate
methodology.
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Farrell-MacDonald et al. (2014) examined the return to custody rates of three
convenience samples (n=137) of Canadian federal women offenders, with problematic
opioid use. This quantitative study used the Cox proportional hazards model to determine
the time to return to custody and Pearson’s X or ANOVA to determine associations
between the sample group and study variables. The control group, those who did not
receive MMT while incarcerated was compared to those who received MMT while
incarcerated. Women in this study, who received MMT while incarcerated and continued
MMT once transitioned into the community, were less likely to return to custody. Some
continued to use MMT post transition into the community, while others did not. The
group that continued MMT post transition into community programs had much lower
rates of return to custody. This finding suggests that community MMT is an effective
measure to reduce crime and improve opioid recovery in women. This study suggests that
MMT acts as a support to women opioid users, who leave the custody of the correctional
system in Canada.
This study had several limitations. The study sample was small and only
offenders who had community-based urinalysis data available were included in the study.
Since women offenders are not required to share treatment information once released, the
measure of urinalysis as evidence of participation in community MMT are flawed and the
findings of the study may inadvertently be biased. Length of time participants were in
MMT prior to and after release was not included in the study but may have been helpful
in explaining study outcomes. Finally, the potential benefits of illegitimate use of MMT,
those who used methadone to get high rather than for treatment uses were not considered
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in the study. Strengths of the study included the finding that return to custody rates were
lower in the MMT group that continued treatment into the community. Additionally, the
design of the study included comparison of three groups including a group of women
offenders identified as having a substance use problem that was predominately opioid
related. The study took place in Canada where MMT is available free of charge to federal
Canadian women offenders.
Synthesis. In the studies by Rubio (2016) and Marks and Leukfeld (2017), OUD
and was influenced by a variety of factors. According to Rubio, the journey of addiction
included triggers such as family stressors and peer pressure, especially from a male
significant other. However, when women reach a tipping point, which they can relate to a
specific event, they seek recovery for opioid use. Poverty, poor physical health, and lack
of access to health services contribute women’s addiction experiences including OUD
(Marks & Leukfeld, 2017). The healthier women were, the more likely they were to
participate in substance related behavior change which can include methadone treatment
(Marks & Leukfeld, 2017). Rubio describes the time when women choose to change
addiction behavior as the tipping point. Strength based factors noted in Marks and
Leukfeld including resilience and positive perceptions of quality of life can positively
influence women’s recovery from OUD.
Women offenders had varied experiences with MMT. Farrell-MacDonald et al.
(2014) found that some women chose MMT while incarcerated while others did not.
According to the themes identified in Rubio (2016), some women reached a tipping point
while incarcerated while others did not. Some of the women who chose MMT while
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incarcerated chose not to continue MMT once transitioned into the community (FarrellMacDonald et al., 2014). What factors influenced these results are unknown. Incarcerated
women are a unique group receiving MMT.
Differences in the methodology of the studies provided unique insight into
women with OUD and their treatment. The phenomenological methodology of Rubio’s
(2016) study gave insightful descriptions of women’s experiences with methadone:
positive, negative, and indifferent. Marks and Leukfeld (2017) and Farrell-McDonald et
al. (2014) both utilized quantitative designs. Marks and Leukfeld’s quantitative study
sheds light on how women’s strengths that supports recovery from OUD and the barriers
that they experience. Farrell-McDonald et al.’s (2014) quantitative study offers that
women who continue to use methadone when transitioned into the community are less
likely to return to custody than those who do not. Marks and Leukfeld investigated
outcomes for a variety of factors of a large sample and Rubio concentrated on the
experiences of a very small and specific group of women. Farrell-McDonald et al.’s
quantitative study had a relatively small sample size; participants were separated into
three groups for comparison. Rubio and Marks and Leukfeld’s study relied on selfreported data for analysis. Farrell-McDonald et al. evaluated community-based urinalysis
results and reports from Corrections Services of Canada data, removing the limitation of
self-reporting. The chosen methodologies provide a unique perspective on women’s
experiences of methadone treatment for OUD but are very different in their approach and
findings. This may be an indication of why there is little consensus on the most effective
practices to support woman’s access, retention, and successful completion of MMT.

60
Perspectives of Mothers in Methadone Treatment
Many women who receive methadone treatment are also mothers. Using
phenomenological qualitative methodology, Letourneau et al. (2013) conducted a study
in Atlantic, Canada. They examined the experiences of mothers, who are receiving MMT
and their relationships with care providers to better understand the effects on parenting. A
second aim was to gain knowledge of the impact of MMT on mother-child relationships,
in order to facilitate retention in MMT. Twelve women in a community MMT program
and six of the care providers participated in semi structured interviews. A mix of
convenience, snowball, and word of mouth strategies were used to recruit the
participants. Themes and sub-themes emerged after interviews that focused on answering
the research questions.
In their study, Letourneau et al. (2013) found that accessibility, safe childcare, and
family responsibilities act as barriers to mothers participating in MMT. Parent and
family-based interventions were identified by women to help support and build
relationships with their children and assist the children to understand the parent’s
addiction. The women in the study reported that they relied predominately on friends and
family for support and then community, and social supports. Finally, the women
discussed service provision preferences, including individual counseling, to address more
sensitive issues; followed by group sessions to receive support from other mothers.
Telephone access to service provider support was indorsed by women in the study. The
findings of the research identify specific needs of mothers to attend and persist in MMT,
from their perspective.
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Themes identified in this qualitative study were trajectory of addiction and
treatment, parenting and parent-child relationships, and support needs and preferences.
The article provides excellent insight of the facilitators and barriers associated with being
a mother and attending MMT. A strength of this research was the use of triangulation of
the data by source. Mothers in MMT, service providers and researchers reviewed the data
for accuracy enhancing the value and validity of the study outcomes. However, women in
methadone treatment for OUD can come from a variety of backgrounds and experiences.
A limitation of Letourneau et al.’s (2013) study was that participants were unanimously
white. Responses from both groups, mothers and service providers, shared commonalities
which led the researchers to believe the themes were accurate. The study was published
six years ago, and the findings may not still be relevant due to changes in the
demographic of those using opioid drugs (Hedegaard et al., 2018) and legislation
surrounding opioids that has changed over time. This legislation includes Bill C-32 which
incorporates several amendments from the Controlled Drugs and Substances Act like
making the application for safe injection sites more accessible, changes to offences and
penalties, and amending regulation-making authorities (Canadian Centre on Substance
Abuse and Addiction, 2017). Limitations of the study’s design and age warrant
consideration.
Mothers, who use opioid drugs, may find themselves faced with concerns from
CPS. Falletta et al. (2018), using general qualitative methods, examined currently or
recently pregnant women’s perceptions about CPS. Convenience sampling was used and
16 women from a drug treatment facility in Ohio, USA, participated in the study. The
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authors performed semi structured interviews with each woman. Themes and sub-themes
were identified in the data. Two primary themes appeared. The themes were: participants’
feelings/emotions about CPS and interaction-based perceptions of CPS functions and
performance. It is evident in the findings, that mothers had strong feelings related to CPS.
While they were receiving substance abuse treatment, women’s feelings about
CPS involvement were varied. On the one hand, many women saw CPS positively;
especially when the outcomes of the involvement ended favorably. CPS involvement was
an opportunity for children to be cared for while mothers attended treatment to recover.
One participant indicated that CPS removing her child from her care was beneficial to her
in that she was able to focus on and be successful in treatment for OUD. Case workers
who listened and were not judgmental facilitated mothers’ involvement in services
including OUD treatment. On the other hand, some of the women feared CPS
involvement; which in turn acted as a barrier to receiving treatment. One participant
considered detoxing and birthing her child at home to avoid seeking treatment for OUD
and inevitably having CPS involved. Insincere and negative attitudes of CPS workers
facilitated womens’ disengagement from services including treatment for OUD.
Study limitations include the small sample size. Although the sample size was 16,
the intent of the research was not to generalize, and the researchers felt that they reached
saturation to identify themes in the responses. Additionally, the participants were from a
small geographic area presenting with context specific issues. Women from other
geographical areas with differing contexts may have very different experiences and
perceptions of CPS; future research will need to be pursued in different areas and
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contexts. A final limitation of this research is that participants had both opened and
closed cases with CPS. Responses may be limited based on their current or past
involvement with CPS and therefore may differ.
A strength of this research is that by understanding participants perceptions of
CPS, women can be encouraged into treatment. Facilitating addiction care of women who
are pregnant or have recently been pregnant can occur if their fears of CPS involvement
can be alleviated. Another strength of this research is that it is part of a larger mixed
methods study that will elaborate on the issues of women’s experiences of CPS when in
treatment for OUD. The qualitative nature of this part of the larger study allows for
important insights of how women perceive CPS. Obtaining this information would have
been difficult using other methods. A final strength of this research is the number of
participants in the study. Saturation was achieved due to having enough participants to
reach that end.
Initiating and engaging with methadone treatment among pregnant and
postpartum women was the focus of another study. Mattocks et al. (2017) explored the
perceptions of experiences and challenges with MMT and obstetrical care among
pregnant and postpartum women enrolled in a methadone maintenance program.
Grounded theory approach was used, and the data was collected using two focus groups
at a methadone maintenance clinic in a large urban area in Worcester, Massachusetts. A
convenience sample of 14 women participated in the focus groups; five of the women
were pregnant and nine were postpartum. Eighty percent of the participants were
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Caucasian, and 20% were Hispanic/Latino ethnicity. The interviews were completed
during the regular scheduled support group times at the addiction treatment center.
Five themes emerged from the study. First, guilt along with fear of negative
outcomes for their infants, determines women’s MMT decisions. Women were concerned
with the withdrawal symptoms their babies would experience when born, due to their
methadone treatment during pregnancy. Although the women understood the importance
of continuing or starting methadone when pregnant, they considered alternative recovery
strategies other than methadone. Second, finding an obstetrician with experience treating
women receiving MMT can be challenging. Some women in the study found that
obstetricians would refuse care due to their MMT. Some physicians admitted that they
had little knowledge and experience caring for pregnant women on MMT. Stigma
amongst care providers was also noted among women. Third, methadone clinic
physicians are instrumental in helping women find the right methadone dose during
pregnancy. Physicians needed to adjust the dose of methadone for pregnant and postpartum women. This caused anxiety for some women due to fear of effects on the fetus.
Additionally, women experienced some difficulty distinguishing symptoms of
withdrawal and pregnancy symptoms. Overall, women noticed significant improvement
when doses were titrated properly by physicians. Fourth, some of the women in the study
expressed strong preferences for methadone over buprenorphine. One woman expressed
that her preference for methadone was due to having someone else administer it. Others
expressed preference for methadone due to experiencing sickness while on
buprenorphine. Fifth, women experience substantial substance abuse treatment challenges
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after delivery. Women expressed the challenge of having to travel back and forth each
day from the neonatal intensive care unit and methadone treatment. Other post-partum
treatment challenges included finding the right dose of methadone while experiencing
hormone changes and suffering from post-partum depression while trying to maintain
methadone treatment. Each of these themes derived from women’s responses directly
affect the women’s ability to access and utilize methadone while in the perinatal period.
Limitations exist in this study. The study takes place in a large urban setting, an
investigation in rural setting may yield different results. Another limitation is that women
may not have felt completely comfortable disclosing information in a focus group;
individual interviews may have yielded more intimate experiences. Despite the noted
limitations, there are strengths of this study. This study supports the idea that a
multidisciplinary approach is beneficial to women in addiction recovery. Further, the
study findings shed light on the fact that obstetricians need to be knowledgeable of the
treatment options of women experiencing OUD.
The experience of addiction and the process of recovery for women with children
must be understood to effectively engage them in MMT. Secco et al. (2014), performed a
mixed methods study with a convenience sample of 12 mothers who had been in
methadone treatment for three months or more. The quantitative analysis was completed
using three separate tools to evaluate strengths, stress, and parenting. Interviews using
open ended questions were performed for the qualitative portion of the study. The authors
describe characteristics of mothers who successfully engaged in MMT and how addiction
and MMT affect mothering and the mother child relationship. The qualitative aspect of
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the study focuses on mothers’ perspectives of their experiences of mothering and the
mother-child relationship during addiction, MMT and recovery. The study was completed
in New Brunswick, Canada.
Maternal identity and the mother-child relationship played a pivotal role in the
mothers’ choice to enter MMT and begin recovery. Findings indicated that women had
more strengths than stressors, high social support, and better family functioning. Yet,
mothers in the study struggled with high depressive symptoms, difficult life
circumstances, and family dysfunction. Three themes emerged from the data: diminished
maternal identity, choice for mothering, and redefined maternal identity. The authors
explained that during addiction the mothers’ limited in their ability to care for their
children. Interrupted mothering occurred due to physical removal of the child from the
mother or from the inability of the mother to care for children due to illness caused by
withdrawal. The second theme occurred when mothers eventually chose to begin
recovery using MMT. Mothers indicated that they made the choice in order to retain
custody of children and build relationships with children. Restored maternal identity
occurred with successful MMT and recovery which allowed mothers to lose their
preoccupation with drugs and enhance their performed mothering and mother-child
relationships. Unfortunately, some never reached this stage of relationship recovery. This
study yielded insights into mothers’ characteristics of strengths, stress and parenting as
well as mothers’ experiences in MMT.
Limitations included the homogeneity of the sample and the small sample size.
The mixed method design used in the study is a strength because it allowed for
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triangulation of qualitative and quantitative findings confirming the strengths, stresses,
and experiences of mothers in MMT.
Synthesis. Similarities exist between each study on perspectives of mothers in
methadone treatment. All four studies utilized qualitative methodology and homogeneity
of the samples was consistent; each study contained predominately or completely white
participants. Consistency was also noted in the study’s findings. Mothers in Falletta et al.
(2018) identified fears of removal of their children by CPS as a barrier to accessing
MMT. In fact, some of the mothers attempted to detox on their own due to these fears,
often leading to failure to recover. Participants in Mattocks et al. (2017) also attempted to
detox on their own, but their attempts were out of concern for infants’ withdrawal
symptoms rather than CPS. Sicco et al. (2014) indicated their desire to enter MMT to
retain custody of children. However, fear of removal of children was not mentioned in
detail by participants. Services that involve the entire family are emphasized by
Letourneau et al. (2013) but there is no mention of CPS.
Letourneau et al. (2013) and Falletta et al. (2018) noted the need to access outside
resources for support with the families. Letourneau et al. indicated that partnerships with
community agencies that provide parenting support and education, specifically, for
women attempting to recover from addiction, would be essential. Sicco et al. (2014) also
indicated the need for social support and parenting assistance to support mothers into
early engagement with MMT. As well, these authors note the importance of family
functioning and support on mothers’ experiences in MMT. Similarly, participants in
Falletta et al. reported the need to integrate services and provide essential resources to
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women in addiction recovery. Referrals to community agencies for a variety of resources
including healthcare, counselling, and employment assistance were identified by
participants. Community and service providers were viewed as vital supportive elements
to recovery. In fact, Mattocks et al. (2017) noted the essential supportive relationship
between the patient and provider as vital element of support throughout pregnancy and
post-partum period for women. All articles reported on the influence of interactions with
others in the community as either encouraging or discouraging their recovery experiences
as women and mothers.
All four of the studies utilized qualitative methods. Yet, differences exist between
the studies. Sicco et al. (2014) utilized mixed methods including both qualitative and
quantitative aspects. However, Mattocks et al. (2017) was the only research that
performed focus groups, all other studies performed individual interviews. Although each
study uses a different qualitative methodology, the foundation of qualitative studies is the
same; it is descriptive or interpretive and focused on meaning and building an
understanding of phenomenon. Participants in Falletta et al. (2018) and Mattocks et al.
(2017) were from geographically small areas in the United States where healthcare is
privatized. Participants in Letourneau et al. (2013) and Sicco et al., were from Atlantic
Canada consisting of small east coast provinces where there is public healthcare. The
articles were similar in many ways but were diverse in each qualitative method and focus.
Summary & Conclusions
Woman in Canada are experiencing OUD at an alarming rate (Government of
Canada, 2019). Further, opioid related morbidity and mortality rates are also increasing
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for women. Despite this growing problem, few women enter treatment for OUD. This is
particularly perplexing due to socialized healthcare in Canada making treatment free to
many who wish to receive it, removing the financial barrier to treatment. Still, women
experience addiction differently than men (Bawor et al., 2015). Yet, there is a deficiency
of research on women’s experiences with treatment. Specifically, Canadian women’s
perspectives on their experiences in methadone treatment is absent in the literature. This
absence of vital information in the literature contributes to a lack of evidence in which to
determine the most effective practices in women’s addiction care.
The studies in this literature review exhibit consistencies and inconsistencies in
their methods. Seven of the 12 articles in the literature review utilized quantitative
methods to analyze their data. All seven of the articles used regression analysis to
determine the relationship between two or more variables. Self-reported data was used in
all but one of the quantitative studies. Each of the studies had ample sample sizes to reach
power and to make predictions about their findings. Each of the studies contributed to our
understanding of MMT and OUD in women. Five of the studies in the literature review
utilized qualitative analysis methods. However, there was diversity in their methods.
Rubio (2016) used a phenomenological approach; Falletta et al. (2018) and Letourneau et
al. (2013) used a general qualitative approach, however, Falletta et al. used this approach
as part of a mixed methods study; and Mattocks et al. (2017) used grounded theory
approach when analyzing their data. Each of the studies reported homogenous groups of
participants with ample number of participants to reach saturation and provide insights
from participant experiences. All studies except Mattocks et al. used interviews for data
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collection: Mattocks used focus groups to collect data in their study. The qualitative
studies were varied in their approaches and provided information regarding experiences
of OUD and MMT in women.
There were equal numbers of Canadian and American studies. Yet, only one of
the studies found for this literature review considered the perspective of women with
OUD using methadone (Rubio, 2016). That study took place in a large urban city in
Texas, USA; no Canadian studies have addressed this issue. The results from Rubio
(2016) cannot be assumed to be consistent in a Canadian context due to differences in
various factors including the healthcare systems. Nevertheless, in both Canadian and
American studies issues of poverty, health, and access to healthcare services were
identified as contributors to women’s addiction experiences (Bach et al., 2015; Bawor et
al., 2015; Letourneau et al., 2013; Marks & Leukfeld, 2017). Studies must be considered
in the context of their geographical location. Differences attributable to location can
contribute to differences in participant outcomes.
The studies in this literature review exhibit consistencies and inconsistencies in
their findings. Several of the studies noted the importance of resources to attain
successful MMT outcomes in the community (Falletta et al., 2018; Farrell-McDonald et
al., 2014; Letourneau et al., 2013; Mattocks et al., 2017; Sicco et al., 2014). The
researchers determined that continuing with methadone once released from custody;
providing support for parenting; recovery that involved families and social support; all
involved outside resources that were essential in supporting women into recovery and
retaining them. Individual relationships were also seen as important factors in the
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trajectory of MMT for women. In fact, Polenick et al. (2019) reported that interpersonal
relationships contribute by facilitating or hampering recovery and should be seriously
considered in recovery care. Mattocks et al. (2017) regarded the relationship between
service providers and patients as essential in the recovery process. Similarly, Letourneau
et al. (2013) and Bawor et al. (2015), noted that women initiated opioid use after seeking
care from a healthcare provider for a medical condition. Many of the women in Rubio
(2016) described relationships with others as key to their initiation into opioid use;
including family stressors and peer pressure most noted from a male significant other.
However, in Levine et al. (2015) many women reported experiencing interpersonal abuse
at some point in their lifetime. Interpersonal abuse negatively influenced MMT outcomes
for women in the study and requires intervention to mitigate the negative effects.
Relationships with children encouraged women into MMT (Sicco et al., 2014) or created
fears for their removal which led them to avoid seeking treatment (Falletta et al., 2018).
In fact, pregnancy itself is associated with increased MMT enrollment in women (Bach et
al., 2015). Relationships had significant effects on women’s MMT experiences and
decisions.
Perspectives on methadone treatment were mixed among women. Two of the 13
participants in Rubio (2016) expressed feelings toward methadone that were negative
calling methadone a ‘trap’ and ‘money maker’. The participants did not want to remain
on methadone for any length of time. Conversely, the remaining participants in this study
had predominantly positive comments regarding methadone. Mothers in Mattocks et al.
(2014) had concerns about the use of methadone during pregnancy and sought to detox
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independently to avoid their babies having to experience withdrawal symptoms. Whereas,
participants in Letourneau et al. (2013) offered that MMT strengthened their relationships
and improved their parenting. Perspectives on methadone varied among women.
Women’s perspectives contribute to whether they choose treatment.
Other similarities among the articles existed including demographic variables for
women. Studies Zielinski et al. (2017) and Bawor et al. (2015) found that women with
OUD experienced more physiological and psychological symptoms then men. Moreover,
several studies found that women entered MMT sooner, during their trajectory of
addiction and younger than men (Bach et al., 2015; Bawor et al., 2015; Polenick et al.,
2019). Each of these factors contributes to women’s experiences in SUD care. The
demographic composition of women who enter treatment is unique. Therefore, it is
important to examine how to develop practices that are gender specific and encourage
women to enter and remain in treatment.
Resources, relationships, characteristics of methadone, and unique demographic
characteristics of women contribute to their experience with MMT. Yet, there is little
consistency regarding treatment needs with methadone for women experiencing OUD
(Rice et al., 2018). Further, gender specific care is not consistently provided. Gaps exist
in the knowledge of how women in Canada experience addiction, choose to enter
recovery and seek methadone for treatment. Understanding these aspects help to provide
comprehensive gender specific care to this unique population. Research that examines
this chronic issue, from the human perspective, provides insight for understanding the
needs of women with OUD, who choose methadone treatment. The trajectory from

73
opioid use, to treatment, facilitates understanding of how to support women into
treatment and encourage them to persist. Therefore, filling a gap that exists in the
literature contributes to providing optimal care for women with OUD who choose
methadone for treatment.
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Chapter 3: Research Method
Introduction
The purpose of this study was to describe the lived experiences of women with
opioid use disorder who are receiving methadone as their treatment of choice. By
understanding their experience more fully, from their perspective, nurses and healthcare
professionals can provide women with individualized health promotion strategies and
treatment (Rubio, 2016). This study provides insights that may lead to further research
and eventually to better outcomes for women experiencing OUD, thus improving their
quality of life. The research question was addressed by using interpretive
phenomenological methodology, which elicits insights and experiences from the
participants. Interviews and field notes were utilized to develop an understanding of
women’s experiences. This chapter describes the research design and its justification, the
sample selection and measures for ethical protection, and finally, the methodology for
collecting and analyzing the data.
Research Design and Rationale
There is a gap in knowledge regarding women’s experiences with OUD and their
choice of methadone for treatment in Central Canada. Although one American study
addresses this issue (Rubio, 2016), the healthcare systems between the countries differ
greatly. The Canadian healthcare system is socialized, allowing access to healthcare
services at no cost to any Canadian citizen; the American healthcare system is largely
privatized. As such, the experiences of women as described in the research conducted in
the United States may be substantially different from those of women receiving treatment
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in Canada. The following research question was developed to investigate this gap: What
are the lived experiences of Canadian women with opioid use disorder who choose
methadone for treatment?
The central phenomenon was the experiences of Canadian women with OUD who
choose methadone treatment. The focus of the study was women’s experiences from their
perspective to develop a deeper understanding of this phenomenon. From first
experiences with opioids to experiencing addiction, seeking help and how this experience
affected them or those around them was addressed by participants. Participants
determined what their experience was and how they wanted to convey it. Once responses
were gathered, findings were interpreted. The data from responses helped to develop my
understanding of how women experienced OUD and treatment.
A qualitative, interpretive phenomenological design was the best approach to
investigate the lived experiences of women and give meaning to their responses. Through
the research question, I gathered detailed descriptions of women’s experiences. Using
this data, I interpreted responses by naming the data and isolating themes (Smith et al.,
2009). Interpretive phenomenology is focused on the subjective human experience, which
reflects the research question. Qualitative research, as a tradition, has an ontological
understanding that the world is socially constructed, complicated and fluid in nature
(Glesne, 1999). In qualitative research, subjectivity, experiences of the life-world, and indepth descriptions of experiences are foundational. Interpretive phenomenology focuses
on normally hidden human experiences of the life-world and how individuals experience
it (Lopez & Willis, 2004). The term life-world is used to indicate the inseparable nature
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of an individual’s reality and the world they live in. Thus, responses to research questions
are narratives of individual experiences from everyday life. Additionally, a central
concept in interpretive phenomenology is situated freedom, which indicates that all
individuals are free to decide their actions but are subject to conditions of their lives
(Lopez & Willis, 2004). From these decisions, meaning arises, as meaning is derived by
individuals’ being-in-the-world, which is influenced by political, social, and historical
contexts and in turn influences their choices (Lopez & Willis, 2004). A final concept
considered in interpretive phenomenology is constitutionality (Koch, 1995). The concept
implies that findings are a combination of meanings of the investigator and participant.
The background of each of these individuals is unique and contributes individually and
collectively to the research findings. For this reason, there is no one interpretation of the
data, only plausible interpretations justified by participant responses (Annells, 1996).
Performing interpretive phenomenological research requires the investigator to
collect data, analyze and interpret the data, and report on the findings (Sloan & Bowe,
2014). The findings of the research with qualitative interpretive phenomenology are a
collection of the meanings or essence of lived experiences of individuals (Sloan & Bowe,
2014). The essence of the experience is presented in written form to give voice to the
human experience. The investigator has expert knowledge that guides the inquiry and
facilitates meaning making in responses (Lopez & Willis). Prior knowledge of the topic
and awareness of previous research are essential in conducting interpretive
phenomenological inquiry. For this reason, bracketing as a practice to hold back
investigators preconceived ideas and bias, contradicts the interpretive tradition.
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Other approaches and designs were considered for this study. Quantitative
methods were not appropriate for the research question. A narrative approach was not
appropriate to the research questions because the focus of narrative research is on stories
of experiences, often by individuals, rather than a collective (Patton, 2015). Similarly, a
case approach was not applicable because the focus of the research is on a common
experience of a variety of women who may not be from a bounded system (Creswell &
Poth, 2018). Culture based sharing was not the focus of the study; therefore, ethnography
was not the ideal approach (Patton, 2015). Grounded theory was also inappropriate
because the intent of the research was not to find themes and develop a theory; rather, the
goal was to interpret lived meaning of the experience to develop a deeper understanding.
Although a variety of approaches and designs were considered, interpretive
phenomenology fostered the most applicable information to address the research
question. By using this approach in the study of women with OUD who choose
methadone treatment, interpreting meaning and the essence of the experience helped to
better understand women’s meaning making of this phenomenon.
Role of the Researcher
My role in the study was a researcher–observer. By explaining my role as an
observer, the participants were put in the position of experts of their own experiences,
which helps manage any power dynamic that may have existed (Lather, 1991).
Additionally, the qualitative method of interpretive phenomenology requires that the
investigator is an integral part of not only data collection but also the interpretation
(Creswell, 2014). The investigator interprets the data while interviewing, observing, and
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writing. Because people are intricately situated in the world and cannot be separated from
it, acknowledging my experiences and assumptions related to my research topic was
important when interviewing, observing, and interpreting the data. Unlike descriptive
phenomenology, the researcher does not bracket their experiences—rather these
experiences are considered in the research process (Lowes & Prowse, 2003). Personal
assumptions must be considered during the research process using a phenomenological
approach, which is why I provide an explanation of my personal experiences in the
following paragraph.
I have personal experience with SUDs. A close family member experienced SUD
throughout my life and sought treatment through a local 90-day inpatient facility. The
person continued the journey of recovery, as a member of Alcoholics Anonymous (AA),
until death in 2014. For this reason, addiction and recovery were central to my life
throughout my childhood, adolescence, and adulthood. Professionally, I have worked in
community mental health as a registered nurse, as a clinical instructor for students on
psychiatry, and as student advisor and liaison to students for placement in recovery
homes and at inpatient mental health facilities. My personal and clinical practice
experience has given me a unique perspective and in-depth understanding of SUD and
recovery. However, my experience also creates inevitable researcher bias. Specifically,
confirmation bias occurs when the researcher interprets data to support their own
hypothesis whether consciously or unconsciously (Nickerson, 1998). The researcher can
form an early explanation that confirms their previously held beliefs. Due to my
experience with substance use, I have beliefs related to substance abuse and individuals
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that abuse substances that may cause me to focus on the responses of participants that
confirm my beliefs. To manage this, I maintained an analytic memo (Ravitch & Carl,
2016) and used triangulation with my committee to substantiate my research findings.
These measures ensured that the reported results were not solely a function of my
personal experiences.
Further, no conflict of interest existed related to my role as the researcher in this
investigation. The research was conducted at community addictions clinics and
pharmacies. I attended one community clinic as a faculty advisor to students only. No
contact with patients was ever made at the clinic.
I provided a participation incentive to those who agreed to be interviewed for this
study as a token of appreciation for their time. Participant incentives are anything offered
to individuals to encourage their participation in a study (Tri-Council Policy Statement,
2018). A concern with incentives is how they influence voluntariness of participation.
However, I provided an incentive that was reasonable and not so attractive as to
encourage reckless abandon of decision making (Tri-Council Policy Statement, 2018). A
$20 gift card was provided to any participant prior to the beginning of the interview. If
participants decided at the onset of the interview that they did not wish to participate or
after the interview they withdrew consent for their responses to be used, they were still
given an incentive. One participant received a gift card and decided to leave the study
prior to participating in an interview.
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Methodology
Participant Selection Logic
The population of interest for this research investigation was Canadian women
who identify as having OUD who are in recovery treatment using methadone for any
length of time. A purposeful sampling approach was used to recruit participants who met
the pre-determined criteria that were important to the study (Moser & Korstjens, 2018).
This type of sampling ensures that participants were information-rich, providing in-depth
understanding of the phenomenon (Creswell, 2014; Patton, 2015; Ravitch & Carl, 2016).
The inclusion criteria are as follows: adults over 18 years of age and able to understand
and speak the English language. Since too few participants responded to participate or
met the inclusion criteria, snowball sampling was used to recruit participants through
referrals made by those who had already participated in the study (Creswell, 2014;
Patton, 2015; Ravitch & Carl, 2016). By recruiting from community addictions treatment
centers and local pharmacies, I was be able to ensure that all participants were adults and
seeking addiction methadone treatment.
The number of participants was determined by reaching saturation. Determining
saturation is an iterative process that requires the researcher to continuously evaluate the
data (O’Reilley & Parker, 2012). In qualitative phenomenology, the sample is small and
differs between studies (Moser & Korstjens, 2018). Saturation occurs when no new
information arises in subsequent interviews. Once the study has collected the maximum
information on the phenomenon, data collection is complete. Saturation for data
collection shows patterns, categories, and demonstrates variety in the content. Though
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posing an exact number of participants is not feasible, in most cases, no more than 10
participants are required for phenomenological inquiry (Moser & Korstjens, 2018).
Study participants were informed of the study and provided contact information
through recruitment flyers posted in the community addictions clinics and in local
pharmacies. The flyer contained important information including the name of the study,
the inclusion criteria for participation, and my contact information. The criteria for
participation was females 18 years of age or older who experienced an OUD, understood
and spoke English, and were undergoing treatment with methadone, which was assessed
when potential participants contacted me. Any individuals who did not meet the criteria
were thanked for their interest and dismissed. Once participants arrived at the interview,
they were presented with the consent to participate in the study. I offered to read the
consent with them to address any literacy concerns and ensure informed participation.
Otherwise, participants read the consent form independently. Participants signed the
consent form prior to commencement of the interview. If an interview was done by
phone, the consent was read to the participant and they responded with “I consent.”
Participants were recruited by these methods until saturation was determined.
Instrumentation
Data collection occurred using face-to-face interviews and field notes. Interviews
are considered a conversation where the interviewer is the sole instrument (Cypress,
2018). Using the responsive interview method, a mutual relationship of trust was formed.
A friendly supportive tone was taken with minimal confrontation, and questioning was
flexible in nature (Rubin & Rubin, 2012). In phenomenological research, face-to-face, in-
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depth interviews are the most common type of data collection method (Moser &
Korstjens, 2018). In-depth interviews allow for time and privacy with each person to
elicit rich, thick descriptions of their experiences. In-depth interviews addressed the
research question, which related to women’s experiences. Additionally, an interview
guide (Appendix) was used to ensure that all topics could be covered but the interview
remained flexible and responsive to the participant (Patton, 2015). The interview guide
included open-ended questions as well as detailed questions, follow-up questions, and
initial demographic data to describe the sample (Moser & Korstjens, 2018). I created the
interview guide maintaining focus on the research question and the conceptual
framework. Information gained from the literature review helped formulate questions for
the interview guide (Rubin & Rubin, 2012). Finally, questions were revised and reworded
based on responses and information gained from the first initial interview and continued
to be revised based on subsequent interviews.
As part of data collection, field notes were taken to contribute to the detailed
descriptions and environment that are part of data collection. Field notes provided a
means to collect needed contextual information from the interview and audio recording
the interviews ensured verbatim transcription of responses (Phillippi & Lauderdale,
2018). Immediately after the interview, I wrote field notes that describe the setting,
participants, and the interview including each question answered. Finally, I wrote field
notes of critical reflection of the overall interview and my performance. Writing field
notes of critical analysis helped improve successive interviews by refining questions and
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beginning analysis. Using these data collection methods, audiotaping interviews and field
notes, I fostered detailed descriptive accounts of participant experiences.
Procedures for Recruitment, Participation, and Data Collection
Data were collected from participants by telephone in-depth interviews.
Participants determined the time of the interview within my availability. The location of
the interview was intended to be at the addiction treatment center or at the location of the
participant’s choice if by phone. Two of the centers agreed to allow me use of a private
room with a door to conduct interviews with participants, which would have been
convenient for participants since they are familiar with the location and would not have
had to make an additional trip to the center, thus promoting their comfort. However, this
was not acceptable to the participants due to the current COVID-19 pandemic, so I
allowed for telephone interviews.
I collected the data using an audio recording device and transcription software
purchased for this study. A notepad was used for field notes that needed to be recorded in
real time or immediately after the interview to prevent losing important information that
may have been otherwise forgotten. One interview was done with each participant.
Telephone interviews took between 30 and 90 minutes to perform (Moser & Korstjens,
2018). Allowing the participant to express themselves and divulge their experiences
descriptively takes time. Therefore, each interview differed in length, depending on the
individual participant. Transcription software was used to record participant responses in
real time. An additional audio recording device was also used to ensure accuracy of the
transcription. It ensured clarification if any accents or background noises negatively

84
affected the transcription. It was also a secondary measure to ensure the interview was
recorded if the software had failed. When there were not enough participants to reach
saturation, I continued with the snowball sampling technique to gain participants.
Additionally, a few of the flyers for requesting participants had been taken down, so I put
them back up in the clinics and in additional areas with the institutions’ permission.
Participants exited the study having received a small token of appreciation for
their time in the form of a gift card. Resources for follow-up emotional and psychological
support were provided to participants in the event they required them. Phone numbers for
a crisis hotline was also given to participants. My contact information was again provided
to participants if they had any questions or concerns about the study. Further, if
participants were interested in receiving the study results, I offered to send them a copy
using my Walden email or hardcopy when it becomes available. Closure was provided at
the end of the individual interview by thanking participants and offering the support
resources.
Data Analysis Plan
The data collection methods connected to the research question: What are the
lived experiences of Canadian women with opioid use disorder; who choose methadone
for treatment? The question was most effectively investigated using in depth interviews.
Lived experiences were expressed from the individuals’ own perspective using their
voice. As well, interviews provided a more intimate interaction, where participants could
express themselves. Individual interviews, as opposed to focus groups, allowed for
privacy between the participant and I. The participant discussed personal in-depth
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expressions of their experience; that they may not otherwise have felt comfortable
expressing in a group environment. Additionally, individual interviews removed the
concern of dominance of one or more participants in a focus group. Each individual
participant was given ample time to express themselves which also enabled me to probe
and focus eliciting thick and rich descriptions of participant experiences (Rubin & Rubin,
2012).
Field notes compliment interviews. Once interviews were completed, impressions
were made with field notes of the entire interview that contributed to my understanding
of the phenomenon of interest. Field notes include important information that contributes
to answering the research question. When asked about their experiences, participant
responses elicited emotional reactions: anger, fear, shame, sadness, pride that were some
of the many emotions exhibited by participants. These reactions are not always evident in
audio recordings but contributed to my understanding of the individual experience. My
own reactions were uncovered and presented. Biases and feelings that were experienced
during the interviews were relevant and contributed to my interpretations of the data
(Phillippi & Lauderdale, 2018). The environment was also included in field notes. The
location of the interview including the neighborhood and the room itself can influence the
interview and was recorded. Field notes provided another layer of understanding of
participant experiences by providing additional information that may have otherwise been
lost by interviews alone.
Once the data was collected, I transcribed the interviews using voice to
transcription software called Otter.ai. I used an additional audio recording device to
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ensure that all the interviews had been transcribed accurately, by the software. In IPA, the
analysis of data is flexible and dynamic focusing on meaning within the responses (Smith
& Osborn, 2008). I conducted the data analysis using the seven-step guide by Smith et al.
(2009). The first step in the data analysis guide is reading and re-reading the data.
Reading the transcribed interviews multiple times; and listening to the audio recorded
interviews assisted me to be immersed in the data (Pietkiewicz & Smith, 2014). The
second step in IPA is initial noting (Smith et al., 2009). I freely examined the data for
ideas and meanings of words or phrases, noting them in the margin of the document. The
third step is developing emerging themes from the data. Considering chunks of the data;
including the notes that I have made; I identified potential themes. The fourth step in IPA
analysis is searching for connections across emergent themes. At this stage, themes that
can be integrated or brought to a higher level of abstraction were identified in the
analysis. The fifth step is moving to each sequential case. When moving from one case to
another, I bracketed the themes I identified: in order to be open to any new or different
themes. The sixth step in the guide is looking for patterns across cases. This includes
finding similarities and differences within the cases. I noted patterns and higher order
relationships in this step. Finally, the seventh step is taking interpretation to deeper levels.
According to Smith et al. (2009), the use of metaphors and meaningful words or phrases
deepens the analysis. Additionally, applying theory to the analysis, as a lens for
interpretation deepened my understanding of the analysis.
My first attempt at analysis was traditional, using paper and highlighters in order
to have greater control and ownership over the process (Saldana, 2016). After I noted the
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data; I transferred this information to electronic format. Using some basic functions of
Microsoft Office, I added notes to comment boxes in the right margin of the Word
document. Further, I used color coding for each emergent theme identified in the
passages. Thematic analysis continued in Microsoft Word and connections between
themes were easily noted using track changes. Patterns and interpretations of the data
were identified within Microsoft Word. Handling the data, both manually and in
electronic format helped me explore the data in different ways leading to a more thorough
analysis of the data (Saldana, 2016).
Data analysis concluded after a complete review of the data with my chairperson
and committee member. Analytic memos, field notes and triangulation with my
committee contributed to data analysis, as a reflexive measure. Discrepant cases were
reviewed with my committee for clarification. Results of the analysis were examined in
detail in chapters four and five of this dissertation.
Issues of Trustworthiness
Credibility
The measure of quality for all qualitative research studies includes credibility,
transferability, dependability, and confirmability. The first criterion of credibility is
confidence in the interpretation of the data reflecting the insights and responses of the
participants (Korstjens & Moser, 2018). In other words, is there truth in the findings as
they are represented by the researcher (Lincoln & Guba, 1985). In the study, prolonged
engagement contributed to credibility of the data as well as data saturation. Semistructured interviews included questions distinctly related to opioid use disorder
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experiences, and methadone treatment. Participants were requested to provide examples
of their responses, and asked follow-up questions. Studying the detailed interview
responses at length constitutes prolonged engagement (Korstjens & Moser, 2018). In
addition, methods triangulation and investigator triangulation were employed to enhance
the quality of the study. By employing multiple data collection methods including indepth interviews and field notes in the study, data from both methods were compared to
determine credibility (Korstjens & Moser, 2018). Using investigator triangulation, my
chair, committee member and I reviewed the data and discussed coding, analysis, and
interpretation decisions I made (Lincoln & Guba, 1985; Sim & Sharp, 1998). However,
the position of my chair and committee member is supportive; I conducted the interviews
and completed the analysis. Credibility was achieved in the study employing prolonged
engagement in interviews and triangulation of data collection methods and interviewers.
Transferability
The criterion of transferability is the extent that the findings from a qualitative
study can be applied to other contexts and settings, with other groups of individuals
(Lincoln & Guba, 1985). Although, some authors feel that transferability is not
completely achievable, due to the nature of qualitative research (Erlandson et al., 2003).
Lincoln and Guba (1985) proposed gathering as much contextual data as possible to
encourage sense making. Thick rich descriptions included behaviors and experiences but
also included the context from which the events and experiences occurred. By exploring
context, behaviors, and experiences, it becomes more meaningful for those interested in
the research outcomes. Conducting semi-structured interviews with an interview guide,
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including follow up and probing questions, elicited thick rich descriptions from
participants (Morse, 2015).
The conceptual framework of the theory of self-care of chronic illness supported
transferability. By using this conceptual framework to guide the study data collection and
analysis, others who choose to do research using the same or similar theoretical concepts,
are able to determine if the findings of my study can be applied to aspects of their own.
Other researchers will need to consider aspects such as population and setting when they
determine if transferability is appropriate. Transferability was achieved by providing
thick rich descriptions of participant experiences and the use of a conceptual framework.
Dependability
Dependability is the next criteria for trustworthiness. For a study to be
dependable, the results must be stable over time and under the same conditions
(Connelly, 2016). Dependability is often achieved through credibility measures (Lincoln
& Guba, 1985). In order to achieve credibility and dependability in the study; I provided,
a detailed description of the research methodology, data gathering, analysis, field notes
and produced reflexive analytic memos (Korstjens & Moser, 2018). Documenting
decisions made during the entire research process provided a transparent view of the
research and setting. Aspects of the interview, my subjective responses to the setting, and
the relationship with the participants was contained in field notes, and analytic memos
demonstrating dependability.
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Confirmability
The final criterion for trustworthiness is confirmability. This criterion is
determined by the ability of other researchers to ascertain the same findings from an
independent analysis, of the same data (Lincoln & Guba, 1985). Confirmability is
intended to protect participants’ experiences; rather than being a function of the
interviewers aims (Shenton, 2004). To achieve confirmability, I utilized reflexive analytic
memos, reported my assumptions upfront and managed bias through triangulation
methods. Finally, using theory as an orientating framework also reduced my influence.
Ethical Procedures
Women with addictions receiving care are more vulnerable than the general
population; therefore, they require additional protections when participating in research.
Participation in this research did not interfere with their treatment progress, I am not a
trusted authority figure to the participants, and participation in the research study was
voluntary (Walden University, n.d.). Some of the information participants shared in the
interviews was private and was emotionally upsetting for them. To ensure the wellbeing
of the participants’ mental health, they were referred to counselling services available at
some community addictions treatment clinics and a hotline phone number for the
Community Crisis Center. The crisis phone service is available 24 hours a day, seven
days a week. In addition, if physical or mental health issues were revealed during the
interview, the participants were encouraged to seek follow-up care from their care
provider. Next, due to the private nature if what was shared by participants, the
interviews took place in a private area, at the community addictions treatment center. The
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location was private, but participants were given the option to be interviewed via
telephone. Since the interviews took place at or near where participants are receiving
treatment, or by phone, participants were not challenged with additional travel expenses,
inconveniences, or being exposed to an environment that was uncomfortable for them.
To safeguard the protection of human subjects, the Walden University’s Ethics
Guidelines for Clinical Research (n.d.) were followed meticulously. As well, I applied for
and received Walden’s Institutional Review Board (IRB) approval. I had the community
addictions treatment organizations (planned interview sites), sign a letter of cooperation
from Walden University. Treatment clinics and pharmacies where I only posted the
research recruitment flyer demonstrated cooperation by posting the flyer.
Consent forms were provided to each participant and a signed informed consent
was required prior to participation. If participants had conducted their interview and
decided they did not want their responses used in the research, their responses were
removed from the research data. Participants were informed of their right to refuse to
answer any of the questions or withdraw their participation in the study, at any time
during the interview. This was indicated within the consent form and I reiterated this
verbally at the onset of the interview. All other ethical concerns that involved
recruitment, data collection, and analysis were addressed with careful methodological
planning.
Every effort was made to protect the data and participants’ identity. Data from the
interviews was audio recorded using transcription software and a recorder that was
purchased for this study. Interview transcripts were saved on my password protected
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computer at work, located in my locked office. The printed versions of the transcripts
were stored in a locked file cabinet in my office and stored separately from other work
documents. My committee members and I were the only individuals with access to the
data for the purposes of feedback and triangulation during analysis. The transcripts were
kept in a locked cabinet in my office and will remain there for five years and at that point,
they will be destroyed. Transcripts saved on my work computer will also be deleted at
this time. Although anonymity cannot be guaranteed, efforts have been made to protect
the identity of participants including assigned pseudonyms for each participant which
was used when interviewing and reporting the data. Also, masking the locations from
which participants were recruited helped to ensure confidentiality. These methods were
used to protect the identity of participants and integrity of the interview data. When
reporting the data, some individual responses were used as exemplars of thematic
patterns, but no real names were used, only pseudonyms.
Each participant received a small token of appreciation for the time and travel
they had contributed to this project. A $20 gift card was given to each participant who
agreed to participate and attended their interview. The gift card can be used at a store to
purchase personal care items, baby items, and food that might be helpful to participants.
If the participant changed their mind and did not want to participate, or if they decided
they do not want their responses used in the research report, they were informed they
would still receive the token of appreciation for their time and travel.
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Summary
Interpretive phenomenological method was chosen to investigate the lived
experiences of women in Canada with OUD, who use methadone for treatment. IPA
focuses on the hidden experiences of human beings and how they interpret it (Lopez &
Willis, 2004). The role of the researcher in IPA is to report on the meanings or essences
of the experiences of the participants, through their responses (Sloan & Bowe, 2014). The
potential for confirmation bias was mitigated using field notes and triangulation.
Participants were recruited from community addictions treatment centers and
from customers of local pharmacies. Purposive sampling was used to ensure that the
research question could be answered; snowball sampling was used when too few
individuals chose to participate to reach saturation. In-depth interviews and field notes
were the sources of data collection for this study. Interviews are the most common data
collection method in qualitative analysis (Moser & Korstjens, 2018). Transcription
software and an additional recording device were used to ensure all responses were
captured accurately. After data collection, data analysis proceeded using the seven steps
of IPA data analysis by Smith et al. (2009). The steps included reading and re-reading the
data, initial noting, developing emergent themes, searching for connections across
emergent themes, moving to the next case, looking for patterns across cases, and taking
interpretations to a deeper level. My committee contributed to triangulation of the data.
Issues of trustworthiness of the data were addressed using the framework from Lincoln
and Guba (1985).
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Ethical considerations were applied to this study to protect participants.
Participation in this research did not influence their current treatment. All aspects of the
Walden University Ethics Guidelines for Clinical Research (n.d.) were followed
meticulously. Approval from the Walden IRB was obtained before commencement of the
data collection process. Chapter 4 will report the findings of the research. Chapter 5 will
provide a comprehensive interpretation and discussion of the findings.
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Chapter 4: Results
The purpose of this study was to describe the lived experiences of women with
opioid use disorder who were receiving methadone as their treatment of choice. By
understanding their experiences from their personal perspective, healthcare professionals
will be able to provide women with individualized health promotion strategies and
treatment (Rubio, 2016). This could lead to further research and eventually to better
outcomes for women who are experiencing OUD. Thus, these findings may eventually
improve the quality of life for these women. To investigate the research question on
addressing the lived experiences of Canadian women with opioid use disorder using
methadone for treatment, an IPA was taken for this research.
In this chapter, there will be a detailed description of the setting of the research
and presentation of the study participants’ demographic information as it relates. Next,
details of data collection, including interviews and field notes, are presented. Only
participant pseudonyms are used when presenting the data. The process of data analysis is
discussed next. Methods of coding, secondary coding, subtheme development, and final
themes are presented in detail to provide a clear image of how final themes were
developed in a stepwise fashion. Evidence of trustworthiness, including credibility,
transferability, dependability, and confirmability, are also addressed. Finally, a detailed
exploration of the results of the study is provided along with a summary of the answers to
the single research question.
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Research Setting
Changes in the conditions at the addiction treatment center included
organizational and personnel. The arrival of the COVID-19 pandemic during the months
of data collection also contributed to variations in the treatment center operations. First,
the organization where the research participants were recruited had undergone changes in
personnel. The counselor that was employed in the addiction treatment center had
recently begun maternity leave, which meant that there was no onsite counseling for
participants if there was a personal concern after their interview. However, the
participants of this study were presented with other counseling service options in the
consent form, and resources for psychological support were addressed with participants
verbally prior to the interview.
Another personnel change occurred with a member of the clerical staff, as the
intake person was not working at the present time due to the COVID-19 pandemic. The
intake person’s absence meant that one of the participants was unable to receive
injections for pain in her back and forehead as she had at a previous treatment center
because no one was available to process her information.
Other changes had been made in the addiction treatment organization in response
to the COVID-19 pandemic such as the availability of hand sanitizer, distancing from the
pharmacy and treatment center desks, and requirements for wearing a mask. In addition
to this, attending the addiction treatment center to receive care and methadone medication
during the pandemic may have produced additional stress that might influence
participants’ experiences at the center. Staff members indicated that patients usually
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come to the center and leave quickly after receiving their treatment. However, it is not
known if this is due to concerns regarding exposure to the COVID-19 virus. These
changes in conditions at the addiction treatment center may have influenced participant
responses and ultimately the interpretation of the study results.
Demographics
Women in the study did not vary widely by demographics. The women were
between the ages of 28 and 42 years old with a mean age of 36. Most participants, four of
the seven, were in their 30s. Six of the seven women were in relationships with a male or
female partner. Five of the participants indicated that they were living common law with
their partners, meaning they were unmarried but cohabitating. Six of the seven
participants had children, with two of the participants having children still living in the
home. Four of the participants had children, but they were living elsewhere other than
with them. This demographic information is related to the research question and
contributes to a fuller understanding of women’s experiences of OUD and choosing
methadone for treatment.
Data Collection
Seven female participants volunteered to be part of the study and participated in a
single interview. The interview included a collection of demographic data and responses
to interview questions. Interview questions evolved with each consecutive interview
based on responses and information gained from each participant. Each woman met the
following inclusion criteria: adult women over 18 years of age and able to understand and
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speak the English language. In addition, each woman was using methadone for the
treatment of opioid use disorder.
Recruitment flyers were posted in two additional treatment centers in central
Ontario. Flyers were also posted in the attached pharmacies at both treatment centers.
Initially, the flyers were posted throughout the centers and pharmacies. After two weeks,
the flyers were removed, and a single flyer was posted in a designated area at the
entrance of the facility, where a new bulletin board had been created.
All data collection occurred by telephone interview. I completed interviews in my
home office, where I have a private work area with a locked door. Each interview took
less than 90 minutes. The first interview happened within a week of posting recruitment
flyers at both sites of the addiction treatment center and pharmacies. In fact, the first six
interviews occurred between June 12, 2020, and July 2, 2020. The final interview
occurred on September 11, 2020. No more than one interview per day was scheduled to
allow me to review each recording and download it to transcription software and make
notations in my field notes. Additionally, the deeply personal nature of the women’s
shared experiences made it necessary to take time for myself in between interviews.
Field notes allowed the collection of information related to the setting, the
participants’ privacy, and interruptions when they occurred. Emotional responses to
interview questions such as hesitating, crying, shame, pride, or frustration were also
noted in the field notes. Unfortunately, due to the COVID-19 pandemic all interviews
were completed by phone; therefore, no facial expressions or body language was
observed. However, this information contributed to a clearer understanding of
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individuals’ experiences. Finally, I used field notes to critically reflect on the overall
interview and my performance as an interviewer. By collecting this information, I was
able to consider my responses and how the questions were asked. This led to improved
interviewing and refined interview questions as the interviews progressed. Additional
notes made were based on my own personal reactions to participant responses. For
example, a participant whose pseudonym was “Amanda” discussed her experience with
having her son taken by CPS and how she has re-established a trusting bond with him
over time. This information was difficult for me as a mother, and I could feel my own
emotions during the interview. In my field notes dated July 2, 2020, I wrote,
Amanda’s deep love and sacrifice for her son is something I can relate to. I feel
admiration and sadness at her sacrifice to leave her home and allow her exhusband to have custody. This must have been heart-wrenching for her. I would
hope that I would display this courage if I were in her place.
These feelings and any biases are relevant and contributed to my interpretation of the
data.
Data were recoded using a Sony recorder purchased for this dissertation. The
recorder was then plugged into my personal laptop, and the interview was downloaded
into Otter.ai, transcription software. Once the software finished downloading, the
interview transcripts were saved on a password-protected computer. Notations were
recorded on a small, coiled notebook beside my computer.
There was little deviation from the original data collection plan. Deviations from
the original research plan include the number of participants and the opportunity to
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conduct face-to-face interviews. The number of participants diverged from what was
planned. in the third chapter of this dissertation. After each interview was conducted, I
was able to listen and re-listen to participant responses, transcribe the interviews with
assistance of the transcription software. At this time, the initial noting was completed and
as this was accomplished for each interview, comparisons were made and noting refined.
After the sixth interview, I was convinced that I had reached saturation. But on
September 11, 2020, I had the opportunity to complete a seventh interview and continued
data analysis; however, again I was convinced that the data had reached saturation. After
a lengthy discussion with my committee, I was confident that I had reached saturation.
Saturation is not reached by a specific number of participants but by continuously
evaluating the data (O’Reilley & Parker, 2012). In qualitative phenomenology, the
sample is small and differs between studies (Moser & Korstjens, 2018). Saturation is
determined by exhibiting patterns, categories, and demonstrating variety in the content,
which had occurred. For these reasons, I was certain that saturation had been reached,
though it was with a different number of participants than expected as noted in Chapter 3.
The second variation from the plan in Chapter 3 was completing face-to-face
interviews. Due to restrictions of the COVID-19 pandemic, all interviews were conducted
by telephone, which posed challenges. Audio recordings were not always clear and
required repeated playing to ensure accuracy. Moreover, telephone interviews removed
the opportunity to observe facial expressions and body language, which can provide
valuable interpretive data. Participants also indicated that using their telephones for
lengthy interviews was a challenge. Some potential participants used calling cards and
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would not participate in a lengthy interview for that reason. Others found it challenging
to find privacy for the length of the call and were interrupted, although infrequently,
during the interviews. COVID-19 may have also discouraged participants from
participating and potentially increased stress levels that may have influenced their
behavior. However, the telephone interviews still provided the valuable data needed to
answer the research question despite these challenges.
Data Analysis
The inductive process moving from individual coded units to broader
representations was completed using the 7-step process of IPA by Smith et al. (2009). In
the first step of this process, I was able to listen to the audio recording and read through
the transcribed recordings, making changes where the Otter.ai software was not accurate.
Once this was complete, I read each transcript in its entirety for clarity. This process
immersed me in the original data.
I performed another reading of each transcript, once the interviews were
completed and transcribed, to complete initial noting of the data and form codes. This is
the second step of IPA. I coded each transcript, first using hard copies of the data. I
indicated the codes in the margins of the transcript. The first cycle coding method used
was initial coding, otherwise known as open coding (Charmaz, 2014). Using this method,
the data are broken up and examined as parts of the larger whole (Strauss & Corbin,
1998). Initial coding is intended to be flexible, as the codes may change as the analysis
progresses. When coding, the coded parts are scrutinized for their similarities and
differences and decisions are made to maintain or modify codes. A word or short phrase
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is given as a code for each part. This type of coding is done line by line and is appropriate
for interview transcripts (Strauss & Corbin, 1998). After using the open coding method, I
reviewed all transcripts and completed a second round of coding, finishing with a total
384 codes. All codes derived from the data were transferred into a code book that make
analysis more organized and logical. Themes began to emerge within the codes of each
individual transcript.
In this third step of IPA, I used color highlighting on my computer to cluster the
codes and begin to develop themes. In this cycle of analysis, I used a pattern coding
method to collapse the large number of codes into more meaningful, focused units of
analysis (Miles et al., 2014). The intention of using this process was to support the
eventual development of larger themes in the data as analysis continued.
The fourth step of IPA, thematic analysis, occurred next. The purpose of this step
was to find connections between the themes, as they became more conceptual and
cohesive (Smith et al., 2009). Again, I used color codes to chunk the themes. Each
subsequent interview transcript, or case, went through the same process; step five of IPA.
A total of 34 subthemes emerged from the codes. After conferring with my committee, I
chose to complete a second round of subthemes, collapsing the 34 subthemes into 14
second level subthemes. As each case was examined, patterns of shared higher order
qualities were considered between the cases; the sixth step of IPA. Once this process was
complete, four major themes were established. The major themes included sense of self,
experiences with methadone, accessibility, and supportive others.
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In the final step of IPA, interpretation is taken to a deeper level. Once again, I
reviewed the transcripts to find deeper and more meaningful ways to represent the data in
the four major themes. Participant statements were discovered that encapsulated the
themes and it was felt that using the participants own words would enhance the
meaningfulness of the themes. The major themes were then renamed as learning how to
be you again, reaching out for help, finding your way to methadone, and going down the
path of methadone.
Using the seven steps of IPA from Smith et al. (2009), each step of analysis
allowed for deeper interpretation, allowing the essence of lived experiences of
participants in written form (Sloan & Bowe, 2014). This process produced four major
themes that best represented the data. Data analysis occurred with ongoing feedback from
my chair and committee member. The discussions included topics of saturation, analysis
measures, and suggestions for improvement. Analysis concluded after multiple reviews
and discussion with my committee member and chairperson. Discussion and feedback
contributed to data analysis as a reflexive measure.
Discrepant Cases
Discrepant cases existed among the data set; however, when discovered,
discrepant cases were factored into the analysis. One discrepancy in a response from a
participant whose assigned pseudonym was “Ella” was that she could not get “carries”
because she was still using “Ice.” Carries are doses of methadone that are taken
independently, meaning that the person taking the dose does not have to attend the
pharmacy for witnessing ingestion on those days. Getting carries occurs once the person
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demonstrates their commitment to receiving treatment daily and have had urine
specimens that are negative for street drugs for a defined period. Ice is a
methamphetamine not an opioid drug. Even though Ella was still using illicit drugs, she
felt that the purpose of accessing methadone was to get off opioids, which she states she
was. Ella felt that since she was not using opioids, she should still get carries regardless
of her urine samples coming back positive for Ice, a methamphetamine. Ella admitted to
still using illicit drugs and was the only participant to do this. However, the inclusion
criteria did not limit her participation, only that she was on methadone for opioid use
disorder, which she was. Additionally, it is not uncommon for individuals receiving
methadone treatment to use illicit drugs simultaneously. This discrepancy in the
participant’s response was handled by incorporating it into a broader theme of going
down the path of methadone.
One participant also provided a discrepant response related to the effects of
COVID-19 on their treatment experience. A participant whose assigned pseudonym was
“Evelyn” indicated that due to the changes in the current work environment, her
boyfriend was not working. She offered that if he was working, she would be forced to
take her two children with her to treatment, possibly taking two busses to get there and
back. Otherwise, she would have to find childcare each day. Since Evelyn’s boyfriend
was not working, he was able to take care of the children while she attended treatment.
Although her oldest child is school age, schools were closed during this time due to
COVID-19. Evelyn did indicate a negative influence of COVID-19 on her treatment; she
spoke of changes in the bus system that challenged her ability to attend methadone
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treatment including limited bus times and limits to the number of passengers on each bus.
However, one good outcome was Evelyn had childcare in home. In contrast, all other
participants who spoke of the effects of COVID-19 on their treatment experience
identified negative effects only. This discrepant case was included in the data analysis
and contributed to creating the theme of effects of COVID-19. In this way, all responses
were included in a broader context. Additionally, all discrepancies in responses were
discussed with my committee.
Evidence of Trustworthiness
Credibility
To ensure trustworthiness in this qualitative study, the criteria of credibility,
transferability, dependability, and confirmability were addressed. The first criteria of
credibility relates to confidence that the data is representative of participant responses and
insights (Korstjens & Moser, 2018). In other words, has the researcher truthfully
represented participant responses? Prolonged engagement and data saturation were used
as measures of credibility. Reading and reading transcripts, reviewing audio transcripts,
and studying responses in detail to perform analysis constitute prolonged engagement.
After prolonged engagement with the data and confirmation with my chair and committee
member, it was determined that saturation had been reached after seven participants.
Semi-structured interviews were performed, and questions reflected experiences with
OUD and treatment (Appendix). Questions were modified after the first interview and
throughout the data collection to address participant experiences more adequately.
Participants provided detailed examples of their experiences and answered follow up
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questions, for clarity and detail contributing to credibility of the data. In addition,
methods of triangulation and investigator triangulation were employed. Data was
collected through in-depth interviews and field notes. Data from each data collection
method was compared for accuracy and clarification, during data analysis. As well, my
chair, committee member, and I conferred over the data and engaged in discussion
regarding my coding, analysis, and interpretation decisions. This led to revisions and
additions to the analysis. Credibility was achieved using the methods of prolonged
engagement in interviews, saturation, and triangulation of data collection methods and
interviewers (Korstjens & Moser, 2018; Lincoln & Guba, 1985; Sim & Sharp, 1998).
Transferability
Transferability criteria is described as the ability of a qualitative study to be
applied or transferred to other contexts while still maintaining context richness (Lincoln
& Guba, 1985). Thick, rich descriptions help to achieve transferability. In this study,
behaviors and experiences became more meaningful when the context was explored in
semi-structured interviews. Participants responded to interview questions previously
developed in an interview guide (Appendix C). However, the interviews remained
flexible and participants provided insights and interpretations, from their perspective.
Follow up questions were asked and elicited more robust responses and provided context,
contributing to deeper sense- making of the data (Lincoln & Guba, 1985). Semistructured interviews that remained flexible with follow-up, probing questions, provoked
thick rich descriptions from participants during data collection.
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The conceptual framework of the Theory of Self-Care of Chronic Illness
supported transferability. By using this theory to guide the study data collection and
analysis; others who choose to conduct research with similar theoretical concepts, can
make the determination of applying my study findings to their own. Population and
setting are additional considerations for researchers to determine transferability. Analysis
and interpretation of the findings, in the context of the Theory of Self-Care of Chronic
Illness, are further delineated in chapter five of this dissertation. Thick rich descriptions
of participant experiences and the use of the conceptual framework, The Theory of SelfCare of Chronic Illness, endorse the criteria of transferability.
Dependability
The next criterion for trustworthiness is dependability. A study is considered
dependable if the results are stable over time, under the same conditions (Connelly,
2016). In qualitative research, dependability and credibility measures are often mirrored
(Lincoln & Guba, 1985). Dependability and credibility were achieved by providing a
detailed description of the research methodology, data gathering and analysis, within
chapter four. Reflexive analytic memos were produced during data analysis and provided
evidence of each step in the analytic process. A data analysis table indicating codes, first
and second level themes, and finally, larger themes was made. Developing this table was
not a strategy planned in chapter three. However, the document materialized as an
organizational measure and provides a transparent view of the rational for moving from
codes to larger themes. Descriptions of research methods, data gathering, analysis and
reflexive analytic memos; all contribute to dependability in this study.
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Confirmability
The final criteria considered for trustworthiness is confirmability. Confirmability
is determined by an independent researcher finding the same results of a study based on
their own analysis (Lincoln & Guba, 1985). The intent is to prevent researcher bias from
dominating the findings; rather than exposing participant experiences (Shenton, 2004).
To achieve confirmability reflexive analytic memos were utilized to delineate each step
of the research process. Field notes were used to expose researcher assumptions that may
contribute to bias. Additionally, triangulation methods and researcher triangulation were
utilized. Finally, using the Theory of Self-Care of Chronic Illness further reduced my
influence in the analysis and interpretation of the data. Memos, fieldnotes, triangulation,
and an orientating theory supported confirmability in the research.
Study Results
The single research question for this dissertation is What are the lived experiences
of Canadian women with opioid use disorder who choose methadone for treatment? The
process of data analysis using IPA by Smith et al. (2009) led to four major themes that
evolved in the interpretation of participant responses. The themes derived from
participant statements include learning how to be you again; reaching out for help;
finding your way to methadone; and going down the path of methadone. Each of these
major themes offers insight into participant experiences with methadone treatment and
are illustrated more clearly in the Venn Diagram of Major Themes (Figure 1).
This section of this dissertation is organized by major themes. Detailed
information to support the evolution of each major theme is presented. Direct participant
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quotes provide textual descriptions of their lived experiences to support the identified
major themes. However, consistent with the concept of constitutionality in qualitative
research, findings are a combination of meanings of the investigator and participant;
leading to plausible interpretations justified by participant responses (Annells, 1996;
Koch, 1995). Essentially, there is no single interpretation of the data. In this section,
women’s experiences with OUD and methadone treatment are offered with interpretation;
to better understand women’s meaning making of this phenomenon. The collective
narrative summary was constructed to highlight the essence of women’s accessing
methadone treatment. Each major theme presents a segment of the interpretation of
women’s experiences.

110

Figure 1
Venn Diagram of Major Themes
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Learning How to be You Again
Many of the women in this study made statements pertaining to their ability to be
themselves and independently make decisions. Women offered a sense of self
determination that was captured in many of the statements. Each woman may have
phrased it differently, but each indicated a sense of self and how their recovery with
methadone was dependent on their decision making and self-determination. The second
sub-themes were evident in their sentiments including: motives for change, mothering
role, hiding and gender specific understanding.
Amanda, the sixth participant, was asked what helps her stay in methadone
treatment? She answered: “myself”. She also indicated that “just not wanting to use” was
her internal motivation for staying in treatment. Jen, the final participant offered insight
related to her self-determination to remain in treatment.
I don’t want to be like that no more. I want to be better. Honestly, I don’t want to
be like that (addicted to opiates). I want to be happy. I don’t want to be miserable
on drugs. It’s not fun. I enjoy life so much better (on methadone).
Another participant named Becky offered the following insight regarding her plan
to complete her treatment with methadone and move forward with her life. Other
participants also felt as though methadone treatment was not a lifelong treatment. Becky
expressed desire to transition off methadone at some point in the future.
And I find that I am a strong enough women because I’ve done it before without
and I just gotta find, I gotta find me, right? So, I’m gonna go to counselling and
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I’m gonna try to empower myself through other things. And I’m hoping that I can
cut that ball and chain off my ankle for the rest of my life.
All but one participant indicated that they had experienced relapse during their
methadone treatment or previous suboxone treatment. Yet, despite setbacks such as
relapse, women continued to be resilient and were determined to work towards treatment
rehabilitation. Despite being disappointed in herself for relapsing, Mary indicated that she
was confident in her ability to be successful in treatment again.
…and then I relapsed, used again for a while and relapsed and went back again.
Around March, I went back in to start treatment over again. I knew I could do it, I
did it before.
Some women indicated that methadone treatment offered an opportunity to
restore their lives. Jen offered that her decision to go on methadone changed everything.
She now had an apartment, her children in her life and a supportive significant other.
Another participant named Daisy indicated that she had to relearn many of the skills that
she had forgotten or left behind when she began to use opioids. Daisy compared being
addicted to opiates, to being like a child.
You have to learn to rebuild your life. You got to figure out how to be that adult
again. When you’re a drug addict, it’s like you are worse than a kid. Like, you
will cry and steal from people, just to get what you want right? Your basically
worse that a child. Because a child has reasons, you know, they are kids, they are
learning. There’s reasons they act the way they do. The drug addict knows… how
not to act like that and still chooses to just so they can get their high. Like, I know
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it’s not okay to steal from this person but hey, I need to get high. Like, you have
got to learn how to be who you are again.
Becky expressed how methadone treatment can present possibilities for women
living with opioid use disorder to improve their lives. Her statements were hopeful and
positive for the future.
We have treatment that betters human beings lives, that means they can better
themselves. And that means they can be more productive on an everyday basis.
So that they will be able to study and get a job and you know, they can get off of
welfare and they can maybe have a family and have kids and just live a normal
everyday life and be happy. It’s happiness at the end of the day that people look
for right?
Collectively, the women noted a point at which their opioid use disorder led them
to decide that change was critical. Many of them noted that losing custody and contact
with children finally was a culminating factor that led them to decide to stop taking
opioid drugs and get treatment. However, each participant had their own version of a
breaking point that led to methadone treatment. Becky, who had adult children who lived
abroad for school, indicated a multitude of factors that culminated in deciding to get
treatment for OUD.
So realizing, no I actually OD’d (overdosed). That sort of gave me a wake-up call.
And the fact that everything in my life was falling apart. I found myself without
work, I lost my job. I lost my family. I lost my friends. I was losing my
relationship, my wife and myself. So I decided to go into treatment.
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In the final interview, Jen’s experience included violence and homelessness as
factors leading to her deciding to get methadone treatment. When asked what led her to
methadone treatment, Jen provided the following answer.
My life was completely over. Like, I was in a motel. The guy I was dating beat
me. I was worried about how I’m gonna pay my motel. How am I gonna live? I
don’t want to have all my bags and be in the street. I’m losing everything. I can’t
even pay my room to live in let alone have a drug problem and pay for that. It was
terrible. I got to a point where I was on the street with bags and nowhere to go.
And my boyfriend said you need to get on methadone at that time. I was very,
very sick from withdrawals.
All the women who had children indicated their role as a mother was prominent in
their decision to get addiction treatment. Many women saw methadone treatment as an
opportunity to get access to their children and begin to re-establish their relationships
with them. As Mary indicated “A lot of them (women) are going through the methadone
program to show, and get clean, so that they can get their children back”. After
experiencing opioid use disorder and receiving methadone treatment, Evelyn indicated
that “being a mom, it (methadone) makes me feel more alert and happy, before I
wasn’t…” Ella, a study participant, discussed how methadone provided an opportunity to
get her “family back together”. Ella had lost custody of her children, who live with their
father, her husband, and her home.
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I am a mom of three and they are with their dad. I’m on methadone so I’m just
trying to get my life together right now. And I am waiting to get into rehab right
now. I want to get my kids back into my life.
One participant Amanda expressed a close loving bond with her son. Despite
being on methadone for more than 15 years and not living in the same home as him,
Amanda felt that her decision to have her son live with his father was the best for him.
...I knew it would be no life for him in the city. I knew it would be a better life for
him in the country with his dad. Leaving him in the school, leaving him in the
matrimonial home…
Similarly, Daisy discussed “a mother and child’s bond” expressing her love for
her son and his attachment to her. However, the decision, as a mother, knowing what is
best for him, is priority.
That’s my baby, you know, but he still loves me to death (despite her drug use).
He’s like; I’m his number one mom no matter what I do. I am the best person in
his world, like he wants to live with me still and everything and I’m like, oh babe,
I wish that was possible.
The theme of hiding was prevalent in many of the woman’s experiences. Woman
hid their opioid use and methadone treatment from several others including families,
significant others, bosses, and landlords. When women experienced relapse, they also
expressed hiding this from others due to feelings of guilt, shame, and embarrassment. For
example, Becky relapsed while in treatment with suboxone, before going on methadone,
and was hiding this, among other things, from her spouse. Unfortunately, that meant that

116
she had to go through relapse and treatment initiation alone. Similarly, Amanda hid her
opioid use from her family after she completed detoxification treatment and was without
any illicit drugs for four months. Amanda admitted that she didn’t admit this to her
family because she felt like a failure. After attaining methadone treatment completely on
her own, Amanda still had fears related to her ability to care for her son and concerns of
how her relapse would affect others.
I just didn’t want to be sick (going through withdrawal) because if I went home
sick, everybody would know what I was going through again and then my son, I
wouldn’t be able to take care of him as good as I should be able to and I just felt
like I was letting everybody down. So it was scary.
Ella hid her methadone treatment from her landlord due to fears that he might
discriminate against her. Unfortunately, Ella was right and at the time of the interview
was having to actively look for another place to live due to being harassed by her
landlord once he found out. Amanda had similar concerns with telling a potential
employer that she would need to have one afternoon off a week for her appointment with
the addiction treatment doctor. She indicated that she would hide her treatment from them
“because then they look at you like you’re a drug addict.”
Some of the women did not recognize their experiences with methadone being
different than men’s. Daisy answered that she had not considered it and stated that “we
are all the same”. Yet, Amanda, who initially stated that she looked at it as the same as
being a man in methadone treatment, paused and stated that since women care for
children and also carry children; that women’s experiences are different. She elaborated
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on how women, such as her sister, who are pregnant and on methadone are discriminated
against, referring to her nephew as a “methadone baby”. Mary interpreted the question a
little differently than Daisy and Amanda and discussed the gender stereotypes that
women with opioid use disorder experience.
Participants in the study offered valuable insight into their sense of self and selfdetermination as indicated in the major theme of Learning How to be You Again. The
second sub-themes were evident in their sentiments including: motives for change,
mothering role, hiding and gender specific understanding. These women discussed how
they saw treatment as an opportunity to improve their lives, their motivations for getting
into treatment despite setbacks and how they arrived at a point of readiness to change
their substance use behavior. Additionally, the influence of children on treatment
decisions and reasons for hiding treatment was evident in women’s responses.
Reaching Out for Help
When seeking treatment for opioid use disorder, women in this study experienced
a variety of responses from those who were considered supportive others. These
responses came from family, friends, significant others, healthcare professionals and
community support. The responses from supportive others included positive encouraging
statements and behavior; as well as negative discouraging statements and behavior. Each
woman experienced reaching out differently; but expressed common threads that led to
the major theme of Reaching Out for Help. Participant responses included elements from
the following second sub themes: systems of support, referred ignorance, and positive
emotional engagement.
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Woman in the study indicated that there was a difference in treatment by
healthcare professionals, from those who worked in addiction treatment and those who
worked in other sectors. However, responses from participants were positive overall
when asked about treatment for opioid use disorder. Jen felt very strongly that healthcare
providers were a source of support to her and others. This is evident in her statement:
…if you really want help, everybody in healthcare would in turn, put their back
down, like everybody will help you as long as you want help That’s what I
believe. I … I’ve had nobody, when I asked for help, I’ve had nobody say no, like
especially if you’re in a really bad moment and you feel like using, talk to
somebody, you can call the crisis line.
On the one hand, all the women in the study were complimentary when discussing
the pharmacy at the addiction treatment center. Additionally, participants were sincerely
appreciative at the care they received from the addiction treatment physician. Evelyn’s
response was poignant and warrants repeating; “But my doctor, he saved my life. I owe
my life to my doctor, he’s, he’s, he’s amazing. …not everybody has those, right?”
On the other hand, women felt that treatment, from larger pharmacies and
healthcare providers that were not specifically associated with addiction treatment, were
not supportive and sometimes were judgmental. After attending a large pharmacy for
methadone treatment initially, Mary found that when it was time to go for treatment, she
was experiencing anxiety due to judgement from the staff. Her statements are concerning
because she revealed that their judgmental treatment deterred her from receiving
treatment, at times.
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…there were times when I had so much anxiety from the buildup to go (to the
pharmacy) and be judged. Like, I think they thought I looked high, like I would
make sure I was always showered right before I go. I didn’t want them to like, if I
was cleaning up around the house and like a little bit sweaty with my hair in a
bun, I didn’t want them thinking that like I was just coming off a bender and like
just constant judgment from the bigger chain pharmacy.
Although the treatment by healthcare providers in non-addiction treatment roles
were found to negatively influence treatment experiences; two of the women in the study
expressed understanding of the frustration that healthcare providers must feel, when
dealing with patients who have SUDs. For example, Becky discussed attending the
emergency department and while she felt the treatment was not positive, she did express
empathy for all the staff who cared for those with SUDs.
I understand their frustration because, I’m not there every day, I don’t see them
[individuals with SUDs] and I don’t experience what they are experiencing daily,
having to deal with people who don’t want help and just want to get high, so it’s
gonna be frustrating. But…you know, you chose that occupation, and you need to
be prepared for these things. You need to know that with that occupation, these
kinds of things are gonna happen. So, you need to have patience with them. And
if you don’t have patience…they’re not going anywhere; those things are never
going to change (drug seeking).
Significant others and close friends and family had an influence on treatment for
women accessing methadone for opioid use disorder. Often women felt that when there
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was a lack of support it was due to ignorance or lack of knowledge of methadone.
Evelyn’s boyfriend did not understand that methadone was used for opioid use disorder.
Initially, he thought that methadone was only for individuals taking methamphetamines.
When Evelyn told her boyfriend, she felt attacked by his emphatic reaction. However,
once she reviewed the information with him and he saw the positive effects of methadone
treatment on her life, he became supportive. Similarly, Mary’s significant other
discouraged her from receiving methadone treatment due to her significant other’s initial
ignorance.
She clearly didn’t understand the disease and I believe it is a disease. Addiction is
a disease and is genetic and runs in my family. She actually didn’t understand it.
She just thought it was a choice. And I tried to explain to her you know, at first it
might have been a choice but now its, its, its not a choice anymore.
Unfortunately, some of the women did not receive support from their families and
friends. Ella discussed her best friend who commented that she shouldn’t be on
methadone or anything else. She told Ella that she should “just be clean”. It did not come
as a surprise that Ella felt that more positive support services would be helpful for women
receiving methadone treatment. Similarly, Daisy had experienced negative interactions
with friends and a family member who were not supportive of her treatment. Daisy’s
friends made statements that appeared to be supportive but immediately following, they
would offer to give her drugs to get high. Daisy’s sister followed suit. Her sister
attempted to sabotage Daisy’s methadone treatment by offering her elicit drugs even
though she was aware of Daisy actively working towards recovery. Several of the women
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noted that removing yourself from those who are not supportive, or those who you used
to use opioids with is critical to staying on methadone treatment and not using illicit
drugs.
While some women found a lack of support from family and friends, others were
grateful for the support they were receiving from them. Becky’s family was no longer
present in her life, but she spoke optimistically about the friendships that she had
developed by being honest about her experiences with opioid use disorder and treatment.
My friends, I have a good group of friends. I have some really, really tight knit
friends that no matter what time of the night I can call them, and they will be
there. So that’s a bonus for me. Not everybody has that.
Similarly, one participant, Amanda found that once her parents also entered
methadone treatment; it improved their experiential knowledge and hence improved their
relationship. Amanda indicated that it gave them insight that she was not using illicit
drugs and that methadone had positively influenced her life. As well, Amanda felt her
parents understood and empathized with what she had experienced receiving methadone
treatment for opioid use disorder contributing to a closer bond between them.
The women unanimously felt that having a significant other, who was also in
treatment for opioid use disorder was advantageous. Six of the seven women had partners
who were currently receiving treatment. Mary indicated that having both partners in
treatment was essential; each partner was able to keep the other accountable. In fact, she
felt that being in treatment together actually brought them closer together. Mary
identified another advantage to both partners being in treatment together, “you know the
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lies so you know when the other one is lying.” Another participant, Amanda, began using
opioid drugs with her current significant other. Although she felt initially that their
relationship was “codependent”, she later felt differently.
But now he’s on suboxone and I’m on methadone so it’s nice because we know
what each other went through and we’re there for each other and it’s awesome. I
wouldn’t change it.
Some of the participants had significant others already in treatment for opioid use
disorder; when they themselves began treatment. Their presence in treatment had an
influence on the women to attend treatment themselves. Jen claims her significant other
was already on methadone and was the one who told her about methadone, encouraged
her to get treatment and attended her first treatment. “The guy I am with right now said,
Jen, you should go on methadone, and I went on methadone and it changed my life.”
Community organizations played a significant role in the women’s experiences
related to supportive others. Some experiences with these organizations was very
positive, while others were negative. Either way, participants were emphatic regarding
their experiences creating a polarity in responses. The community organizations most
mentioned were the Children’s Aid Society (CAS), police services, counselling services
from various organizations and withdrawal management services (otherwise known as
Detox).
Women had very different views of their treatment by CAS. Ella was pregnant
when she interacted with the CAS and expressed concern that they were not at all
supportive and that she felt judged by her worker. Ella insisted that she understood the
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significance of CAS; but recalled a difficult experience when she was in contact with the
organization.
I was on suboxone and they had contact (with her) but it was not helpful because
you make one mistake and you are in trouble. They don’t understand that relapse
is a part of recovery. My worker, she would tell me that she knew nothing about
suboxone. And I thought, why are you my worker?
Similarly, another participant, Amanda, recounted a painful experience with CAS
where she felt they unnecessarily removed her son from the family home. While Amanda
acknowledged that the job of CAS is to protect children who are in danger, she was
frustrated because her son was never at risk. Yet he was still removed from the home.
Amanda indicated that she should have been taken out of the home and not her son. This
was clearly upsetting for Amanda and left her with a negative opinion of this community
service.
In contrast, Daisy credits her CAS worker with having a positive influence on her
treatment access. The CAS worker supported her getting into treatment and continuing to
have access to her son. Yet, CAS did remove her son from her home, but Daisy felt that
due to the potential dangers that her lifestyle was posing for him, it was the best decision
to remove him.
When he got taken that was the best time for him to be taken, believe me. That’s
when I first overdosed on fentanyl. That’s when I started doing fentanyl. It was an
environment I didn’t want to have him in.
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Another community organization that was mentioned with opposing views was
withdrawal management. While Jen felt that she received caring support that was above
and beyond, from the staff at withdrawal management; Becky referred to withdrawal
services in the community as “a joke”. She indicated that the organization was turning
people away who were trying to access treatment, and this was resulting in unnecessary
deaths, in Becky’s opinion. Later in the interview, Becky offered that services are lacking
in the community, due to poor funding.
The women unanimously felt that accessing counselling services was positive for
women accessing methadone and persisting in treatment. For some, counselling was seen
as a tool to deal with past trauma; that potentially led to using opioids. However, some of
the women noted that the counselor, at the addiction treatment center they were attending
was not working currently, due to a maternity leave and she had not been replaced.
Furthermore, the participants felt that the service is not well advertised. Jen indicated that
she was accessing counseling services from outside community organizations. She
expressed overwhelmingly positive experiences related to the accessibility and
compassionate care she received. Jen indicated that “as long as you are willing to work
the program, it’ll work with you. Ella observed that from her own experience, counselling
was beneficial; but had to be accessed by women on their own accord and not forced
upon them. This made the service more effective.
Overall, the desire for more support from the government, community
organizations, from healthcare providers and the community at large, was glaringly
evident in participant responses. Women expressed the need for empathy, sympathy,
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compassion, common decency, removing discrimination and stigma; which women felt
could be achieved with broad educational interventions. Statements made by Jen are
impassioned and embody the women’s experiences. “I feel that like people should talk
more to people and care and show more compassion to people… we don’t have diseases
we’re not bad people. You know, there are really good people out there”. Additionally,
Jen offers that “people can just talk to people and just have some sympathy and just care
about them a little bit. It helps so much because half these people feel so alone, all of the
time.” However, Becky expressed frustration over feeling judged by others due to their
lack of knowledge of SUDs.
I find that people are very judgmental. As soon as you tell them you’re on a
medication that controls your urges to use drugs, again in their minds they think
well, it’s a choice, you’re choosing to go and use (drugs). Well, what they don’t
understand is, yeah, it might have been in the beginning but now it’s a necessity.
People are not nice whatsoever, So, that also makes it that much harder to see the
light at the end of the tunnel (treatment).
Mary echoed Becky’s frustration over the stigma and discrimination of
individuals with SUDs by different groups within the community. She expresses her
shock over finding out that a Facebook page shaming individuals who were using
addiction treatment services and others who were seen actively using elicit drugs. Mary
uses the phrasing ‘on the nod’ which means to be in a sleep like or an extremely drowsy
state; where the person has taken a large dose of a drug.
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A lot of the problem that police have, especially in our downtown area, is that
they don’t have very much patience. Again, not just them though, it’s our nurses,
even our local workplaces, fast food restaurants, and the businesses around there
like there was actually a Facebook page that had come up…showing people on
the nod and coming out of getting their methadone treatment.
Womens’ responses that led to the major theme of Reaching Out for Help, varied
and were deeply personal. Whether interactions with supportive others were positive or
negative, it was clear that women’s treatment experiences were affected by them. Women
saw the support of others as integral to their treatment. Healthcare professionals,
especially those with addiction treatment knowledge were found to be more supportive.
Women with significant others and family members in treatment were supportive; while
others who were not knowledgeable about methadone treatment were initially not
supportive. Education for these individuals led to a change in support. Community
organizations were experienced differently according to the women. However, it was
clear that increased support from all individuals and organizations was desperately
needed to foster successful treatment outcomes. Overall, women felt that education was
an essential component to increase support and combat stigma and discrimination, by
these supportive others. Elements of the second sub themes were noted in participants
responses including: systems of support, referred ignorance and positive emotional
engagement.
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Finding Your Way to Methadone
In the third major theme, Finding Your Way to Methadone, women in the study
indicated that accessibility to methadone treatment had a tremendous effect on their
experience of receiving methadone treatment, for opioid use disorder. Travelling to get to
daily treatment was a challenge for many. Other issues like housing and additional costs
are prevalent in women’s responses, especially considering that all the women were
unemployed or laid off. Additionally, the inconvenience or inconvenience of treatment
factored into women’s consistent ability to get to the treatment clinic. The second sub
themes included: treatment accessibility, social determinants of health and a Canadian
treatment barrier were identified within participant responses. The major theme of
Finding Your Way to Methadone factored in each of the other themes that represented
women’s ability to get treatment and continue to be successful in treatment.
Women in the study identified that getting to the pharmacy to receive treatment
was a challenge. The women received rides from others, taxis, walked, biked, and
attempted to take the city bus to get to treatment. Because of changes in the bus schedule
due to COVID-19, buses in the community were not running as often and had a limited
number of passengers at one time. This severely limited access to treatment for women.
In fact, Evelyn noted that because of the changes to the bus system due to Covid-19 that
she had to find the new bus times and negotiate a ride from her mother halfway to the
treatment center. Evelyn felt that this inconvenience upset her mother. If she had not
taken the first bus, it would take her mother 30 minutes each way by car so that Evelyn
could obtain her methadone treatment. What is more, changes to the bus system also
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made getting a spot on the bus more problematic. Only ten people were able to be on the
bus at one time and once the bus was full, it would continue past anyone waiting for the
bus at any further bus stops. If you were unable to get on the bus, you might not get to the
pharmacy on time and therefore not receive your methadone dose. Evelyn noted that this
was especially concerning on the weekends when pharmacy hours were so limited.
Even if you left at ten (to take the bus), you might not make it (to the pharmacy
for 12). You should just make it but, you never know, if it (the bus) reaches
capacity, you could very well get on one bus and the next one (she has to take two
busses to the pharmacy) so you might have to wait for it to come and what if it’s
the same thing again?
Becky’s response echoed Evelyn’s. She noted, not only the difficulty in finding a
pharmacy located a reasonable distance from her home; but she also pointed out the
obstacle of getting to treatment in good and bad conditions.
So, finding your way to a pharmacy that actually gives out the methadone, that’s
around you, if you don’t have transportation, that becomes a factor, weather
becomes a factor. It’s a pain in the ass, honestly.”
Another participant, Ella, was hoping to move soon to make access to treatment
less challenging for her; since she did not have a vehicle or anyone to provide
transportation. Ella states “I am looking to move right now. I am looking at a place closer
to my methadone clinic”. When asked what she thought would help women like her stay
in methadone treatment, Ella was insightful and stated that a bus that was dedicated to
those receiving methadone could pick them up and drop them back off in a centralized

129
area. This type of transportation system exists in the city, for patients with renal dialysis.
Having a dedicated bus system accessible for those with opioid use disorder accessing
methadone treatment; would eliminate the challenges of transportation for many women.
Location of the pharmacy and pharmacy hours played a part in the accessibility of
treatment. Many pharmacies do not dispense methadone, and this created an issue with
getting to treatment in a timely way. One participant noted that when she was working,
attending a pharmacy; that did not have flexible hours led to missing doses.
With my job it became an issue, because my pharmacy, if you don’t go to a 24hour pharmacy, they closed, and I had a nine to five job at the time. I was going
through the treatment when I first started so I had to find a way to go on my
lunch. I tried to explain to my employer. And sometimes that’s without
transportation, so how do you do that? It I was tough.
Jen was also challenged by the pharmacy hours and the absence of transportation.
She, like many women, was balancing several commitments that created barriers for her
to get to treatment on time. The limited hours of the pharmacy posed great difficulty for
her, in getting methadone treatment. At the time of the interview Jen was in a dilemma
between her commitment to caring for her son and getting to the pharmacy before it
closed.
I have no transportation. I’m gonna be honest with you, I have to get my
methadone by five o’clock. I have to get it today but my fiancé’s not back yet. I
have a son here that is sick so I can’t leave right way. You know what I mean? I
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can’t do that. So, it’s hard when women don’t have transportation or somebody by
them to say, I can get you there.
Several women felt that having to receive daily treatment was inconvenient. They
indicated that daily treatment prevented them from doing things like having a job,
travelling, and making plans unless they revolved around receiving their methadone dose.
This was especially difficult for women who did not have full “carries” of methadone;
meaning they were required to give urine samples daily, as opposed to weekly. Women
who had “carries” were not required to attend the pharmacy each day as they received
methadone doses for multiple days. Women felt that they were tethered to getting
treatment and had challenges of getting to work and keeping a job and not having to tell
their employer. Others found it limited their lives, in that they could not go anywhere
because they had to be present at their home pharmacy; to provide urine samples and
receive their daily dose. Mary offered this insight into her experiences with making plans
while going through methadone treatment.
Up until you build up daily (carries), you always got to fit it in, especially on the
weekends because hours (of the pharmacy) are so limited. So, you only have from
eight am until noon. Everything is planned around making sure that you go and
you dose. And sometimes if you don’t; you might actually start to feel sick, which
will make you want to go relapse.
Despite the challenges and inconveniences of daily methadone treatment, women
accepted responsibility for attending the pharmacy and did their best to get there. One
participant Daisy summed up her acceptance of the challenge of accessing methadone
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daily. “Um, it’s okay. I have to go out and get drunk. I still have to go out and gem my
methadone, too right? So, it’s basically the same thing.”
The social determinants of health including income, housing, food security,
unemployment, health services, social safety nets, social exclusion and gender were all
mentioned in participant responses. Of the social determinants of health mentioned,
housing was the most pronounced in their responses. The participants described concerns
with homelessness, safety in their current living environments, motel living and
cohabitating with others. Daisy discussed her situation when she first started on
methadone treatment and she was homeless and the difficulty that posed. As Daisy
continued to receive treatment, her family noted her progress, and she was able to move
in with them.
At first, I was homeless. I was living in a tent. And so, I would have to ride my
bike, hopefully make it on time or wake up during that time. Didn’t know what
time it is or nothing. But I still made it to methadone. I ended up moving in with
my parents and getting my ‘carries’.
Mary discussed the prevalence of the homeless problem in her community. From
her perspective, one of the greatest challenges of being homeless and trying to continue
on methadone is that once you choose a pharmacy to get your treatment, you can’t go to
other pharmacies; even if you are not living in the same place from day to day. She
identified this as a failing of the current system. Mary stated the following regarding the
nature of homelessness.
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You may end up on the other end of the city, they might miss a dose because they
can’t get back, they can’t get back, they can’t go even if there is a pharmacy that’s
closer to them or where they’re at that day, if it’s not the one they agreed to when
they went on their weekly appointment. They can’t get methadone.
Another participant noted additional challenges when trying to persist in
methadone and being homeless. When you are homeless, you are often still living in the
same area as you were previously. You are still surrounded by those you may have done
drugs with or those who have sold you drugs, making staying in treatment and not using
illicit drugs more difficult.
Unanimously, the participants in the study expressed a desire to obtain their
methadone treatment as early in the day as possible. Some participants indicated that they
would attain their dose as soon as they awoke in the morning. Others chose to eat first or
had to wait for childcare. Early access was important to participants because they started
to feel “unwell” and “miserable” due to withdrawals from their treatment wearing off by
that time. This is what participants often described as being sick or feeling sick. This
feeling was avoided at all costs due to the intense pain and discomfort that was felt and
was often a stimulus for using other drugs. Amanda describes that she needs to take her
methadone treatment as soon as she opens her eyes in the morning and she needs an hour
post treatment to begin the tasks of her day. Amanda has “full carries”; meaning she
receives doses from the pharmacy for the week and is only required to do a urine test
weekly and see the doctor monthly in order the get her weeks’ worth of methadone.
Amanda illustrates what it is like to take methadone each day.
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By the end of the day, I can start to feel it wear off. So, I’m like achy but I know
as soon as I go to bed, I’ll be fine, I will make it through the night. And then, but
again, like I said as soon as I open my eyes, I need my methadone.
Other participants did not have “carries” and were forced to get to the pharmacy
as early as possible every day to avoid feeling unwell. Evelyn illustrates what it is like to
have to try to get her methadone dose as early as possible and simultaneously care for her
two children.
I wake up, I give my kids food like breakfast and I try to go early, because I’ve
been going early since the second day. I go there and sometimes I feel like, really crappy
in the morning at first and then I feel, shortly after I have the drink, I start to feel a lot
better and just in a positive mood. You feel a lot better from it (methadone treatment).
The final second sub theme that needs to be addressed, in this major theme, is the
Canadian treatment barrier. This finding was surprising considering that Canada has
socialized health care called Ontario Health Insurance (Settlement.org, 2017). If you are
over the age of 25 and do not qualify for the other programs that are offered in Ontario
based on your diagnosis, income or type of drug, you are required to pay for drug
treatment. If working, someone with opioid use disorder would not qualify for additional
funding unless their drug costs were greater than four percent of their family income.
During the third interview, Becky, expressed concern that if you did not qualify for social
assistance, or were identified as having a disability, you would have to pay for your own
methadone treatment. Unfortunately, this meant that if you were working at a job, you
would be forced to pay approximately five dollars per dose every day. This amount is
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equal to $1,825 (Canadian) per year for daily methadone treatment. This may be a
deterrent from receiving treatment. Becky offered this insight:
There’s no way, you’re forced to go on welfare, or you’re forced to stay on drugs.
You have no other option. There are no other outlets. Everything is so expensive
and how do you expect people to pay for treatment even though they want it?
How do you expect them to pay for it if there’s no government help?
The major theme of Finding Your way to Methadone is evident in participant
responses. For women, finding their way to treatment posed unique barriers that affected
their ability to get to and consistently receive methadone treatment. Women were
challenged with travelling to treatment every day, especially due to bus changes, because
of the current pandemic. Issues like housing, employment, convenience or inconvenience,
social determinants of health and issues that are specific to Canadians, all contributed to
the ability of women with different life circumstances, to access treatment. The second
sub themes that were apparent included: treatment accessibility, social determinants of
health and a Canadian treatment barrier were identified within participant responses.
Going Down the Path of Methadone
The second level sub-themes that later were enveloped into the major theme of
Going Down the Path of Methadone are experiences with methadone, ebb and flow of
treatment, challenges in methadone care, and effects of COVID-19. Women expressed a
variety of experiences when going down the path of methadone; some participants
expressed positive experiences, while others did not. Becky welcomed the opportunity to
start on methadone treatment. She saw methadone as an opportunity to rid herself of the
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life she was living when using opioid drugs: “Honestly, it was a relief. I couldn’t wait. I
was excited. I was done with this downhill spiral in my life. And I was looking forward
to it.” However, now that she has been on methadone, Becky expressed that she felt
methadone was a substitution of “one addiction with another”. She stated she does not
intend to be on methadone for a very long time. “I’m tired of having that ball and chain
around my ankle.” Several women felt that methadone was temporary and expressed a
desire to someday be off any drug treatment. Amanda also had mixed feelings about her
experience with methadone treatment. Amanda had been in treatment for 15 years and
spoke with authority. Her experiences were positive initially and now, after this lengthy
period of treatment, it had changed: “So I thought it was the greatest thing in the world.
But now I’ve been on it for 15 years and my teeth are falling out. So maybe not the best
option.”
Ella had an opposing experience with methadone treatment initially. When asked
about when she first received treatment, Ella indicated that she was fearful about the
effectiveness of methadone treatment to effectively manage her symptoms: “It was
painful because I was still getting withdrawals. It doesn’t last very long the first time. It
lasted about four or five hours and I would still be sick.”
This same fear was echoed by Amanda who had unknown treatment expectations;
her greatest concerns was experiencing withdrawal as she had in the past:
It was scary because I didn’t know what to expect. I didn’t know how I was gonna
feel. I didn’t know if it was gonna make me not sick. The withdrawal that you go
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through from opiates, it’s unbelievable. I was really scared because I didn’t want
to be sick again. That was my only like, biggest concern.
When participants were asked what they would say to a woman, who was
enquiring about going on methadone treatment; the women unanimously indicated that
they would encourage her to do so. None of the women indicated that they would
discourage her from accessing treatment. However, most of the women offered a
disclaimer of warning, to those who were considering methadone treatment. Their
warnings were often related to the length of time they could expect to be on treatment.
The treatment length was significant to the women; or they warned that it was
challenging to wean off treatment, when the women wanted to do so. Ella’s response is a
prime example of the women’s emphatic warning. This is how Ella indicated that she
would respond to a woman who was considering methadone treatment.
I would say that if you want to do it, research it because you are technically
replacing it with another drug, whatever drug you are using, but it is more
controlled, but it is really really tough. I never realized how long the process was
like. Do your homework. Like if you can’t get off on your own, know what you
are getting into, because it is a long road.
The final participant Jen offered a much more optimistic outlook on treatment.
Jen indicated that despite any challenges she faced with withdrawals initially, she would
emphatically recommend methadone treatment for any women seeking it. Jen had only
been on treatment for a brief period of time compared to some of the other participants.
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However, she expressed how being in treatment amplified her senses and gave her, her
life back. Jen’s statement to women is encouraging and worth noting:
To all these women, never ever give up. Never! Go to methadone. Even if you’re
sick that day, even if you can’t get a ride. Even if you are desperately sick, your
shaking and everything, go to methadone, the one doctor. Call and go to that
doctor, he’ll put you on methadone and it will change your life. You will feel
better 20 minutes later.
When discussing their experiences with methadone treatment, women often
referred to receiving carries as something to work towards as they traveled the path of
methadone. To women having carries was an achievement, an accomplishment for their
dedication to staying in treatment without relapsing. Further, some of the women
indicated that getting carries for methadone treatment was even more challenging than
getting carries for Suboxone treatment. Once a women relapsed on methadone, one or
more of her carries would be removed. This meant that she would have to come to the
pharmacy more frequently to receive her methadone dose. Daisy was proud when
speaking of her current progress in the methadone program and achieving carries.
“Before I was at five carries, but if I’m sober this week, I think next week I’ll have
another carry.” In the following statements, Mary was equally as enthusiastic about
receiving carries and described the process of earning carries as effective and one that
holds you more accountable.
It’s an accomplishment and a milestone and it gives you that pat on the back to
keep going. Like, yeah, I’m doing the right thing, I’m staying clean and I

138
accomplished something. And even the doctor is like, good for you! You’re doing
it, you’re doing it right so here you go. You earn your carries.
Women in the study understood that relapse was part of being on methadone or
being a part of any type of recovery from addiction for that matter. The women were
candid about how they felt telling others about their relapse or having to return to their
pharmacy or treatment clinic which made others aware of their relapse. Although the
women were not coy about sharing their experiences, they described embarrassment and
disappointment. In fact, Amanda admitted her feelings after a relapse that went on for
nearly four years after quitting using opioids on her own.
And then I decided enough was enough. I just called by myself and I had no
supports because I didn’t want anybody to know that I had relapsed because I felt
like a failure. So, I knew nothing about methadone (when she started).
Mary felt that she would defy the odds and be someone who would not relapse
and remain in recovery. She felt that this unrealistic expectation set her up to be more
frustrated with herself than she might have been otherwise.
I did have a bit more disappointment with myself because it was exactly what
people kind of predicted was going to happen. But then at the same time, as much
as I was disappointed in myself, I’m mot a complete failure because I’m not the
only failure. A lot of people can relapse even if they are 20 years clean now.
As noted in the major theme, Reaching Out for Help, healthcare providers had a
significant influence on women’s experiences with methadone treatment. Women
expressed admiration and appreciation for those who worked with them in addiction
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treatment and described some healthcare providers who worked in non-addiction
treatment less favorably. These experiences do bear mention in the major theme of Going
Down the Path of Methadone, however, briefly to avoid repetition. Participant Amanda
was candid in her appreciation for the addiction care practitioners, as were most of the
women. Amanda discussed her community addictions treatment doctor and pharmacy
and their no-nonsense approach to her and others receiving treatment. Her community
addictions treatment experience stood in stark contrast to her experience in hospital.
I love my doctor. He is amazing. He cares. He’s not gonna let you slide and if you
go and screw up one week, you gotta deal with it like and adult. You know if
you’re dirty, they you’re getting a carry removed and that’s it. There is no making
him a pushover. He will sit and listen and every week he asks if your dose is
okay, and how you’re feeling and if there’s anything you want to talk about; he’s
great. My pharmacy, they’re amazing as well. They know me when I go there.
But when I go to the hospital, they look at me like I’m a street junkie.
A significant part of staying in recovery for women was finding the right
treatment and dosage to adequately treat their opioid use disorder withdrawal symptoms.
Women discussed their struggles with changing medications from one to the other and
the process of increasing the dosage of methadone after initially starting treatment. Each
of these experiences presented challenges for the women but led to the effective dose and
treatment they were at currently. In Becky’s response, she discussed her preference of
methadone over Suboxone but still indicated that there were issues with methadone that
she is dealing with.
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I thought that swapping over to Suboxone was a better choice for me at the time,
which was hell in itself. But now I have swapped back over to methadone. It was
just better for me. So here I am, going down the path of methadone again. I’m
hoping those side effects don’t happen. You retain a lot of water (on methadone)
and I have swelled out a lot. I’m an athlete so I’m not used to being heavier set.
And psychologically that played a big factor.
Comparably, Evelyn experienced challenges on methadone. Even after receiving
her first does, she experienced the symptoms of withdrawal. It took time to finally
achieve a level of treatment that worked for Evelyn.
And since my first dose, I’ve gone up and everything because I still had my
headaches, I was still restless., I was still agitated, my hands would shake and my
legs, like restlessness. So, he (the doctor) increased it (methadone dose). I’ve been
increasing it, but I think I finally found a number (dose) that helps.
The signs and symptoms described by Evelyn are not unique. All the participants
discussed withdrawal in some capacity. They described an intense desire to avoid
withdrawal whether they were still using street opioids or in treatment with methadone.
Some women stated that even when they were receiving treatment initially with
methadone, the dose was low and that caused them to experience withdrawal symptoms.
Jen describes her experience with withdrawals while on methadone.
At first, it was such a low dose that it doesn’t help you. When you go to sleep,
you can’t sleep at night. You fidget your legs are shaky. It’s just terrible. They
can’t put you on a high dose until you’ve been in methadone for a little while,
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then you go up. I missed many days and wasn’t able to go up (in dose) and stayed
at 25ml for a long time. It didn’t help at all. I wanted to use drugs all the time.
Women expressed a strong desire to avoid the symptoms of withdrawal. Daisy
explained how experiencing withdrawal acted as a motivator to get into methadone
treatment rather than suffering the aforementioned symptoms between illicit drug doses.
Like you don’t want to be sick. That’s the last thing you want to be is sick. When
your sick, your skin is crawling. It pushes you to get clean and like go on
methadone. It doesn’t work at first, we got to wait. It always takes time.
A final second sub theme that influenced women’s experience with methadone is
the COVID-19. How the virus effected women’s experiences was surprising. Although
COVID-19 had affected the data collection process for this research, making telephone
interviews the only option, it was not clear that women’s treatment experience was
affected in any way. Only when interviewing the women for this research, did these
issues come to fruition. As already mentioned in major theme Reaching Out for Help,
Evelyn indicated that COVID-19 made accessing treatment easier due to having her
boyfriend available to stay home with the children, so she could get methadone treatment
without having to take them with her, or to find childcare for them. However, Evelyn also
admitted that because parks and other popular places to bring children were closed
initially, she was having difficulty finding ways to entertain her children and keep them
active. COVID-19 effected each women’s experience differently.
Mary offered insight into how COVID-19 was influencing her methadone
treatment. She felt that the loss of her routine of getting her methadone dose, going to
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work, coming home at night, sleeping, and repeating this cycle, had been taken away.
Mary felt that this potentially contributed to her previous relapse. Additionally, she
indicated that the overdose prevention organization she volunteered with saw an increase
in relapses during the pandemic. Mary discussed how regular life routines ceased during
COVID-19 and how this was something she would have looked forward to during her
past when using elicit opioids.
The boring and mundane when you’re using drugs, what you actually want is to
be able not to have to leave your house. A lot of relapses happened as soon as
everything stared to shut down, and it is because our structure and our life went
away. Staying in recovery is bout staying in structure and staying or changing
what you got to do. And that was all shot out of the window come march
(referring to restrictions of COVID-19).
Probably the most surprising and emotional response was how the epidemic had
affected Amanda and her ability to see her son. Amanda’s son lived with his father who
was concerned about exposing the rest of his family to someone who did not live in their
household. Not being able to see her son was difficult for Amanda but she expressed that
she understood the reasoning and respected her ex-husband’s wishes. Prior to COVID-19
Amanda would spend time with her son and provide him with condoms for birth control
and advice. Her only contact with him now was to talk to him on the phone. Amanda
stated “I’m not allowed to see him. I haven’t been able to see him. So, this Covid stuff
(brief pause). His dad has younger kids. Yeah. So he was, you know, pretty leery about
letting me see him.”
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The four major themes developed from thoughtful analysis of the data using IPA
by Smith et al. (2009) included: learning how to be you again, reaching out for help,
finding your way to methadone, and going down the path of methadone. Each of these
major themes has been discussed in detail providing ample evidence to support each
major theme. The major themes were visually organized using a Venn diagram (Figure 1)
to illustrate the relationship between major themes, including the nature of overlap of
content, which is evident in participant statements. Participant responses provided insight
into what it is like to experience opioid use disorder and receive methadone treatment as
a Canadian women. Findings that were most surprising were barriers that were present
for participants despite having socialized healthcare in Canada and the effects that
COVID-19 on participant experiences.
Summary
The single research question for this study is: What are the lived experiences of
Canadian women with opioid use disorder who choose methadone for treatment? The
answer to this question can be divided into four major themes. These themes evolved
from participant responses. The first major theme of Learning How to be You Again
consisted of participant statements that included their role as mothers and how that fit
with OUD and treatment. Also included was the motive for change, which consisted of a
breaking point for participants, where they felt that they needed to make a change in their
lives, which led them to methadone. In their responses, women expressed an
understanding of their methadone treatment experiences as women, specifically. Finally,
women discussed issues of shame and fear, which often culminated into hiding their
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addiction and treatment from others. Each of these second sub themes contributed to
learning how to be you again.
The second major theme of Reaching Out for Help included the role of supportive
others. This role, whether they were supportive or discouraging in nature, influenced
women’s experiences with methadone treatment. Referred ignorance was also included
here and correlated to the lack of knowledge others had, related to OUD and methadone
treatment, which included issues of judgment and stigma. Finally, positive emotional
engagement was found to influence participant responses and included the support,
compassion, and empathy by others and themselves. These experiences culminated into
reaching out for help.
The third major theme was Finding Your Way to Methadone and was focused on
accessibility to methadone treatment. Included, was the cost of drug treatment, as a
surprising Canadian finding, considering that Canada is a country with socialized
healthcare. Finally, specific determinants of health were identified by participants as
influencing their experiences of having OUD and choosing methadone treatment.
Women’s responses produced the theme of finding your way to methadone.
The fourth major theme was Going Down the Path of Methadone. This final
theme included women’s statements that were specifically about medication assisted
treatment with methadone and how that affected their lives. Participants also discussed
what is termed as the ebb and flow of treatment, which included experiences of relapse
and working towards receiving “carries” of methadone treatment. The challenges of
methadone included avoiding withdrawal and the influence of healthcare providers.
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Finally, women expressed how Covid-19 influenced their treatment experience; which
was an unanticipated finding of the study and was not included initially, in the interview
guide. However, each of these participant experiences helped to shape the lived
experiences of women with OUD, who chose methadone as treatment during a global
pandemic.
Chapter 4 has provided a detailed account of the setting, demographic
information, data collection procedures and the data analysis process, that occurred with
this research. Evidence of trustworthiness has been explained and the results of the study
have been expressed in words, providing participant accounts and visually in the Venn
Diagram of Major Themes (Figure 1). In Chapter 5, the findings are explored further in
relation to the current knowledge of peer-reviewed literature, found in chapter two.
Moreover, the findings will be interpreted and analyzed in the context of the conceptual
framework chosen for this study. Finally, limitations of the study, recommendations for
future research, and implications for positive social change are illuminated in the fifth
and final chapter of this dissertation.
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Chapter 5: Discussion, Conclusions, and Recommendations
The purpose of this study was to describe the lived experiences of women with
opioid use disorder who were receiving methadone as their treatment of choice. By
understanding their experience more fully, from their perspective, nurses and healthcare
professionals will be able to provide women with individualized health promotion
strategies and treatment (Rubio, 2016). Interpretive phenomenological qualitative
methodology was used to conduct this study, which elicited insights and experiences
from the participants.
This study filled the identified gap in current research knowledge by shedding
light on the topic of Canadian women with opioid use disorder (OUD) who are using
methadone treatment—a population that is growing (Marks & Leukefeld, 2017; Public
Health Ontario, 2018). No published studies were found that considered opioid use
disorder and methadone treatment from the perspective of Canadian women. Yet the
numbers of women experiencing opioid use disorder and dying from it are growing
(Public Health Ontario, 2018, 2019)
Participant responses from this research were analyzed using the seven steps IPA
of Smith et al.(2009). From this analysis and inclusion of field notes, four major themes
came to the fore. First, the major theme of learning how to be you again was derived
from women’s sense of self and statements of self-determination. Second, the major
theme of reaching out for help was made clear by women’s statements related to
supportive others. Some relationships were supportive, while others were discouraging,
but all relationships affected women’s experiences with methadone treatment. Third, the
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major theme of finding your way to methadone included women’s statements about
accessibility to methadone treatment. Fourth, going down the path of methadone was the
final major theme. Both positive and negative experiences with methadone were
expressed by women in the interviews. These four major themes represent women’s
experiences with methadone treatment.
Interpretation of Findings
Findings from this research study confirm, disconfirm, and extend knowledge in
the discipline of nursing and addiction studies. The current findings are compared with
what has been found in the peer-reviewed literature described in Chapter 2 of this
dissertation. The major themes from the research will be used to organize the
comparisons from the current research to the peer-reviewed content in the focused
literature review.
Learning How to be You Again
In this study, women were unanimously unemployed and experienced many of the
barriers and difficulties that come with low socioeconomic status. Furthermore, all but
one woman had children, and each of them emphatically identified with the role of
mother. But only two of the women had the primary responsibility of caring for their
child, children, or grandchild. Other researchers have also supported a struggle with
access to MMT and unemployment as well as women having children to care for (Bach et
al., 2015; Bawor et al., 2015). Bach et al. (2015 and Bawor et al. (2015) examined
gender-specific issues in methadone treatment. The authors found that women reported
high unemployment rates and children to care for. This may have challenged women’s
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ability to access healthcare services and obtain extended healthcare coverage through
employment. The findings from the current study confirm those from Bach et al. (2015)
and Bawor et al. (2015), in that women with OUD accessing MMT struggle with
unemployment. However, although few women in the current study had children to care
for, whether women had children or not, they lacked access to healthcare services, which
extends the previous research. Whether having children was an additional barrier to
accessing services is not known.
The mothering role was significant for all but one participant in the current study.
Five of the women in the current study sought treatment with methadone in response to
losing custody of children due to their illicit opioid use. Women identified access to their
children as motivation for entering MMT. One woman continued to care for her two
children and did not express concern about CPS removing her children from the home,
though CPS was involved. All the women who had children in the current study
expressed sentiments related to the benefits to the mothering role that being on
methadone presented. In related but different findings, Secco et al. (2014) found that
women attended MMT to retain custody of their children and build relationships with
them. The current study findings expand those of Secco et al., as even when children are
taken from a women’s custody, they are still a primary motivating factor influencing
treatment seeking. Further, research confirms the primary importance of the relationships
and bonds with children (see Bach et al., 2015; Bawor et al., 2015; Secco et al., 2014).
However, in the current study, the findings expand beyond the mother and child
relationship to a broader focus of the role of the mother.
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Initially, women in the current study did not identify gender-specific issues in
their methadone treatment. In fact, most of the women indicated that they did not see any
difference at all and used statements like “we are all people.” However, after some
hesitation and consideration, the women indicated that children were a major difference
between men and women who were receiving methadone treatment. They noted that
caring for children and carrying children were women-specific issues that have a bearing
on treatment. Other research like Bach et al.’s (2015) study has shown many differences
between the sexes when comparing them. Bach et al. found that for women, pregnancy
was a factor that was strongly associated with MMT. In fact, men did not identify
parenthood as a factor influencing their treatment whatsoever. As noted, women in the
current study also identified children as motivation for receiving MMT. Children, for
almost all the women in the current study, contributed to the breaking point where they
experienced critical factors that led them to receive treatment. Children are a critical
consideration when attracting and retaining women in MMT. However, the results did not
show enough about the motivating factors for women who are not mothers.
Further, the participants described how they began using opioids and how it led to
a climax that was described as a breaking point. Each woman depicted a unique
experience of their introduction to using opioids, including losing custody of a child,
pressure from an abusive partner, injury, and chronic pain. They described using opioids
until events led to the feeling that they must make a change because they were desperate,
or they were going to die. Women described this as having nothing left or losing
everything. These findings echoed those from Rubio (2016). In Rubio’s study, women
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described contributions to using opioids, including stressors, peer pressure, and other
triggers. But there was a tipping point at which they made a change to stop using opioids
as “rock bottom.” Both Rubio’s findings and the findings of this current study indicate a
similar decisive point at which they recognized changing their opioid use as critical,
which can act as a reminder to persevere in treatment. However, there are differences
between the current study and Rubio’s study such as one woman being brought to
treatment against her will, whereas the women in the current study unanimously
expressed that getting treatment was their decision. The findings of the current study
were described as the sub-theme of self-determination. Another difference is that women
in Rubio’s study unanimously described their initial drug experiences positively, and
some of the women in the current study described their first experience with opioids
negatively. For example, one participant described this event as being pressured by an
abusive partner. This difference can be due to individual circumstances and should be
considered individually when entering treatment. Additionally, the finding of selfdetermination that exists among most of the women in both studies confirms that women
feel empowered to enter treatment by their own accord.
Self-determination was another finding in the current study. Women made a
variety of statements related to their ability to be themselves and independently make
decisions. Further, women discussed their decision making related to treatment and
returning to treatment after relapse. Marks and Leukfeld (2017) offer a similar finding.
These researchers indicated that strength-based factors, including resilience and positive
perceptions of life, can positively influence women’s recovery from OUD. These positive
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perceptions can include perceptions of the self and the ability to make one’s own
decisions, self-determination. Additionally, resilience in difficult life circumstances or
experiencing a relapse can be a function of a women’s self-determination. Future
interventions to support women in MMT should include methods to empower women and
foster control over their own decision making.
Reaching Out for Help
Systems of support were identified by women in the current study as being an
essential part of their MMT, whether the interactions were supportive or discouraging.
Women provided many statements that indicated that the relationships with friends,
family, children, and significant others were influential to their treatment and recovery.
All but one of the participants identified having a partner who influenced her in
treatment. All participants discussed relationships with friends and family and their
impact on their recovery. Similarly, Letourneau et al. (2013) found that women in their
study relied predominately on family and friends for support and secondarily on
community resources. In a related finding, Polenick et al. (2019) found that women who
reported severe loneliness were three times more likely to use illicit opioids while in
MMT compared to those with moderate, mild, or no loneliness. Though the findings are
not exact to what was found in this current study, they speak to the importance of
significant relationships and their influence on sustaining recovery. Loneliness can be the
absence of close relationships that are supportive, and this connection warrants further
consideration. To be most effective, future initiatives to support women in recovery may
need to be inclusive of significant others, family, and friends.
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In contrast to supportive relationships, stigma from others was a barrier to
receiving methadone treatment. In fact, in the current study, some women reported
stigma and judgment by healthcare professionals as a detriment to their treatment.
Mattocks et al. (2017) reported similar findings in their study of women’s perceptions of
their experiences and challenges with MMT and obstetrical care during pregnancy and
the postpartum period. One of the five themes that emerged from the study included
finding an obstetrician that was knowledgeable of care for women receiving MMT.
Stigma among the care providers was noted among women and acted as a challenge and
barrier for women receiving MMT during this period. The stigma needs to be addressed
within the healthcare system to better support women in receiving MMT during all stages
of life.
Despite potential barriers to treatment, women in the current study also identified
a variety of resources that they considered helpful in supporting women in methadone
treatment. Community resources, including healthcare services like pharmacies and
addiction treatment services, were among those identified by participants. Other
community agencies mentioned by women were employment and life skills training and
counseling services. Other researchers have also recounted a variety of community
services identified by women as helpful in addiction recovery, including healthcare,
counseling, and employment assistance (Falletta et al., 2018). For instance, social support
and parenting assistance support mothers into early engagement with MMT (Sicco et al.,
2014).
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Counseling services were also a support identified by women in the current study.
Women indicated that having the opportunity to receive counseling when they
determined they were ready was a resource that would help women enter and be retained
in treatment. Some women felt that their OUD, and that of others, was precipitated by
traumatic events that led them to abuse opioids. Others felt that receiving counseling
could help them learn how to achieve their goals and transition back into society. It is
important to address the psychological impact of victimization experienced by women to
promote treatment retention (Levine et al., 2015; Zielinski et al., 2017). Counseling is a
vehicle to address psychological issues, such as those raised by women in this current
study and those in Levine et al. (2013). Women in Letourneau et al.’s study reported
service preferences, including individual counseling to address more sensitive issues,
followed by group sessions. Likewise, Zielinski et al. (2017) suggested counseling to
promote better treatment outcomes. Initiating addiction counseling for cannabis use,
OUD, and psychological issues, facilitates recovery for women experiencing SUDs.
Sicco et al. (2014), offer similar findings from their study, stating that social support and
parenting assistance support mothers into early engagement with MMT. Counseling is an
effective measure to support women in substance use disorder SUD treatment.
Finally, relationships with CPS workers were conflicting in this current study.
Regardless of whether women felt that CPS involvement was positive or negative,
women were forthright about their feelings. Some women felt that CPS was supportive
and did what was best for their child at the time, whereas others felt CPS workers were
uniformed and unsupportive. These findings confirm those of Letourneau et al. (2013),
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which showed mixed but strong feelings about CPS. When the outcome of CPS
involvement ended favorably, women felt supported by CPS, even if children were
removed from the home. But when the attitudes of CPS workers were negative and
insincere, women felt that CPS was completely unsupportive. These inconsistent feelings
about CPS were echoed in the current research findings. These findings suggest that
relationships between women and CPS employees needs to be better understood.
Finding Your Way to Methadone
Women experience barriers to accessing methadone treatment in many forms.
Some of the issues related to accessibility for the participants in this study included
transportation, pharmacy hours, location, addiction treatment services, and limited
pharmacies dispensing methadone. Many women discussed their concern with
transportation by bus being a challenge during the current COVID-19 pandemic. Women
in the United States, especially those with low income, have reported access to healthcare
services as a barrier such as difficulty with accessing health insurance, a clinic, a health
center, or a physician (Marks & Leukefeld, 2017). Women in a Canada have expressed
similar concerns over accessibility to healthcare acting as a barrier to mothers
participating in MMT. Women’s concerns included a lack of daycare services,
convenient and affordable transportation, the distance, and frequency of travel between
home and MMT services (Letourneau et al., 2013). Overall, similarities in these findings
suggest that women experience barriers to services that need to be addressed collectively
and individually. Differences in accessibility concerns between women in the U.S. study
and the Canadian studies exist. Women in both Canadian studies discuss transportation,
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including cost, inconvenience, and location of treatment center as barriers in access.
Whereas, in the U.S. study, women identified health insurance, access to a clinic, health
center or physician. These differences may exist due to rural versus urban locations of the
Canadian studies and differences in healthcare systems between the two countries.
Marks and Leukefeld (2017) also found that the healthier women were and the
less pain they reported, the more likely they were to engage in health-related behavior
change, while participating in MMT. Women in this current study expressed a variety of
physical illnesses. One participant reported lifelong issues with chronic pain dating back
to childhood. One woman reported being an athlete prior to experiencing OUD. Despite
the illnesses women experienced while receiving MMT, they may be more likely to
participate in behavior change if they have less pain and see themselves as healthy.
Going Down the Path of Methadone
Women in the current study described both positive and negative experiences
with methadone treatment. Women described methadone and addiction treatment services
as lifesaving, and their statements were positive. In fact, all the women stated that they
would encourage other women to receive methadone treatment if they were considering
it. At the same time, some of the women in the current study had negative outlooks on
methadone, describing the side effects of treatment that were initially unknown to them
and the difficulties in getting off methadone treatment when they wanted to. Moreover,
two participants described methadone treatment as swapping one addiction for another.
Participants in previous research have voiced similar experiences. Findings in Rubio’s
(2016) study were mixed. Nine of the 13 participants in this study expressed positive
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sentiments about methadone treatment, expressing that it was a positive experience to get
back to “normal life.” Conversely, two of the participants had mixed feelings about
methadone treatment, and two others had completely negative views. The findings, of the
current study, confirm what is known from Rubio’s study (Rubio, 2016). Women
receiving MMT indicate both positive and negative views, yet they still choose to access
this treatment. This could indicate that the positives outweigh the negatives when it
comes to MMT.
The preference for methadone over other medication assisted treatment was
another consistent finding between the current study and previous research (Mattocks et
al., 2017). In the current study, some of the women had previously been on suboxone, a
combination of buprenorphine and naloxone, and experienced withdrawal symptoms.
This led to them switching over to methadone treatment, which they found to be more
effective. One participant had been on suboxone previously and relapsed. After returning
to treatment, she found that suboxone was no longer effective in controlling her
withdrawal symptoms and had to begin treatment with methadone, which effectively
managed her symptoms. Participants in a study by Mattocks et al. (2017) also expressed
their preference for methadone because it prevented the sickness associated with
withdrawal. Prior to taking methadone, participants were taking buprenorphine, a
component of suboxone and continued to experience withdrawal symptoms. In that same
study, physicians were essential in finding the right dose of their methadone to treat
women during pregnancy. Correspondingly, women in this current study expressed
concern about receiving an appropriate dose that would prevent withdrawal, something
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they emphasized as being paramount. Finding effective treatment and dosing is a critical
consideration for women seeking methadone treatment.
A final confirming finding was related to the cost of MMT in Canada. This
finding was surprising. Women in the current study indicated that the cost of treatment
was a factor that challenged women’s ability to receive MMT. One woman expressed
frustration in her comment that a woman may have to make a choice between going on
social services, otherwise known as welfare, or continuing to use illicit opioids. Canadian
women have access to free healthcare services through the Ontario Health Insurance
Plan; however, they do not always have access to free medications (Ministry of Health
and Long-Term Care, 2018). Only in specific circumstances do Ontarians have access to
free prescriptions; for example, those who receive social services in the form of Ontario
Works, Ontario Disability Support Program have access to free medications or those
under the age of 24 years old. In an American study, Marks and Leukefeld (2017)
indicated that women in their study who received additional financial support through
various government services were more likely to participate in substance-related behavior
changes such as methadone treatment. In this US study, women with OUD experienced
limited healthcare service access, including prescriptions. While women in the current
study had healthcare access from socialized healthcare found in Canada, they too did not
have access to methadone universally. Additional financial support is needed for women
entering MMT.
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Interpretation of Findings and the Conceptual Framework
The conceptual framework for this study is derived from the middle range theory,
self-care of chronic illness (Riegel et al., 2012). Self-care is defined as a process of
maintaining health through health-promoting practices and managing illness (Riegel et
al., 2004). Self-care is an essential element in chronic illness. Addiction is considered a
chronic illness that requires ongoing treatment and intervention (Morse, 2018). Self-care
of chronic illness theory includes three concepts: self-care maintenance, self-care
monitoring, and self-care management (Riegel et al., 2012). Assumptions, propositions,
and a variety of barriers and facilitators influence the process of self-care. The current
research findings can be viewed through the lens of this theory.
Changes that occur due to chronic illness require adaptation. Participants accessed
methadone treatment and other interventions to maintain recovery, self-care maintenance.
Participants expressed both positive and negative experiences with methadone treatment.
Treatment was required daily, and participants needed to find ways to access treatment.
Supportive systems such as friends, family, counselors, healthcare providers, and other
community support provided much-needed assistance to persevere in treatment.
Moreover, women expressed self-determination in their ability to maintain treatment
despite all the barriers that might have been experienced. Women expressed many
sentiments that exhibited how they were the decision-makers in their treatment and
recovery. Women coped with withdrawal symptoms by continuing to attend their
methadone treatment and physician visits to adjust their dose as needed. They also found
that staying home and disconnecting from those who were not supportive in their
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treatment was an effective measure to remain in recovery. Healthcare provider supported
women in treatment by providing regular medical follow up appointments and
supervision. Daily, women avoided withdrawal symptoms by accessing treatment as early
as possible and one participant managed by using other illicit drugs. Women performed
self-care maintenance by accessing medication and using illicit drugs, distancing from
some, receiving support from others, and expressing self-determination to continue in
treatment and maintain recovery.
The second concept in Self-Care Chronic Illness theory is self-care monitoring.
As change in their chronic condition occurred, women had to self-assess and determine
when they needed to reach out to others for assistance or make changes. For example,
when one participant was using Suboxone, body listening led to her accessing the
addiction treatment physician to adjust her treatment. The participant was experiencing
withdrawal symptoms that were causing her to relapse. Women in the study performed
other forms of self-care monitoring, including urinalysis. Supervised urinalysis was
completed by participants to determine if other drugs were in the women’s system. If
drugs were found, women could have a carry removed or otherwise be set back in
treatment. Other assessments were performed to monitor for changes by the physician,
nurses, and pharmacy staff. These included medical exams and assessments. Women
attempted to be vigilant in self-care monitoring to prevent relapse but recognized this was
not always perfect, as relapse was part of their recovery journey. Self-care monitoring
was ongoing and required body listening for signs and symptoms of a change in
condition. Women expressed that sometimes they would experience cravings and
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withdrawals, a change in their condition. Once the participant recognized a change in
their condition, the action required was the next step in self-care of chronic illness theory,
self-care management.
Self-care management occurred when women accessed a healthcare provider in
response to changes in their conditions. These conditions included withdrawals or
cravings. Treatment from the addiction treatment physician and other healthcare
providers included adjusting the methadone dose, helping to find community supports,
and making suggestions for behavior change. Other women acted on this change in their
condition by accessing illicit drugs. No matter their choice, women acted by selfdetermination to initiate the course of action. When women identified triggers to using
opioids, they altered their behavior accordingly. For example, some women identified
individuals who were not supportive of their treatment. When they did, women chose to
distance themselves and disconnect from them. Other responses to changes included
talking to a counselor or a community support person, friend, or family member who
would provide assistance or a listening ear. Their responses were often positive and
helped to maintain their recovery. Women made decisions to act on changes in their
condition to seek help, use illicit drugs, or change their behavior.
Essential components to the three concepts of self-care of chronic illness include
the processes of decision making and reflection. The first process, decision making, was
reflected in the response by women in the current study. As discussed, women expressed
self-determination in their actions to enter and maintain recovery. However, some
decisions made were not always appropriate. In the past, when the women experienced

161
withdrawal, some returned to using opioids or other drugs to relieve their discomforts.
The second process is evident in women’s decision to change that behavior and not return
to opioids at other times. Of the women who relapsed, some experienced shame and were
embarrassed to return to treatment. Other women chose to hide their relapse or treatment
with MMT. Their decisions were based on their reflection of previous behavior and
decisions. Both processes of decision making, and reflection are evident in women’s
experiences in this study.
Limitations of the Study
There are several limitations to the current study. The smaller sample size and
purposive sampling method limit the generalizability of the findings. However, the
purpose of the study to develop a deeper understanding of women's experiences, which
was achieved. The descriptive nature of the research enables readers to determine
transferability to other contexts, in part or whole. To mitigate the issue of smaller sample
size, snowball sampling was used as planned, and seven participants were included in the
research.
Further limitations exist in the data collection method. The COVID-19 pandemic
also posed challenges that led to limitations in this study. Due to requirements to limit
contact, all interviews were conducted by phone rather than face to face, as initially
planned. Using voice to text software and a recording device limited clarity of some
responses, which led to reviewing the recording and transcripts multiple times to ensure
accuracy. This occurred despite the exemplary quality of software and the recording
device. The inability to have face to face interviews posed additional limitations. Having
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to use a phone for the interview required participants to have access to a cellular phone,
with 30 minutes to an hour of time available on their phone plan or purchased minutes for
‘pay as you go’ phone cards. This would be an additional cost for participants. In
addition, keeping a phone charged for 30 to 60 minutes presented a challenge due to
transient living conditions. Although the addiction treatment centers offered for
participants to use their landline phone, none of the participants felt that it was an option
they would agree to. This may be due to not wanting to be seen spending any more time
than necessary at the clinic, transportation issues or concerns related to COVID-19.
Lastly, face to face interviews allow the interviewer to see expressions and emotions that
were otherwise lost with phone interviews. The initial plan of face to face interviews
would have alleviated these limitations.
Recommendations
A variety of recommendations for further research exist that are grounded in the
strengths and limitations of this study; as well as the literature reviewed in Chapter 2 and
the findings of this research. First, additional phenomenological studies need to be
conducted to examine the experiences of Canadian women with opioid use disorder who
choose methadone for treatment. As indicated in Chapter 2, this is a significant gap in the
qualitative literature. Expanding our knowledge of women’s experiences can help add to
what is now known by confirming the emergent themes of self-determination, improving
care experiences, fostering support of others, and promoting accessibility of care for
women in these circumstances found in this study.
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At the present time, methadone continues to be the most widely used ORT for
those with OUD; and the number of women being treated continues to rise (Public Health
Ontario, 2018). Women from this and other studies indicated mixed perceptions of
methadone (Rubio, 2016). To have a clearer understanding of this phenomenon, future
studies, including replication of this study, should be accomplished using other groups of
women. Results from this finding may help healthcare professionals collaborate with
women; to emphasize the positive and mitigate the negative effects of treatment. For
example, women expressed that knowing how difficult it would be to transition off of
methadone treatment completely would have influenced their decision to accept treatment
or at least they would have been prepared for their future on methadone.
Second, while some quantitative studies have been conducted on OUD and MMT,
few phenomenological studies have been conducted on just women and no studies on just
Canadian women. Based on the findings of the current study, future studies should
consider women’s self-determination in treatment and motivation for perseverance.
Overall, studies should explore how women’s self-determination is a key factor in
treatment perseverance. Knowing this information may foster future interventions that
strengthen women’s self-determination, which may influence women’s participation in
MMT.
Third, future research should focus on accessibility of treatment for women and
include a variety of factors that influence women entering and continuing in treatment.
Past research studies have found accessibility to be a barrier for low-income women with
no health insurance and for women with children in tow (Letourneau et al., 2013; Marks

164
& Leukefeld, 2017). Based on the findings of the current study, the specific aspects of
accessibility including transportation, availability, and cost need to be investigated as
they relate to women’s MMT. Specifically, in Canada, studies that consider medication
cost in socialized healthcare should be conducted. Other countries with socialized
healthcare, which have paid medication costs, may not experience the same barriers.
Knowing this information can assist in policy development that focuses on supporting
women into treatment.
Fourth, the effects of COVID-19 are another surprising finding of this research.
Women experienced mostly negative effects on their care due to COVID-19, while one
participant experienced the positive effect of having a significant other unemployed due
to COVID-19. The significant other’s unemployment allowed him to stay at home with
the children while the participant received methadone, rather than having to take the
children with her. To more fully support women who are currently accessing methadone
treatment or may be in the future, a deeper understanding of the effects of COVID-19 on
MMT needs to be investigated further.
Fifth, women in the current study, identified children and mothering as motivating
factors to treatment; but also discussed mixed experiences with CPS. Similarly, other
studies examined the effects of MMT on parenting and the relationship between mother
and child (Letourneau et al., 2013; Secco et al., 2014). Another examined women’s
perceptions of CPS with mixed results, similar to the current study. The mother’s
relationship with children, as well as CPS, was complex and requires further investigation
to better understand the factors that influence these experiences. Concerns with removing
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children from home; and judgment from CPS workers worried women in MMT (Secco et
al., 2014). The focus of future studies should be on how access to children, parenting, and
relationships can be fostered to support and retain women into treatment. Studies
regarding the effects of child separation from the parent during treatment on the parentchild relationship may help provide evidence to encourage women into treatment.
Additionally, motivating factors for women who do not have children may also prove
fruitful determining factors that can promote treatment motivation and persistence.
Finally, significant relationships in a woman’s life who is receiving MMT is
another area that requires further research. Fostering these relationships for women in
MMT can potentially improve women’s addiction care. Women noted the importance of
these relationships in getting into treatment and providing much needed support like
transportation and emotional support. Support systems can also include healthcare
providers. Supportive relationships between healthcare providers and patients have been
found to be essential for patient in MMT (Mattocks et al., 2017). Studies that focus on
this supportive relationship must be investigated further to gain knowledge of how
healthcare providers can improve treatment retention by their personal interactions with
women. Studies that investigate the nature of these relationships and how to foster them
fully can contribute to successful recovery for women with OUD accessing MMT.
Implications for Positive Social Change
The potential impact for positive social change at the individual, family,
organizational, and societal levels can be noted. Here, tangible improvements are
described, and the implications are discussed. Finally, recommendations for practice are
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explained. This study presents many opportunities for positive social change and practice
changes in nursing and healthcare.
Outcomes of this study can influence positive social change for individuals.
Women who have had the opportunity to tell their experiences felt as though they were
helping other women by sharing their insights. This may have empowered women to feel
more positively about treatment and their contribution to the understanding of OUD.
Additionally, the findings support improvements for gender-specific care for women. By
receiving more individualized care, each woman can be supported to improve their
quality of life by remaining in treatment. Other women may be attracted to treatment; if
they are aware of the practices that have been implemented to support them. For example,
if women have resources that support their mental health, like counseling, at the place
where they receive MMT, women may be more likely to experience positive outcomes.
Practices that facilitate women’s self-determination may improve their ability to enter
and remain in treatment. As well, women may benefit from having their treatment facility
implement more family-centered treatment. Including family and close friends in
treatment may facilitate better understanding and support from them. This action may
broaden the much-needed support system of women with OUD, who choose methadone
as treatment.
Individual healthcare providers, healthcare organizations, and CPS will benefit
from positive social change based on the findings of this research. By reading and
understanding the implications of their behaviors towards women with OUD; these
individuals can self-reflect and provide appropriate support to women with OUD who are
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experiencing OUD. These individuals and organizations can review the findings of the
research and implement practice changes that support women with OUD, who have
children, and are accessing MMT. These changes can reduce stigma and fear of
healthcare providers and members of CPS. For example, providing reassurance and a
non-judgmental attitude towards women can foster a more collaborative relationship and
help women to continue on in treatment.
Organizations may benefit from positive social change related to the findings of
this research study. Organizations that care for individuals with OUD may benefit by
reviewing their policies and procedures that may create barriers for women with OUD.
Influencing change in organizations’ policies like hours of operation on weekends, access
to additional services on-site, and attitudes of staff may help to improve accessibility to
services. City organizations may benefit by understanding the importance of frequent and
reliable public transportation for individuals with OUD receiving MMT, even during
times of pandemics. The current COVID-19 pandemic continues, and access to care
should be a primary consideration for healthcare organizations and communities.
The impact of positive social change at the societal level can be incurred when
considering the improved outcomes of a healthier society. Society may be improved
when knowledge is gained regarding a highly stigmatized group. By presenting insights
from women themselves, knowledge can be gleaned of the struggles and barriers women
face; when trying to get into and succeed in recovery. Educating the public may help to
reduce the stigma experienced by women who have OUD and accessing MMT. As well,
the findings of this study shine a light on the barrier of cost of methadone treatment.

168
Although Canada has socialized healthcare, the lack of access to free medication as part
of healthcare presents barriers to women getting help. This finding exposes a barrier to
health. It is a lack of access to medications based on income and private insurance. A
final societal implication for positive social change is the need to provide access and
support to women with OUD during a pandemic. The findings expose the need to change
the response to pandemics, specifically for women with OUD. The current study findings
can influence positive social change for societies and policies.
The findings of this study add to the body of qualitative researcher overall. It also
adds to the limited qualitative research on women with OUD who choose methadone as
their treatment of choice. This current research study is the only Canadian
phenomenological study on women’s experience with OUD accessing MMT. The study
adds to Canada’s body of knowledge on this growing epidemic. Although research in this
area is expanding, most of the research studies that were found on this topic were
quantitative. It can be difficult to gain access to vulnerable groups to participate in
research. Moreover, due to the personal nature of the phenomenological inquiry,
participation in research studies such as this can pose additional challenges. To access
women with OUD using MMT, who will discuss their sometimes painful and difficult
experiences is challenging; and makes the insights of this research that much more
poignant.
This study extends the use of self-care of chronic illness theory by Riegel et al.
(2012) to addiction studies. The conceptual model has been applied in other chronic
conditions, including heart failure (Jaarsma et al., 2013), diabetes (Ausili et al., 2017),
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and, more recently, eating disorders (Sitarz, 2020). However, this is the first study of its
kind to apply this theory to addiction, OUD. In the future, other types of SUD studies
may utilize this theory in their investigations.
Based on the findings from this study, practice recommendations can be made.
Nurses and other healthcare professionals need to be aware of the impact their attitudes
and interactions on women with OUD who are accessing treatment. Since negative
attitudes deter women from accessing treatment and positive interactions made women
feel supported, nurses need to ensure a positive approach to these women. By improving
attitudes and interactions, nurses can help to improve women’s methadone treatment
experiences. Nursing assessments should include such areas as self-determination and
accessibility to facilitate women receiving treatment. Practice changes should also
involve the inclusion of the women’s support systems in treatment interventions. By
including supportive others in women’s OUD care, families and friends can develop
knowledge to adequately support them. Knowledge can also be supported by nursing
student education. Nursing education should include a robust mental health and
addictions curriculum. More knowledgeable nursing students will eventually become
nurses who understand OUD and can act as future advocates for women’s OUD care.
Conclusions
This phenomenological study focused on women’s experiences with treatment for
OUD in a Canadian context. Seven women provided their thoughts and experiences on
accessing methadone treatment for OUD and how this affected them and those around
them. The influence of their families, friends, significant others, and children have been
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discussed in detail, exposing personal feelings. Women offered their thoughts on how to
support women in treatment and their experiences, both positive and negative, with
MMT, including interactions with healthcare professionals. Perceptions of community
organizations, healthcare providers, and accessing treatment were exposed. Woman’s’
path to methadone treatment, including the breaking point at which women were faced
with treatment, as the best or only option, was revealed. Finally, women expressed a
strong personal conviction leading them to make the decision of treatment and continue
the path of methadone, which I termed self-determination.
To date, researchers have not adequately examined the experiences of this
population in terms of perceptions of their experiences in methadone treatment in
Canada. These insights can support healthcare providers, organizations, and society; to
improve care for Canadian women who are accessing methadone treatment. Nurses and
other healthcare providers can use the findings of this research to positively influence the
experiences of women with OUD who are in MMT, and support them to continue their
lifelong recovery process.
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Appendix: Interview Guide
Central Research Question: What are the lived experiences of Canadian women with opioid use disorder who
choose methadone for treatment?
Main Questions
Potential Follow
Conceptual Framework
Research Question
Up/Focus Questions
Element Alignment
Purpose Alignment
Demographic Questions:
Establishing
How old are you?
demographic data to
Do you work? What type of
compare other
work do you do?
populations or
Where do you live?
samples.
Do you have anyone living
with you?
Do you have a significant
other? Are you married,
divorced, common-law,
widower?
Do you have any children
living with you?
Do you have any children who
don’t?
Please tell me about yourself.
Reflection is an essential
Open dialogue for
aspect of all concepts within
participant to begin
the Self-Care of Chronic
sharing personal
Illness Theory (Riegel,
information related to
Jaarsma & Stromberg, 2012).
the phenomenon.
Please tell me about your
experience of first using
opioids.

Can you describe a typical day
in your life when you were
struggling with using opioids?

What did that
experience mean to
you?
Were there others who
influenced your
experience?

Reflection is an essential
component to the definition of
self-care and is also an
important element in the
concepts of self-care
maintenance, monitoring and
management (Riegel, Jaarsma
& Stromberg, 2012)
Self-care is a daily activity
that involves maintenance,
monitoring and management
with chronic illness (Riegel,
Jaarsma & Stromberg, 2012).

Contributes to our
understanding of the
participants
individual lived
experience of this
phenomenon.
Contributes to CRQ
Provides greater
depth of
understanding of the
individuals lived
experience.
Contributes to CRQ

What life events if any
influenced your
decision to use
opioids?
What led you to methadone
treatment?

Decision making in response
to signs and symptoms is an
essential aspect of self-care in
chronic illness. Self-care
monitoring of physical and
cognitive changes leads to the
response of decision making
about taking action (Riegel,
Jaarsma & Stromberg, 2012).

Establishes
understanding of the
development of
chronicity of
addiction in this
context.
Contributes to CRQ
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What was the experience like
receiving methadone treatment
for the first time?

Was there a specific
event or series of
events? Can you tell
me more about that?
In what way, if any, do
your relationships
impact treatment?

Please describe your
experiences in the healthcare
system.

Was there
anyone/anything who
encouraged you to get
help? Prevented you
from getting help?
Were there any factors
that influenced your
experience?
Please describe your
experiences in the
healthcare system.

How does methadone treatment
affect your life?

What was it like to
access methadone?
How has this affected
you and your
family/relationships?

What was it like to receive a
diagnosis of opioid use
disorder (opioid addiction)?

How did healthcare
professionals influence
your experience?
How did it affect you
positively and/or
negatively?

What is it like being a woman
on methadone?

What did it mean to
you?
What should people
know about being a
woman on methadone?

How would you describe a
typical day for you when you
receive treatment?

Self-care management
involves treatment decisions
in response to signs and
symptoms. It also requires
attention to the effectiveness
of the treatment and
determination of the success
of the approach and if it
should be repeated. Support
from others is factor affecting
self-care of chronic illness
(Riegel, Jaarsma &
Stromberg, 2012).

Establishes
understanding of the
unique experience of
the phenomenon.

Access to healthcare
influences self-care in
chronic. Lack of access leads
individuals to seek guidance
from less qualified others
including friends, neighbors
and parented. This can lead to
poor health (Riegel, Jaarsma
& Stromberg, 2012).
Adherence to therapy is
influenced by healthcare
providers and is associated
with evidenced based care
and therefore, the best
outcomes (Riegel, Jaarsma &
Stromberg, 2012)

Establishes our
understanding of the
experience of
receiving care in a
Canadian context.

Self-care management
involves evaluation of
changes and how to respond.
In self-care monitoring,
recognizing an emotional
change occurs with personal
insight and interpersonal
awareness (Riegel, Jaarsma &
Stromberg, 2012)
Self-reflection involving
awareness and insight
influences all concepts within
the framework (Riegel,
Jaarsma & Stromberg, 2012).

Establishing the context of
chronic illness self-care
involves daily processes of
self-care monitoring
maintenance and management
(Riegel, Jaarsma &
Stromberg, 2012).

Contributes to CRQ

Contributes to CRQ

Establishes chronic
illness and/or nursing
contexts
Contributes to CRQ

Establishes
understanding of the
unique experience of
women with OUD.
Contributes to the
CRQ
Contributes to our
understanding of the
lived experience of
receiving daily
treatment in the
community for OUD.
Contributes to CRQ
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Do the attitudes of other affect
your experience when
receiving treatment?

Is there anyone who
helps you? In what
way do they help you?
In your opinion, what
needs to be added or
changed to help
women in treatment?

Support from others directly
influences all concepts within
self-care including
monitoring, management and
maintenance (Riegel, Jaarsma
& Stromberg, 2012).

What supports are in place to
help you stay in treatment?
What supports do you need to
stay in treatment?

What makes receiving
treatment more
difficult? What makes
receiving treatment
easier?

In self-care management,
treatment implementation and
evaluation occur. Treatment
often involves consultation
with a healthcare provider.
Evaluation of the treatment
approach can lead to
repetition and adherence to
the treatment. A personal
cost-benefit analysis can
influence an individual’s
decision related to treatment
(Riegel, Jaarsma &
Stromberg, 2012)
Support from others directly
influences all concepts within
self-care including
monitoring, management and
maintenance (Riegel, Jaarsma
& Stromberg, 2012).

Some people find that
issues like: Food,
finance, travel,
childcare can make
getting treatment
difficult. Do you find
that?
What supports do you see that
other people need to get into/
keep coming to treatment?
In a perfect situation, what
would be in place to help
women get methadone
treatment?
Is there anything that I have not
asked that you think that I
should know?

If yes, what are their
attitudes and how do
they affect you?

Contributes to our
understanding of
contributing factors
associated with
experiences of
treatment.
Contributes to CRQ
Establishes the
concepts of nursing
care and chronic
illness care within the
community.
Contributes to CRQ

Establishes the
concepts of nursing
care and chronic
illness care within the
community.
Contributes to CRQ

Reflection is an essential
component to self-care of
chronic illness (Riegel,
Jaarsma & Stromberg, 2012).

Providing the
opportunity for
participants to
address any thoughts
or ideas related to the
experience that have
not been addressed in
the questions asked.
Contributes to CRQ
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Figure A1
Reflection Sufficiency and Decision-Making Self-Care

The relationship of decision-making and reflection on self-care. Reflection
promotes knowledge development and helps to determine the quality and effectiveness of
self-care. when individuals make decisions, they can be sufficient or insufficient,
purposeful or unintentional, reasoned and reflective, or automatic and unobservant. The
goal is reflective sufficient self-care.
Combinations of self-care and reflection are illustrated by Riegel, Jaarsma and
Stromberg, 2012 A middle-range theory of self-care of chronic illness. Advances in
Nursing Science, 35(3), 194-204. doi: 10.1097/ANS.0b013e318261b1ba.

